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RNA binding proteins play a crucial role in normal cellular functions.  However, 
little work has been successful in developing a code of recognition that may be exploited 
for the creation of novel RNA binding proteins.  Research presented here has attempted 
to discern applicable specificity rules of the most commonly found RNA binding motif, 
the ribonucleoprotein (RNP) domain.  
I have employed in vitro selection to facilitate this, as it has been utilized in the 
past to discover the natural binding sequences of nucleic acid binding proteins.  The 
process of in vitro selection results in the evolution of nucleic acid binding species, or 
aptamers.  In order to perform these experiments within the span of my graduate career, I 
have developed an automated robotic workstation that is capable of performing in vitro 
selection.   
I have performed experiments that validate this automated system, and have 
further confirmed that it can successfully generate aptamers to protein targets possessing 
high specificity and affinity to their protein ligand.  Moreover, this automated selection 
 vii
system has been able to recapitulate the natural sequence and structural specificity of the 
RNP-containing protein target used as a model system here, U1A.  This evolutionarily 
conserved spliceosomal protein is chosen due to the extensive amount of biochemical and 
structural data available regarding binding to its cognate RNA. 
Twenty-one in vitro selection experiments have been executed in an automated 
manner against U1A point mutants.  The results of these selections suggest that in vitro 
selection can be used as a tool by which determinants of specificity may be elucidated.  
Additionally, these selections have uncovered new information regarding U1A cognate 
specificity and affinity not currently known to the community. 
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Chapter 1:  Introduction 
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS  (HNRNPS) 
Proteomic modulation of a cell is chiefly organized by protein interactions upon 
the ribonome[1, 2], a grouping of RNA elements and motifs that are evolutionarily 
conserved throughout eukaryotes[3].  These motifs are specifically bound by nucleic acid 
binding proteins for the purpose of regulating certain essential processes such as message 
capping[4], polyadenylation[5], regulation of intron splicing[6], exportation of message 
to the cytoplasm[7], etc.  The mechanism of specific recognition of RNA binding 
proteins on their ligands has undergone much investigation[8].   
Many ribonomic interactions are carried out by single-stranded RNA recognition 
proteins.  These proteins are generally referred to as heterogeneous nuclear 
ribonucleoproteins (hnRNPs).  The ultimate fate of mRNAs is largely governed by 
hnRNPs.  This class of proteins has been shown to control intron splicing in the nucleus, 
as in the case of hnRNP A1[9, 10].  Transport of messages through the nucleus into the 
cytoplasm is often regulated by hnRNPs, as in the example of the NPL3 gene product in 
yeast[11, 12].  Localization of messages are also controlled by this nucleic acid binding 
class, like the hnRNP I protein[13].  In fact, mRNA localization plays a pivotal role in 
developmental biology often providing cellular polarity[13, 14].  Translation of messages 
is sometimes prevented by hnRNP association[15], and this inhibition mechanism is one 
of many natural anti-viral cellular defenses[16, 17].  Stability of transcribed messages is 
managed by hnRNPs in some cases[18].  For instance, hnRNP D has been demonstrated 





There are several types of hnRNPs based upon the class of RNA binding element 
they possess.  These proteins typically contain domains containing one or more (usually 
more) small RNA-binding elements (~ 20 – 100 amino acids, typically) that also tend to 
be conserved throughout eukaryotes.  Some examples are the ARM (arginine-rich motif), 
the KH domain, the RGG (Arg-Gly-Gly) box, OB-folds and the RNP domain[21, 22].   
ARMs have little similarity to one another other than a simple preponderance of 
arginine residues which recognize the major groove of RNA helices[8]. The KH domain 
refers to protein domains with homology to hnRNP K, a domain that is conserved 
through prokaryotes as well as eukaryotes that binds to single-stranded RNA for control 
of splicing and translational effects[21].  RGG domain-containing proteins often 
associate with ribosomal components for promotion of messenger translation[23, 24].  
OB-fold domains are conserved by their secondary structure rather than by their primary 
residue sequence and bind a variety of single-stranded nucleic acids[25].   
RNP DOMAINS 
RNPs, or ribonucleoprotein domains, are also referred to as RBDs (RNA binding 
domains) and RRMs (RNA recognition motifs).  RNP-containing proteins are the most 
abundant type of RNA binding proteins in the cell, and are found in prokaryotes, fungi, 
plants, and animals[26].  They have the ability to bind nucleic acid with high affinity and 
specificity and often rely upon residues immediately N- or C-terminal of the domain for 
recognition specificity[21, 26].   
The RNP domain is defined by an evolutionarily conserved 8-mer sequence 
(referred to as RNP2) and 6-mer sequence (RNP1) that are typically separated by ~30 
residues [26].  The structure of the domain is highly conserved, and consists of a total of 
four β-strands and two α-helices (Figure 1-1) in the primary order β1-α1-β2-β3-α2-β4[21, 
26].  In general, RNA recognition is accomplished by the antiparallel β-sheet[27, 28].  
The two center β-strands of the sheet containing the RNP2 and RNP1 elements are 
structured so that aromatic residues on those elements are exposed into the solvent for 
hydrophobic stacking with RNA bases[26, 29, 30].  RNA sequence specificity is usually 
imparted by residues located near the N- or C-terminus, loop regions, or in the case of 
certain RNP-domain proteins, additional α-helices (e.g., U1A[31]) or β-strands (e.g., 
polypyrimidine tract binding protein[32]). 
 
Figure 1-1. The RNP domain.  Shown is a three-dimensional rendering of an RNP 
domain.  The binding domain consists of four antiparallel β-strands (diagrammed as 
arrows) adjacent to two α-helices.  The evolutionarily conserved RNP1 (on β3) and 
RNP2 (on β1) elements are highlighted in orange.   
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The structure of the RNP domain has been extensively studied in many RNA 
binding proteins[30, 33-35].  This body of knowledge can serve as a foundation upon 
which mutations to RNP domains might be made in order to alter the binding specificity 
of the protein.  Such ability facilitates the production of ‘designer’ RNA binding proteins 
that would be capable of regulating cellular processes in concerted, directed manners.   
DESIGNER NUCLEIC ACID BINDING PROTEINS 
 Some designed nucleic acid binding proteins already exist, and significant strides 
have been made in their design and modifications to alter specificity.  A remarkable 
example is the zinc-finger class of proteins.  These zinc-dependent transcription factors 
have been designed with mutations to be used as tools to activate genes, repress genes, 
chemically modify DNA, modify chromatin, integrate exogenous material into existing 
DNA, and to perform many other modifications and screening assays[36]. 
 Investigations have produced designed nucleic acid binding proteins other than 
zinc-finger proteins, such as homeodomain protein α2 and a DNA methyltransferase. 
Examples of how these proteins have been rationally altered are provided below.  
Regardless, the majority of engineered complexes have been exclusive to DNA binding 
proteins.  While few designed RNA binding proteins exist in the literature, a pertinent 
example of a designed RNA binding element is also provided.  In short, the design of a 
zinc-finger element specific for HIV RNA is known to inhibit its replication. 
Homeodomain protein α2 
The yeast homeodomain protein α2 has been mutated at a specific residue in order 
to bind a mutated binding site preferentially over wildtype.  In one instance, researchers 
instituted a mutation (S50K) of the homeodomain which altered the specificity of the 
second nucleotide from adenosine to guanosine, and the third nucleotide from thymidine 
 5
to guanosine[37].  This change allowed the mutated homeodomain to bind its ‘new’ 
nucleic acid target sequence roughly four-fold better than the original wildtype sequence. 
 EcoRV DNA Methyltransferase 
In another instance, a change in the specificity of EcoRV DNA methyltransferase 
was rationally designed based on structural considerations[38].  The methyltransferase 
normally recognizes the palindrome 5’-GATATC-3’ and methylates the first adenosine at 
N6.  The native enzyme also has a modest ability to methylate cytosine at N4 when 
encountering a CT mismatch at the same position (GCTATC with the reverse 
complement of GATATC).   
Based on the structure of the enzyme, the researchers engineered a substitution 
(L16K) which sterically blocked adenosine binding to the active site and resulted in an 
enzyme variant with a 22-fold preference for cytosine over adenosine.  Continuing their 
progress, they introduced a second steric impediment (Y196W) to adenosine binding.  
This double mutant enzyme could now fully discriminate between adenosine and 
cytosine (i.e., there was no detectable methylation of adenosine).   
Zinc-finger proteins 
Researchers have previously engineered 16 individual zinc-finger proteins to 
specifically recognize the 16 variants of the sequence 5’-GNN-3’.  Phage-display 
selections were first performed before applying rational design-based changes to the 
evolved constructs.  In one example, changing the -1 position of the second zinc-finger 
helix would generate simple changes in specificity.  For example, switching a threonine 
at position -1 for aspartate changed the recognition specificity from thymidine to 
cytosine[39]. 
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More recently, the same research group continued their efforts and modularly 
constructed an amazing 80 distinct and novel zinc-finger proteins, each possessing high 
specificity for a new, individual 9-mer recognition sequence[40].  The investigators were 
able to generate empirical rules such as target site overlap of an aspartate residue in 
position 2 of one of the zinc-finger α-helices elicits contact with only extracyclic amine 
groups (i.e., cytosine and adenosine).  Another finding illustrated that an arginine residue 
at position 2 specifically interacted with guanosine, unless arginine appeared in position 3 
as well.  In this case, specificity was shifted from guanosine to adenosine. 
Such designed elements have even been successfully ‘grafted’ onto other proteins.  
For instance, a rational, structure based approach was used to design a zinc-finger to bind 
to the Rev response element (RRE) of HIV-1, normally bound by the Rev protein.  The 
arginine-rich motif (ARM) portion of the Rev protein that specifically interacts with the 
RRE was then replaced by the engineered zinc-finger domain.  It was demonstrated that 
this new Rev construct with the zinc-finger specifically bound the RRE in a zinc-
dependent manner[41]. 
Another research group has taken an approach very similar to this by designing 
various zinc-finger proteins that recognize different HIV-1 sequences.  They then 
attached these fingers to a potent repressor domain (Kruppel-associated box repressor 
domain KOX1).  In the best example, using zinc-finger domains that bound to the 5’ LTR 
promoter obscured Sp1 sites as well as the TATA box.  This resulted in a reduction of 
HIV-1 replication by 75%[42]. 
IN VITRO SELECTION AS A SPECIFICITY PROBING TOOL 
Very little work has been successful in imparting novel and specific functional 
changes to RNA binding proteins, especially RNP-domain proteins.  This can be 
attributed to the complexity created by the extensive network of intraprotein interactions 
that tend to cause a global deformation of structure when individual residues are 
altered[43].  Because of this, there is currently not enough empirical data with which 
binding rules may be extrapolated.  
I have attempted to determine binding rules of an RNP-domain (see below) using 
in vitro selection (Figure 1-2).  In vitro selection imitates evolution by assaying a 
population of nucleic acids for ‘fitness’ of binding to a given target.  Those nucleic acids 

















Figure 1-2.  Simplified scheme of in vitro RNA selection.  This schematic depicts a 
simplified flowchart of in vitro selection for RNA aptamer generation.   A random RNA 
pool containing ~1013 – 1015 unique individual sequences is incubated with a target 
(upper left corner).  The pool / target complex is washed in order to remove low-affinity 
nucleic acid.  Next, high-affinity RNA is eluted from the target and reversed transcribed 
to produce template for a PCR reaction.  The product of the PCR reaction is subsequently 
used as template for a transcription reaction to generate the newly winnowed random 
pool.  This lower diversity pool is then incubated with a new aliquot of the selection 
target, and the selection cycle begins again.  Low-affinity RNAs are illustrated in a thin 
blue line; high-affinity aptamers are shown by a thick blue line.  RNA is indicated by 
blue lines; DNA is indicated by red lines. 
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that can bind specifically and/or tightly are amplified.  These binding ‘species’ are called 
aptamers and are comparable to antibodies in their affinity and specificity of binding to 
their ligands[44].  A target can be a variety of chemical species including, but not limited 
to, ions[45], small molecules[46], peptides[47], proteins[48], membranes[49], cells[50], 
and organisms[51].  The process of in vitro selection of RNA aptamers, first reported by 
two separate research groups in 1990[52, 53], can also be used to generate therapeutic 
compounds[54-56]. 
In vitro selection has been employed by others to elucidate the natural sequence 
specificity of nucleic acid binding proteins.  Aptamer selection has determined the DNA 
binding elements of the methionine repressor (MetJ) of E. coli[57], the specificity 
determinants of MS2 coat protein[58], and the wildtype binding element of SelB, an 
elongation factor of E. coli that facilitates the incorporation of selenocysteine at opal 
codons[59].  In same cases, in vitro selection has yielded aptamers that bind a protein 
better than the wildtype nucleic acid sequence[60].  
I have attempted to use in vitro selection as a tool whereby we can elucidate clear 
binding rules for RNP domain : RNA interactions.  Here, I have chosen the RNP domain 
of the human spliceosomal protein U1A.  I have investigated specificity of ligand binding 
to U1A by performing in vitro selection on 21 point mutants of U1A in an automated 
fashion (Chapter 6).  The point mutations have been chosen based upon experimental and 
hypothetical evidence (refer to Chapter 6).   
U1A AS A MODEL SYSTEM 
U1A is an excellent candidate as a model complex for elucidating intricate nucleic 
acid : protein interactions via in vitro selection techniques.  U1A is a member of the U1 
small nuclear RNPs (snRNPs), a component of the nuclear spliceosome that participates 
in processing of pre-mRNA splicing[61].  The first 96-100 amino acids of U1A are 
responsible for binding hairpin II of U1 snRNA in the splicing complex as well as the 3’ 






























































Figure 1-3.  Natural U1A binding elements.  The left structural element is the U1 snRNA 
hairpin II; the right structural element is the 3’-UTR of U1 mRNA.  The heptamer 
sequence critical for recognition by U1A is highlighted in a black bar.  The 3’-UTR of 
U1 mRNA contains a second heptamer sequence (Box I) that contains a base change 
(AUUGUAC) at the fifth nucleotide.   
These two nucleic acid structures present a single-stranded nucleotide sequence, 
allowing U1A to contact a run of seven nucleotides that it possesses exquisite specificity 
for.  Its N-terminal portion contains two highly conserved ribonucleoprotein (RNP) 
domains and has been shown to maintain the binding characteristics and sequence 
specificity of the full-length protein[64, 65].  The structures of U1A bound to its cognate 
RNAs have been solved and refined (Figure 1-4)[29, 35, 66-70].   
Most importantly, U1A has previously been targeted by both manual and 
automated selection experiments[71, 72], of which the automated selection is presented 
in Chapter 5.  These selections, in particular my contemporary automated selection, 
 9
 10
illustrated the wildtype sequence specificity of U1A, as well as demonstrating the 
structures of both the U1 snRNA hairpin II and the 3’-UTR of U1A exemplifying the use 
of in vitro selection as a specificity- and structure-mapping tool[71].   
Because U1A is so well studied and characterized, several mutations of the 
protein or the RNA have been constructed in order to potentially map rules of amino acid 
: nucleotide interactions for RNP domains[26, 29, 43, 62, 64, 65, 70, 73-75].  Despite 
this, little progress has thus far been made in actually exposing the natural laws involved 
in RNP domain : RNA interactions, even within U1A.  This is untrue for other nucleic 
acid binding domains, as described above.  Recall that zinc-finger DNA binding domains 
have a straightforward nucleotide : amino acid interaction set and can be rationally 
designed to bind new specific DNA sequences[36, 39, 40].   
Initial efforts in this field have garnered the ability to swap the specificity of U1A 
for that of a homolog, U2B”.  This homolog possesses 75% of the identical primary 
structure of U1A and recognizes hairpin IV of U2 snRNP which differs from hairpin II of 
U1 snRNP by only a few nucleotides and only by one nucleotide in the canonical 
heptamer recognition sequence[31, 76].  Performing a swap of the non-conserved region 
linking the RNP2 and RNP1 segments did permit a respective swap in specificity, but 
still did not illuminate how specificity recognition might be encoded into the protein[77]. 
RNP domains, and U1A in particular, have a large amount of hydrogen bonding 
and van der Waals contacts, which would typically suggest that the single-stranded bases 
confer most of the specificity seen in U1A[26].  However, thus far, lock-and-key 
approaches have failed to identify nucleic acid : amino acid interaction rules that survive 
experimental examination.  For example, five of the seven bases in the heptamer 







Figure 1-4.  The RNP domain of U1A bound to U1 snRNA stem II.  This rendering is 
derived from the crystal structure by Oubridge et al.[35].  Shown are the first 96 residues 
of U1A that comprise its RNP domain.  The domain is bound to one of its two ligands, 
hairpin II of U1 snRNA. The RNP domain is green with the conserved RNP2 and RNP1 
elements highlighted in orange.  The RNA loop is blue, and base identity is indicated by 
white letters.  U1A has high specificity for the first seven bases of the loop (AUUGCAC) 




  In fact, it has been shown that a C45G mutation in the hairpin II U1 snRNA 
receives only a humble increase in Kd[65].  This is especially notable considering the fact 
that structural studies demonstrate that a purine would not fit in place of the C45; 
additionally, C45 is the nucleotide of the heptamer sequence that differ between hairpin II 
U1 snRNA and hairpin IV U2 snRNA[70]. 
Rather than these interactions participating in a uncomplicated one-to-one 
participation set, it seems that the mechanism of discrimination is a mutually induced-fit 
mechanism that functions as a cooperative network[31, 43]. Both the RNA and protein 
are relatively unstructured in their uncomplexed forms and appear to scaffold each 
other[8, 31, 43].  Viewing nucleotide : amino acid interactions as participating in a 
cooperative network explicates how individual mutations often have sweeping, 
unpredictable effects[8].  This network is likely not instituted solely by hydrogen 
bonding; it seems that packing of non-polar residues also contribute to the establishment 
of specificity[8, 62, 70].   
The elucidation of binding rules concerning RNPs will make rational design of 
RNA binding proteins approachable.  As stated above, rational design has been 
successfully used to create new nucleic acid binding proteins after domain binding rules 
were determined.  Revealing rules applicable to rational design efforts will open up this 
largest class of RNA binding proteins to design manipulation.  Automated in vitro 
selection techniques are an obvious method for this investigation.  Binding rules can be 
extrapolated from in vitro selections against proteins with mutations in residues that 




The elucidation of binding rules concerning RNPs will make rational design of 
RNA binding proteins approachable.  As stated above, rational design has been 
successfully used to create new nucleic acid binding proteins after domain binding rules 
were determined.  The utility of such ‘designer’ proteins has been detailed above, but can 
also be applied toward therapeutics to treat diseases derived from erroneous message 
splicing[79].  Revealing rules applicable to rational design efforts will open up this 
largest class of RNA binding proteins to designed manipulation.  Thus, in vitro selection 
techniques are an obvious method for this investigation.  Binding rules can be 
extrapolated from in vitro selections against proteins with mutations in residues that 
participate in the cooperative hydrogen-bond or hydrophobic stacking network.  
In order to perform the several in vitro selection experiments that are required of a 
project this size, an automated in vitro selection system has been created (Chapter 2).  
This system has been proofed with simple targets (Chapter 3) and further modified for 
selection against protein and RNA binding proteins (Chapter 4).  The system has been 
further verified by successful selection of wildtype U1A (Chapter 5) before the selection 
of the mutant U1A proteins (Chapter 6). 
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Chapter 2:  High throughput in vitro selection 
INTRODUCTION 
Laboratory-based automation of experimental procedures is an increasingly 
principal component of modern science.  The fields of genomics, proteomics, 
metabolomics, and combinatorial chemistry deal with so many individual molecules and 
conditions such that experiments can be daunting or intractable to perform without 
mechanization. 
Initial forays into laboratory automation gave way to robotically performed 
procedures that can replace the repetitive and laborious practices of common 
experimental methods such as microarray creation and processing, plasmid purification, 
and PCR or DNA sequencing reactions[80-87].  More recently, the integration of these 
individual procedures into fully automated experimental conduits has facilitated the 
execution of large-scale projects.  These include projects such as automated protein 
crystallization and analysis[88], mass spectroscopy for protein-ligand interactions[89], 
expression of soluble recombinant proteins[90], mammalian cell-line propagation and 
preparation[91] and the sequencing of the human genome[92, 93]. 
As laboratory robotics become more modular and pervasive in common research 
settings, it is likely that molecular and cellular biology labs will possess robust robotic 
platforms that tend to lengthy and repetitive tasks while in exchange providing the end-
user with more analysis and management time.  For instance, scientists have recently 
married artificial, computational logic algorithms with a specific task-performing robotic 
platform in order to create the first rudimentary robotic scientist[94].  This automated 
researcher devises hypotheses based upon observations, designs simple experiments and 
then tests and refines the hypotheses.  Future development of such ‘robotic researchers’ 
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will in essence transform each individual researcher into their own principle investigator.  
Dedicated robotic platforms will ensure the continuity of research by maintaining the 
execution of experiments during times of manuscript preparation, grant writing, studying 
for examinations and qualifications, illness, vacation, sleep, etc. 
In addition to providing an immense increase in throughput, robotic research 
platforms also outperform human researchers in their consistency of repetitive tasks.  
Applying this consistency to idiosyncratic procedures such as in vitro selection obviates 
questions arising from variations in selection procedure seen between individuals and 
laboratories.   For instance, in vitro selection experiments have been used in the past to 
probe proteins for their natural sequence binding substrate[53, 57, 58, 60, 72, 95].  When 
pursuing these evolutionary questions, it remains unclear how uniform and relevant the 
results are when manual selections are executed differently on both an individual and 
laboratory basis.  The automation of this largely varied process provides an additional 
advantage that can confer the ability to yield reproducible benchmarks and allow results 
from different selections to be combined and analyzed with higher confidence. 
To this end, we developed fully automated in vitro selection chemistries and 
protocols on a laboratory robotic platform.  Initially, isothermal (“continuous”) 
amplification was employed before the evolution of molecular parasites specific to this 
method of amplification.  We then switched to standard in vitro (“discontinuous”) 
amplification in order to prevent replication ‘monsters’ from usurping the selections.  As 
our experience progressed both in adaptation and target complexity, we continuously 
refined the hardware, software, and chemistries employed on the robotic platform.  Major 
revisions to the selection protocols are summarized in Table 2-1 and are discussed in 
more detail below. 
 
RESULTS AND DISCUSSION 
Adaptation of bench chemistries 
 While the individual steps performed in a manual selection are largely straight-
forward, certain procedures were exceedingly technically difficult and/or expensive to 
implement on a non-institute scale robotics platform.  Most notably is the routine gel 
purification and ethanol precipitation of binding species performed during manual 
selection steps.  At the beginning of this body of work, there existed very few feasible 
methods whereby nucleic acids could be quickly and easily purified wholly in an 
automated fashion.  At that time, 96- or 384-well nucleic acid purification plates were 
rare and prohibitively expensive, and the hardware and software integration of a 
centrifuge for on-robot ethanol purification or a camera and arm system for on-robot gel 
purification and excision was physically impossible on our robotics platform.   
Primer and pool design for robotic selections 
Because of the above, we initially chose to avoid nucleic acid purification entirely 
and instead focused on enhancing the amplification chemistry to maximize the 
amplification of binding species while minimizing the evolution or amplification of any 
other products.  Accordingly, we initially chose to use the random sequence pool N30 
(Figure 2-1).  This pool had been used successfully in the past for several types of protein 
targets[96, 97].   
 
Figure 2-1.  The N30 pool.  Capitalized residues represent bases transcribed into the 
RNA pool; lower case bases represent priming sequences.  The 41.30 primer incorporates 
a T7 RNA polymerase promoter (gataatacgactcactata).  Restriction endonuclease 




A unique property of this pool is that it had been designed with ‘weak’ 3’ ends, 
contrary to traditional primer design.  Usually, references designate the design of primer 
ends with S bases, such as …GGC, etc., to increase the efficiency of priming[98]. 
This strategy of poorly hybridizing 3’ clamps (SWW ends) has been previously 
shown to facilitate ‘infinite amplification’ of PCR products without generation of higher 
molecular mass amplicons that is usually seen with serially-cycled nucleic acid amplified 
with typical WSS clamps[99].  The application of this approach is important since mass-
based purification of amplifying species does occur on the robotic system.  It becomes 
more critical considering that the extent of or even success of amplification goes 
unmonitored.  This causes the amount of template used for each round of selection and 
amplification to vary.  Despite that the number of PCR cycles is a static value with 
fluctuating amounts of template as a given selection progresses, we rarely observe 
alternative products, even after 24 rounds of selection.  
The importance of weak clamping primers for robotic in vitro selection is best 
illustrated with selections attempted with the random sequence pool, K30.  The K30 pool 
was created by former student Kristin Marshall[100], and is essentially the inverse or 
opposite of the N30 pool.  That is, all pyrimidines had been replaced with purines and 
vice-versa (A→T, T→A, G→C, and C→G) with the exception of the T7 promoter 
sequence, which remained unaltered[101].  The main effect is that the primers now 
possessed the traditional strong 3’ clamps often utilized in routine PCR amplification.  
When used as the native starting pool for automated in vitro selection, the K30 pool was 
seen to generate higher molecular weight species[102].  During the course of an 
automated selection, these higher-massed amplicons would become the dominating 
species (Figure 2-2).  
 
 
Figure 2-2.  Effect of strong and weak primer clamps in automated in vitro selection.  
Robotic selections were performed against lysozyme with the K30 and N30 pools under 
identical conditions.  Twelve rounds of selection with the K30 pool evolve a higher 
molecular weight species that predominates the selection, seen in both the reverse 
transcription/PCR reaction (RT/PCR) and transcription reaction (TXN).  On the contrary, 
higher mass amplicons do not evolve after eighteen rounds of selection with the N30 
pool. 
Additionally, I have synthesized a second ‘robot-friendly’ random nucleic acid 
pool, R50.  This pool follows many of the design elements of the N30 pool, including 
weak 3’ primer clamps, a decreasing ∆G towards the 3’ end, obviation of primer dimers 
and internally stable stem-loops, etc[103].   This pool contains a string of 50 random 
nucleotides surrounded by static priming sequences (Figure 2-3).  R50 was created to 
execute robotic selection against targets which may naturally bind specific nucleic acid 
structures requiring more nucleotides, such as G-quartet structures[104, 105].  Thus far, 
the R50 pool has been successfully used by student Carlos Garcia to generate aptamers to 







Figure 2-3.  The R50 pool.  Capitalized residues represent bases transcribed into the RNA 
pool; lower case bases represent priming sequences.  The 41.30 primer incorporates a T7 
RNA polymerase promoter (gataatacgactcactata).   
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Robotic partitioning of binding species 
The most significant step in in vitro selection is the actual partitioning of the non-
binding individuals of the random pool from those species which specifically bind the 
target of interest (refer to Chapter 1).  There are several published methods for 
implementing the physical partitioning[106-108].  Often, a protein target is 
nonspecifically immobilized to a nitrocellulose membrane.  Binding species are retained 
on top of the membrane bound to the protein, while the non-binding species are washed 
through the protein.  Binding species are then eluted under denaturing conditions while 
boiling the filter[108].  Another popular method is to immobilize the target of interest to 
an agarose bead column.  Again, individuals binding nonspecifically are removed by 
vigorous washing of the column, and high affinity / high specificity binders are amplified 
after denaturant elution or affinity elution of the column[109].   
Initially, partitioning occurred by attaching a biotinylated target of interest to 
streptavidin-coated paramagnetic beads, which were washed several times with a wash 
buffer.  The beads were manipulated in a magnetic particle separator with a computer-
controlled magnet[110].  In the ‘down’ position, the magnets are physically far from the 
microwells, allowing the robot to easily mix the wash buffer / bead slurry.  In the ‘up’ 
position, magnets rise to contact the microplate and pull the beads and bound species to 
the edge of each microwell.  At that point, the liquid transfer workstation slowly aspirates 
the wash buffer containing non-binders or weak binders and discards it, proceeding to 
another wash cycle step or nucleic acid amplification.  This procedure worked well for 
the ‘proof of principle’ selections against nucleobase polymers, detailed in Chapter 3. 
However, simple bead-washing protocols appeared to lack the ability to impart a 
high enough wash stringency for certain positively charged targets.  Selections against 
positively charged protein targets would be unable to significantly winnow the population 
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of the random pool even after extensive buffer washing, most notably in the case of the 
tyrosyl-tRNA synthetase CYT-18 (whose selection is described in detail in Chapter 4).  It 
has been demonstrated in manual selections that filter-based partitioning imparts 
separation of binding from non-binding species more efficiently than bead washing[107].  
For instance, it is easy to envision a lower affinity aptamer dissociating from its ligand 
and quickly being washed away through the vacuum membrane.  In contrast, a lower 
affinity aptamer had greater than 20x the amount of time in which to reassociate its 
ligand in the simple bead washing protocol.  Wash buffer flows through the vacuum 
membrane in a few seconds, whereas mechanical mixing of the beads by aspiration and 
dispensing followed by a short incubation for the beads to move toward the magnet 
requires more than one minute. 
 Thus, we changed the actual selection step from simple bead washing to a 
combination of bead washing and partitioning on a filter membrane.  We believe that this 
also confers an advantage, in that species that specifically bind the filter are retained on 
the filter and not amplified.  In this fashion, automated selection ought to be much less 
prone to accretion of filter binding species than its manual selection counterpart.  
To carry this out, we integrated a commercially available vacuum manifold 
system on the robotic worksurface and integrated to a computer controlled vacuum valve.  
Initially, we used nitrocellulose and modified-nitrocellulose membranes, since we knew 
these to possess low nucleic acid affinity.  However, because nitrocellulose has intrinsic 
protein binding effects, it was difficult to mechanically render the beads and the bound 
species off the nitrocellulose solution for amplification.  We instead implemented the use 
of a low protein binding PVDF membrane which facilitates easier bead manipulation on 
the membrane surface by the robotic platform. 
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We then made further alterations to the beads-on-membranes wash protocol in 
order to recover the highest affinity binding species.  At first, the robotics platform would 
elute aptamers from the ligands by heat denaturation in a thermalcycler.  Next, it would 
transfer the beads to the magnetic particle separator in order to pipette off the aptamer-
containing supernatant.  Because the liquid transfer and magnetic manipulations require 
roughly 45 seconds, the heated bead solution cools down to room temperature during that 
duration and some of the highest affinity aptamers reassociated to the ligand.  To 
overcome this phenomenon, we elute bound binding species during the heat denaturation 
step of the RT-PCR reaction.  The amplification of bead-bound nucleic acid in PCR 
reactions has been previously described[111, 112], and in this manner we ensure that all 
species bound to the immobilized bead target are placed in the RT-PCR reaction.    
Chemical adaptations 
At the start of this project, the amplification and cycling conditions of the N30 
pool had already been highly optimized by former post-doctoral fellow Rick Conrad and 
graduate student Sulay Jhaveri.  Those conditions were the starting point for the creation 
of the robotic amplification buffers, with the exception of the initial buffers used for 
isothermal amplification (see below).  Isothermal amplification buffers were based on a 
previously published continuous amplification system[113]. 
A reverse-transcriptase coupled PCR reaction (RT/PCR) buffer was created by 
combining the average working pH and salt conditions for Taq DNA polymerase and 
Avian Myeloblastosis Virus reverse transcriptase (AMV RT).  AMV RT was initially 
chosen as it was employed in the early isothermal amplification selections for possessing 
RNase H activity.  This enzyme was later replaced by SuperScript II and then 
SuperScript III, due to their high thermal stability and lack of RNase H activity, which 
facilitates a greater yield of first-strand cDNA during the reverse transcription[114, 115].  
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The initial transcription buffer used during the proof-of-principle selections was a 
standard T7 RNA polymerase reaction buffer, containing among other ingredients 
spermidine (a polyamine) and Triton X-100 (a nonionic detergent).  These two reagents 
are added to maximize transcript yields, and apparently did not significantly negatively 
effect the proof-of-principle hybridization-based selections (Chapter 3).  However, 
amplification after the selection steps of our first protein target, CYT-18, amplified 
poorly (this selection is fully discussed in Chapter 4).   
CYT-18 is a tyrosyl-tRNA synthetase that is known to specifically bind to and 
assist in Group I intron splicing[116].  During a manual selection, the selection step does 
not occur in the presence of selection buffer, since the transcribed RNA is first 
acrylamide gel purified and ethanol purified[108].  On the robotic workstation, this is not 
the case; some percentage of incubated transcription reaction mixture is added to a fresh 
aliquot of target in selection buffer.  We expected CYT-18 to bind a large amount of 
pool, since it is a tRNA synthetase, Group I intron scaffold, and very positively charged 
(pI = 9.34).   
Because we obtained poor amplification results after switching from 
polynucleobases to protein targets, we hypothesized that components in the transcription 
buffer may interfere with binding, since the presence of transcription buffer in the 
selection step is a large difference between manual and automated selection.  Free NTPs 
and glycerol were shown to have no effect on the binding of wildtype intron to CYT-18.  
However, the incidence of spermidine and Triton X-100 in the selection buffer greatly 
reduced the ability of CYT-18 to bind wildtype intron (Figure 2-4).   
Spermidine could easily affect the pool structure; as a polyamine, it has been 
shown to precipitate nucleic acid and alter the secondary structure of nucleic acids[117-
120].  Triton X-100 could interfere with nucleic acid:protein binding if the binding occurs 
within a hydrophobic pocket.  Furthermore, the removal of those two components yielded 
higher levels of transcription (Figure 2-5).  This is presumably because more pool was 
being specifically bound and amplified, rather than being washed away, or perhaps 
because some component of the template (unpurified RT/PCR reaction) was negatively 
interacting with those components. 



















Figure 2-4.  Effect of transcription buffer on pool:protein target binding.  Standard 
nitrocellulose binding assays are performed as the actual selection step on the robotic 
platform would occur.  Binding assays were formulated to 1X TMK and 0.5X robotic 
transcription buffer; one constructed with 2.5mM spermidine and 0.01% Triton X-100, 
the other without either.  Unselected pool (Round 0 RNA) and mock target (β-
galactosidase) are used as negative controls.  TMK = 10 mM Tris, pH 7.5; 100 mM KCl; 




Figure 2-5.  Example of amplification with traditional and modified TXN buffers.  
Selections against CYT-18 utilizing transcription buffers with and without 2.5mM 
spermidine and 0.01% Triton X-100 were performed in parallel.  Aliquots taken from the 
reverse transcription coupled PCR reaction (RT/PCR) and transcription reaction (TXN) 
are shown.  The mass of the DNA and RNA species of the pool are indicated by arrows.  
The first two rounds of selection are shown, and illustrate the difference in transcriptional 
product levels between the two transcription buffers. 
Spermidine and Triton X-100 were removed from all subsequent selection buffers 
without any observed adverse affect upon selection.  Other chemical modifications made 
to selection chemistries tend to be specific to the target, and will be addressed in each 
target’s individual section (Chapters 3 - 5).   
Isothermal amplification 
Originally, we attempted to amplify binding species using a self-sustained 
sequence replication (3SR) system.  In such a system, a template can be rapidly amplified 
in isothermal conditions precluding the need for thermalcycling or thermal denaturation 
of templates.  3SR requires the addition of a DNA-dependent RNA polymerase activity, a 
reverse transcriptase activity, and an RNase H activity (Figure 2-6).  RNA is reversed 
transcribed into a cDNA, which is in turn amplified by transcription into RNA, and so on, 













Figure 2-6.  Schematic of isothermal amplification (3SR).  RNA (dark red) is eluted from 
target beads and anneals with a 3’ (cDNA generating) primer.  Reverse transcriptase (RT) 
extends the primer with deoxynucleotides to form a DNA strand (dark blue) to create a 
RNA/DNA duplex.  RNase H or an RT with RNase H activity digests the RNA portion of 
the duplex, leaving a minus strand ssDNA.  That ssDNA hybridizes with a 5’ (dsDNA 
generating) primer, and the RT extends the primer to create a dsDNA, which functions as 
template for an RNA polymerase.  The RNAP then regenerates and amplifies the initial 
ssRNA species. 
Also, implementing this specific amplification strategy rather than traditional 
discontinuous amplification (described below) presents several advantages on a robotics 
platform.  Since reverse transcription and transcription are coupled in a single tube, less 
mechanical movements are programmed in order to amplify binding species, and 
available worksurface area is conserved since fewer wells and plates are required.  
Additionally, isothermal (“continuous”) amplification facilitates the same amount of 
material amplified in half the time, allowing a doubling in throughput over uncoupled 
RT-PCR and transcription amplification.  Finally, isothermal amplification can be 
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accomplished with only the physical integration of an inexpensive block heater.  In 
comparison, staggered amplification methods require the integration of a more expensive 
thermalcycler, both physically and by a cable connection with a computer possessing 
appropriate device controlling software. 
However, our attempts to generate aptamers from a fully randomized nucleic acid 
pool using isothermal amplification reactions evolved replication parasites that rapidly 
out-competed native pool for amplification[110].  These parasites were seen to ‘take 
over’ any isothermal amplification reaction performed on the robot or at the bench 
(Figure 2-7).  Moreover, individual researchers with any set of reagents would 
consistently amplify these molecular parasites no matter how much effort was taken to 
prevent contamination of the isothermal reactions.  The parasite had seemed to ‘overrun’ 
any isothermal amplification with the nucleic acid pool we were currently employing 
(N30).  This was unfortunate, as the N30 pool was particularly well-designed for 
enzymatic manipulation on a robotic platform.   
Molecular parasites have been described in the past, most notably the replicase 
‘monsters’of Q β phage[122-124].  Furthermore, a replication parasite specific to 
isothermal amplification has been previously described in the literature[125].   Our N30-
pool specific parasite was later experimentally investigated by former student Kristin 
Marshall[126].  Her initial results demonstrated that the molecular parasite was unable to 
‘survive’ uncoupled, discontinuous amplification.  For this reason, isothermal 
amplification was quickly abandoned in favor of proceeding with the less optimal 
‘staggered’ amplification (RT-PCR discontinuously followed by transcription). 
 
 
Figure 2-7.  Isothermal amplification yields replication parasites.   A selection against 
oligo (dT)25 was carried out as described in the Experimental Methods in Chapter 3.  An 
aliquot of binding species is shown (“Selected RNA”) along with the same binding 
species amplified after isothermal amplification (“Selected RNA Amplified”).  Starting 
unselected pool is shown to demonstrate native pool size, and only RNA molecules are 
labeled in this gel.  The relative sizes of the replication parasite and native pool are 
indicated by arrows.  
Staggered amplification  
Due to the molecular parasite, the generation of DNA and RNA were separated 
into discontinuous events.  Although this required approximately twice the amount of 
incubation time per day as well as using more microplate reagent space, switching to 
staggered species amplification quickly eradicated ‘take-over’ by the isothermal 
parasites.  We now amplify the recovered binding species in a coupled RT/PCR reaction, 
and then use an aliquot of the finished reaction to seed a separate transcription reaction.  
After incubation, an aliquot of the transcription reaction is added to immobilized target to 
begin a new round of selection (Figure 2-8). 
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Figure 2-8.  Staggered (discontinous) automated selection scheme.  Magnetic beads 
derivatized with streptavidin are shown as red balls, biotinylated protein targets are 
shown in green, and the RNA pool is purple.  Liquid manipulations are shown in black 
tubes, while enzymatic amplification steps are shown in red tubes.  A typical round of 
selections involves adding the RNA pool to a protein target captured on magnetic beads, 
filtration washing of the beads, elution of selected binding species, and amplification to 
regenerate RNA for the start of the next round. 
Progression of robotic in vitro selection protocols 
Throughout the course of all experiments presented in this body of work, as well 
as work performed by other roboticists in the Ellington lab, we made numerous upgrades, 
fixes, adjustments, and enhancements to the software, hardware, chemistries, and 
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selection procedures in automated in vitro selection.  These progressions are summarized 
in Table 2-1, and are further expounded below. 
Series Version Main revision(s) 
0.x Adaptation of 16bit controller software to 32bit operating system 
1.x Isothermal amplification protocols 
2.x Discontinuous amplification protocols, TXN buffer modifications 
3.x Multiple selection targets in parallel (first adaptation), 96-well cooler 
4.x Integration of vacuum filter, start of ‘bead-washing’ protocols 
5.x Multiple selection targets in parallel (second adaptation) 
6.x Initiation of anti-contamination procedures 
7.x Individualized selection protocols based on target class, new hardware 
Table 2-1.  Summary of major revisions of the automated in vitro selection system. 
SELECTION version 0.x series 
Before establishing either isothermal or discontinuous amplification, I largely 
worked on making the robotic workstation (a Beckman Biomek 2000) ‘up-to-spec.’  We 
upgraded the mainboard to revision 2, which facilitated the replacement of a Intel 80386 
CPU for the older 80286 chip, allowing the use of Beckman’s Bioworks version 2.  A 
main upgrade to this version was the ability to perform complex scripting methods 
written in TCL (tool command language), and the implementation for spatial collision 
detection of non-Beckman components. 
At this time, the software supplied with the robotic workstation was coded to run 
from Windows 3.1, a 16-bit operating system (OS).  This antediluvian OS was the 
predecessor to Windows 95, Windows 98, and Windows Me, and was notoriously 
unstable.  An automated selection run requires 18-20 hours of continuous communication 
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between the robotic platform and the computer controller, and it was rare for the 
operating system to not crash during that period of time (recall that Windows 3.1 has no 
protected memory modes, so fatal exceptions affect all programs running in the OS). 
In order to obviate this problem, I manually compiled certain dynamically-linked 
library (DLL) files for a 32-bit, protected memory mode OS, Windows NT 4.0.  By 
converting some of the program files to 32-bit and running the remainder of the 
executables under 32-bit NT emulation mode, the archaic Bioworks 2 controlling 
software was easily able to run overnight without the OS crashing.  Beckman has since 
released Bioworks version 3, which fully runs from Windows NT. 
SELECTION version 1.x series 
This selection protocol employed isothermal amplification, which was abandoned 
due to the evolution of replication parasites (see “Isothermal Amplification”).  In this 
series, a magnetic particle separator was integrated onto the worksurface in order to 
partition binding species by bead washing.  This computer-controlled device controlled 
magnets for 16 microplate wells, and was constructed by former post-doctoral fellow 
Peter Rudolph.  Additionally, a 24-well microplate Peltier-based enzyme cooler was 
integrated, and also constructed by Peter Rudolph.  Finally, a thermalcycler was 
integrated into the left-side module (positions A1 & B1) of the Biomek 2000 
worksurface.  This system allowed five rounds of selection to be executed per day. 
SELECTION version 2.x series 
Here we switched from isothermal to discontinuous amplification, as previously 
described.  Also, we removed spermidine and Triton X-100 from the transcription 
reaction buffer, also discussed above.  In this revision, we began setting up the robot’s 
worksurface so that the ‘cleanest’ areas were on the rightmost section, and the ‘dirtiest’ 
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areas were on the leftmost section, in regards to amplicon presence.  This procedure 
ensured that a disposable tip could not accidentally dribble a drop of RT/PCR or 
transcription buffer into clean wash buffer, etc., as pipette tips covered with low to high 
amounts of amplicons always moved left toward the PCR machine and trash disposal 
chute.  
SELECTION version 3.x series 
This revision marked our first attempt to perform multi-target selections in 
parallel.  To accomplish this, we had to replace devices that were incapable of handling 
entire 96-well microplates.  Therefore, we integrated a 96-well enzyme cooler built by 
former undergraduate and current Masters student Timothy Riedel.  This cooler was 
chilled to -20ºC by a circulating liquid bath and engineered to fit within the tight spatial 
constraints of the worksurface.  We also purchased and integrated a computer-controlled 
96-well magnetic particle separator.  Next, we integrated a four-stack carousel system to 
parse out the additional disposable tip boxes required for multiple target selection.   
During this program version, the layout of individual microwells and microplates 
was optimized in order to provide six rounds of unattended selections every 18 – 20 
hours, rather than five rounds.  However, this program version was largely unsuccessful 
due to a (still uncorrected) bug in the robotic controller software.  This fault causes 
misalignment of manually defined devices (e.g., thermalcycler, enzyme cooler, etc.) 
between the single- and eight-channel pipetting tools.  The end result is that when 
pipetting into non-Beckman devices, the height of the pipetting tool is either too high to 
aspirate the liquid, or so low as to cause a collision with the labware.  Parallel target 
selection was temporarily suspended to resolve this issue (series 5.x) while progress 
continued with enhancement of selection and partitioning conditions (series 4.x). 
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SELECTION version 4.x series 
This major upgrade focused around changing the method in which we partition 
binding species from non-binding species, as described above.  We custom integrated a 
commercially available vacuum manifold onto the worksurface in order to wash target-
immobilized beads on a filter membrane.  This procedure facilitated the significant 
winnowing of pools that otherwise would not resolve with just bead washing (Chapter 4). 
We also constructed a new version of the enzyme cooler (by Timothy Riedel and 
student Travis Bayer) that was cooled by standard phase-change compression technology 
(like that of typical refrigerators).  Again, this was a striking job of design to fit in the 
small footprint available on the worksurface.  A cooler of this type had two major 
advantages.  First, the ramping time in order to reach -20ºC was more than halved.  More 
importantly was the obviation of a circulating liquid bath, which had the potential to 
develop leaks while running unattended.   
SELECTION version 5.x series 
During this period a time, a remote alpha dock (RAD) was integrated into the 
thermalcycling subsystem.  A RAD allows the separation of the Peltier-containing 
thermalcycling block from the controller and power device.  The ultimate result of this is 
a PCR machine requiring a much smaller footprint on the worksurface, since the PCR 
controller can now be kept nearby.  This allowed us to gain another worksurface space 
(position B1), providing a location for another device.  This extra space becomes 
especially important in multi-target selections. 
With this program revision, we created a protocol to perform eight selections in 
parallel based upon the beads-on-filter partitioning method (series 4.x).  In order to avert 
the pipetting height problems from the robot’s operating system bug (see series 3.x), we 
elected to dispose of the single-channel pipettors and use only the eight-channel pipettors 
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regardless of the number of targets run at any given time.  While this causes a small 
waste of sterile pipette tips, it is vastly preferable over the laborious task of recalibrating 
the entire worksurface and integrated devices each time we wished to switch to a single-
channel pipettor in order to save tips (e.g., for one for two target selections).  
SELECTION version 6.x series 
This revision focused on methods and technologies to minimize evolution of 
matrix-binding aptamers (Appendix B).  In short, selections were performed against more 
‘difficult’ targets that we would expect to elicit aptamers with higher dissociation 
constants than is traditionally seen for proteins (e.g., very short synthetic peptides, small 
molecules, and hydrophobic, negatively charged spores).  Rather than generating 
aptamers to these immobilized targets, binding species were evolved that were specific to 
the streptavidin-bead surface, as well as the hydrophilic PDVF membrane.   
These matrix-binding species were seen to quickly arise in selections against 
other ‘difficult’ targets.  At this time, we employed several steps in order to minimize 
contamination of new selections with the matrix binders.  First, we placed an ionic air 
purifier directly next to the thermalcycler.  It was hoped that the positively charged plates 
of the ionizer would draw any aerosolized nucleic acid away from the worksurface when 
the thermalcycler lid opens.  Second, the thermalcycler was programmed to not open its 
lid until the block was cooled to room temperature in order to minimized the amount of 
reaction that might be aerosolized (before, the lid opened at the completion of a PCR 
reaction while the liquid was still warm). 
Third, I created an entirely new selection pool in the event that the current native 
pool aliquots had been contaminated by the matrix binding species.  Furthermore, I 
created a “Round 0” PCR airflow hood.  We deemed all pool construction and handling 
of “round 0” native pool to be manipulated within the confines of the airflow hood to 
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prevent contamination of any future pool aliquots.  This became especially important 
considering that we investigated the matrix binders by assaying large quantities of them 
at our bench spaces.  More so, any new matrix binding species evolved in the future 
would also first be assayed at our benches before we would be able to determine that they 
had evolved, thus resulting in potential contamination of any native pool we handle at the 
bench. 
 Obviously, the highest concentration of amplicons is the thermalcycler.  We 
established a vigorous routine of decontaminating the thermalcycler immediately after the 
execution of a run, and also prior to the start of a new run.  This is done by treating all 
surfaces with liberal amounts of a commercially available metal-catalyzed DNA cleaving 
cocktail, followed by several water washes of the surfaces.   
 Also, we began running selections whereby we switch out the types of beads used 
every six rounds.  We utilized two different formulations of streptavidin-coated beads.  
The two forms differed mainly in their surface charge; one had a slight positive charge 
and is more hydrophilic.  Conversely, the second type had a slight negative charge and is 
more hydrophobic.  It was hoped that by alternating between the two bead surfaces that 
we could prevent evolution of bead binders.   
Finally, we observed that matrix binders arose after performing more than twelve 
rounds of selection (typically to 18 rounds) when a binding signal had for round 12 pool 
had not been seen.  We now stop selection at round 12 if no increase in binding is 
observed for the target when compared to native pool.  Because it is unlikely that a 
selection will work after twelve rounds without any measurable increase in functionality, 
we believe that such a condition favors the evolution of matrix binding species.  In vitro 
selection always generates some type of binding species; if not aptamers specific to the 
target, then matrix binders or replication parasites. 
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We also increased the customizability of selections by replacing large reservoirs 
of wash and elution buffers with a deep-well microplate.  The use of a microplate allows 
us to use a different wash and elution buffer for each selection target for each round of 
selection.  Thus, it is easy to use one set of wash buffers for one target, while using a 
completely different set for another, perhaps where the monovalent salt concentration is 
steadily increased each round in a wash buffer[127]. 
SELECTION version 7.x series 
The series 7 program version is our current selection protocol revision (depicted 
in Figure 2-9).  This advancement centered on developing individualized selection 
conditions for specific target classes.  Previously, we had developed very stringent 
washing protocols for selections against nucleic-acid binding proteins, which typically 
possess a large amount of non-specific pool binding ability.  However, such harsh 
partitioning conditions are likely to be excessive for targets expected to generate 
aptamers with poorer dissociation constants, like those of small molecule selections.   
Another reason to develop individualized protocols was issues relating to target 
immobilization.  Earlier, we altered the selection procedure so that random pool was first 
incubated with free, biotinylated target in solution.  After incubation, the pool/target 
mixture would be pipetted onto streptavidin-coated beads in order to immobilize the 
target for partitioning.  This was essentially the case for chemically biotinylated proteins, 
and was set up this way to allow the binding event to occur in a more naturalistic fashion 
(free in solution rather than near a solid bead surface). 
Still, certain targets have to be pre-immobilized to the beads due to their 
biotinylation methods.  This is particularly true with coupled transcription and translation 
reactions (which possess thousands of proteins) and the biotinylation of small molecules 
which cannot be purified using size-exclusion chromatography (in this case, 
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unbiotinylated target is in excess due to the biotinylation protocol).  For these, the 
biotinylated target mixture is incubated with the streptavidin-coated beads to capture the 
target.  Afterwards, the beads are vigorously washed before placement on the robot in 
order to remove cellular lysate components or excess unbiotinylated small molecule 
which would negatively affect the selection step. 
Therefore, I split the main selection program up into four variants:  high-
stringency and low-stringency partitioning methods were developed for selections where 
the pool incubates with unbound biotinylated target in solution, and also for selections 
where the biotinylated target is pre-immobilized on the streptavidin-coated beads.  This 
procedural separation allows further refinement of one type of selection without the need 
to globally change all selection parameters for all target types.  The creation of these 
specific target protocols have facilitated the selection of more ‘difficult’ selections (e.g., 
aminoglycosides) where the previous generalized protocols were unable to do so[128]. 
Additionally, the first-generation automated thermalcycling block and lid from 
MJ Research was replaced with a newly designed version that fixed several issues of the 
old design (detailed in Appendix A).  In short, this remedied an issue whereby the 
thermalcycling plate would create a vacuum between the microwells and the disposable 
lid within the thermalcycler, preventing the PCR machine from mechanically opening. 
Finally, we integrated a small-footprint orbital plate shaker for the bead and 
reagent plate (position B4).  We observed that certain hydrophobic targets tended to stick 
to the bottom of the reagent tray, preventing the robot from pipetting the beads into the 
vacuum manifold.  We found that briefly shaking the beads during the incubation step 
resolves this situation. 
 
Figure 2-9.  Current in vitro selection worksurface schematic.  The current setup of the robotic selection worksurface is 
depicted on the bottom half of the figure.  Devices and/or plate names are shown, followed by manufacturer, and type of 
labware.  Red “P”s denote a physical hardware connection to that location, green “D”s denote a data cable connection, and 
blue “E”s denote an electrical connection to supply energy.  The upper right portion illustrates the starting configuration of 
items in the stacker carousel at the beginning of a selection run.  The upper left portion represents physical devices that are 




We have developed a fully automated in vitro selection system.  This robotic 
platform is capable of performing eight selections in parallel, proceeding through six 
rounds of selection before fresh reagents are required (usually a 18 – 20 hour period).  
We designed this system in a modular format, utilizing as many off-the-shelf components 
as possible so that we can quickly replace broken subsystems, or rapidly build new 
workstations.  Despite the modularity of this system, it remains highly configurable, 
allowing a wide variety of selection conditions and procedures.   
Because we employ bead-based target immobilization technologies, a number of 
different derivatization chemistries can be selected to for target conjugate onto beads.  
Targets can easily be biotinylated with anime-reactive reagents such as N-
hydroxysulfosuccinimido esters[129, 130] and tetra- and pentafluorophenyl esters[131], 
sulfhydryl-reactive compounds such as N-iodoacetyl-N-biotinylhexylenediamine[132, 
133], carbohydrate-reactive molecules such as biocytin hydrazide[134], nucleic acid-
reactive reagents such as biotin-psoralen[135, 136],  and lipid-interacting molecules such 
as N-(biotinoyl)dipalmitoyl-L-phosphatidylethanolamine[137, 138]. 
Furthermore, biotin capture is not the only means available for target 
immobilization.  Selection targets can be conjugated to a bead surface through 
immobilized metal affinity chromatography (IMAC) for capture of histidine-tagged 
proteins[139], protein A or G interaction for capture of immunopurified proteins[140, 
141], epoxy or tosyl group chemistry for covalent linkages to proteins and primary 
amines[142, 143], and antibody-coated beads for purification of specific bacterial 
subtypes, such as E. coli O:157[144].  
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The nature of the random pool is also very configurable.  While this body of work 
has relied upon selection with RNA pools[71, 110, 128, 145, 146], automated nucleic 
acid selection technologies have also been demonstrated with ssDNA[102] and dsDNA 
pools[147] by student Letha Sooter.  Automated selection is also amenable for use with 
modified nucleotide pools (e.g., 2’-fluoro-pyrimidines and 2’-O-methyl-pyrimidines) 
with minor program modifications.   
Here, I have constructed an automated system based on the Beckman Biomek 
2000 robotic laboratory station.  Selections typically require 12 – 18 rounds of in vitro 
selection, generating aptamers to targets in 2-3 days.  The use of a multi-channel 
pipetting tool facilitates the selection of eight targets in parallel.  This provides a total 
throughput of 336 total rounds of selection per week, or more than sixteen individual 
targets taken to eighteen rounds of selection per week per robot.  However, the 
application of automated selection to metabolomes or entire proteomes remains largely 
intractable at this level of throughput.   
Because of the modularity of the hardware and chemical components, this 
automated in vitro selection technology is easily portable to other robotic platforms.  
Adaptation of this technology to a larger robotic worksurface has been investigated in the 
past by myself and students Letha Sooter and Eric Davidson.  Currently, technician 
Carlos Garcia is amending the selection program for execution on a Biomek FX platform.  
This larger workstation is capable of executing either 96 or 384 selections in parallel, and 
is already partially configured for large-scale automated selection at this time.  This level 
of throughput can easily generate aptamers for construction of large biosensor 
arrays[148] in a short period of time.  A 96-well pipetting head allows 4,032 total rounds 
of selection per week (>192 targets taken to eighteen rounds per week); a 384-well 
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pipetting head allows 16,128 total rounds of selection per week (>768 targets taken to 
eighteen rounds per week).  
EXPERIMENTAL METHODS 
Pool construction and diversity 
Pool construction followed a previous published protocol[96].   
Pool synthesis and purification 
1µmole syntheses of pool template strand and primers were synthesized on an 
Expedite DNA synthesizer (Applied Biosystems, Foster City, CA).  Sequences 
synthesized for construction were the following:  N30 pool (GGG AAT GGA TCC ACA 
TCT ACG AAT TCN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNT TCA 
CTG CAG ACT TGA CGA AGC TT), 41.30 (GAT AAT ACG ACT CAC TAT AGG 
GAA TGG ATC CAC ATC TAC GA), 24.30 (AAG CTT CGT CAA GTC TGC AGT 
GAA), R50 pool (GGG TTA CCT AGG TGT AGA TGC TNN NNN NNN NNN NNN 
NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN NNN AAG TGA CGT 
CTG AAC TGC TTC GAA), 41.R50 (GAT AAT ACG ACT CAC TAT AGG GTT ACC 
TAG GTG TAG ATG CT), and 24.R50 (TTC GAA GCA GTT CAG ACG TCA CTT).  
“N” represents the random region of the pool, where all four phosphoramidites are 
injected simultaneously.  Because each base has a different coupling efficiency, the “N” 
mixture is prepared with A:C:G:T phosphoramidite ratios of 3:3:2:2.4, respectively[96]. 
The synthesized nucleic acid was deprotected by incubation of the synthesis resin 
in 1 ml of ammonia hydroxide at 50ºC for 16 hours.  A 10x volume of n-butanol was 
added and oligos were allowed to precipitate at -20ºC overnight.  The oligos were spun 
down, ethanol rinsed, and then gel purified on polyacrylamide gels.  One-third of the pool 
syntheses were purified per each 10 x 12 x 0.15 cm 8% acrylamide gel.  One-half of the 
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primer syntheses were purified per each 10 x 12 x 0.15 cm 12% acrylamide gel.  After 
running the gels for approximately two hours at 250 V (until the bromophenol blue 
loading dye reaches the bottom of the gel), the nucleic acid was visualized by placing the 
gel on a thin-layer chromatography plate and UV shadowing[149].   
Visual bands containing the appropriate mass of nucleic acid were excised with a 
clean razor blade.  Gel fragments were eluted in pure water, approximately 30 ml per 10 
x 12 x 0.15 cm gel excision.  After overnight elution at 37ºC on a rotator, the water-
nucleic acid mixture was ethanol precipitated with sodium acetate, and quantitated by UV 
spectroscopy.  The purified N30 synthesis was determined to contain a total of 2.44x1016 
strands; the purified R50 synthesis was calculated to possess a total of 2.67x1016 strands. 
Complexity determination 
A substantially large portion of the synthesized pool is not extendable by 
polymerases due to synthesis artifacts such as backbone lesions, bases that have not been 
fully deprotected, and deletions[96].  A pool complexity assay was employed to 
determine what fraction of the total purified synthesis was capable of polymerase 
extension.  The short pool amplification primers (24.30, 24.R50) were radiolabeled.  50 
pmol of each primer were placed in a 10 µl kinase reaction containing 2 µl of 5X forward 
polynucleotide kinase reaction buffer, 0.5 µl of γ-32P ATP [>7,000 Ci/mmol] (ICN 
Biomedicals, Irvine, CA), 1 µl T4 polynucleotide kinase (Invitrogen, Carlsbad, CA), and 
water up to 10 µl.  After mixing, reactions were incubated for 1 hour at 37ºC and then 
purified with an equal volume (10 µl) of phenol:chloroform.  The phases were separated 
with a ‘heavy’ 0.5 ml PhaseLock tube (Eppendorf, Hamburg, Germany).  Finally, free 
nucleotides were removed by size-exclusion chromatography with Centri-Spin 20 
microcentrifuge columns (Princeton Separations, Adelphia, NJ).   
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Pools were tested for extension by both a standard DNA polymerase and a reverse 
transcriptase.  Due to their error-prone nature, reverse transcriptases typically can extend 
a higher percentage of synthesized pool.  Compared to DNA polymerases, RTs will more 
often insert a random nucleotide when encountering chemically modified or damaged 
template strands[150-153].   Pool complexity is determined by the extent to which the 
pool can be extended.   
Nucleic acid pools were tested for extendibility by both Taq DNA polymerase 
(PGC Scientifics, Frederick, MD) and SuperScript II reverse transcriptase (Invitrogen).  
RT extension was evaluated by first annealing radiolabeled primer to the pool.  This was 
accomplished by adding 5 pmol of labeled primer (2 µl) to 50 pmol of purified pool, with 
2.5 µl of 4mM dNTPs, and water up to 12 µl.  This solution was mixed well, denatured at 
65ºC for 5 minutes, and then quickly chilled on ice.  Next, 4 µl of first-strand buffer, 2 µl 
of 0.1 M dithiothreitol (DTT), 1 µl water, and 1 µl of SuperScript II RT was added.  The 
reaction was incubated at 42ºC for 1 hour. 
Taq DNA polymerase extension was also determined by first annealing 
radiolabeled primer to the pool.  This was performed by adding 5 pmol of labeled primer 
(2 µl) to 50 pmol of purified pool, with 2.5 µl of 4mM dNTPs, and water up to 12 µl.  
This solution was mixed well, denatured at 65ºC for 5 minutes, and then quickly chilled 
on ice.  Next, 2 µl of 10X PCR buffer, 5.5 µl water, and 0.5 µl of Taq DNAP was added.  
These reactions were incubated at 72ºC for 1 hour. 
5 µl aliquots of the completed reactions were added to 5 µl of 2X stop/loading 
dye, and denatured at 70ºC for 3 minutes.  The samples were then processed on an 8% 
polyacrylamide gel for analysis, and imaged (Figure 2-10).  This analysis is summarized 
in Table 2-2. 
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Figure 2-10.  Extendibility of synthesized pools.  Shown here is the analytical gel of the 
Taq and reverse transcriptase extension reactions of the N30 and R50 random pool 
syntheses.  For each pool, the first lane shows a reaction without template, followed by an 
extension reaction by Taq DNA polymerase, and then an extension reaction by 
SuperScript II reverse transcriptase.  The bands corresponding to fully extended strand 
synthesis is indicated by a blue arrow for each pool. 
Pool Polymerase Percent viable Number viable 
N30 Taq DNAP 26% 6.4x1015 molecules 
N30 SuperScript II RT 31% 7.6x1015 molecules 
R50 Taq DNAP 15% 4.0x1015 molecules 
R50 SuperScript II RT 19% 5.2x1015 molecules  
Table 2-2.  Complexity of synthesized pools.  The amount (percentage of total synthesis, 
and number of individual molecules) of extendable pool is listed for both pools with both 
polymerases. 
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N30 pool was seen to have a higher percentage of extendable molecules.  This is 
expected due to the longer length of the R50 synthesis construct, which theoretically 
would have more damaged positions than a shorter synthesis construct like N30 (N30 = 
75 nt, R50 pool synthesis = 91 nt).  The reverse transcriptase was able to extend more 
sequences than Taq DNA polymerase.  However, because the diversity of extension is 
sufficient with Taq polymerase, a large scale amplification with this much cheaper 
enzyme was chosen. 
Small-scale PCR evaluation 
Before the selection pools are amplified in a large PCR reaction, they are first 
evaluated on a small scale in order to optimize reaction conditions.  These optimizations 
are critical in preventing under- and overamplification of the purified pool[96].  Small 
scale optimization reactions were performed as identically to the large scale reactions as 
possible.  150 µl reactions were constructed in standard PCR thin well microplates (MJ 
Research, Waltham, MA).  The amount of initial template is derived by the conditions 
and assumptions used to calculate volumes for the large scale amplification. 
The following assumptions were made:  100 µl PCR reaction yields no more than 
1 µg of product, I wanted 10 copies of each viable sequences, and I wanted to initially 
amplify 1x1015 unique sequences from the entire purified synthesis.  For the N30 pool, 
the mass of 1 double-stranded copy of 1015 molecules is 1.01x10-4 g; thus 10 double-
stranded copies are 1.01x10-3 g.  For 1 µg product produced per 100 µl of PCR reaction, 
this mass would require a 101 ml PCR reaction volume.  Also, because the total viable 
sequences is 6.37x1015 molecules, 15.7% of the total synthesis would be used as template 
in the large scale amplification.   
A small scale PCR reaction for the N30 pool was constructed.  2.25 µl of 20 µM 
24.30 primer, 1.63 µl of ssDNA N30 pool (155 ng), and 7.5 µl of 4mM dNTPs were 
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added to 88.62 µl of water, for a total of 100 µl volume of liquid.  Primer and pool were 
hybridized by denaturing at 65ºC for 5 min and then quickly chilled on ice.  Next, 15 µl 
of 10X PCR buffer, 0.3 µl of Taq DNA polymerase, and 32.25 µl of water were added.  
The reaction was then incubated at 72ºC for 1 hour for first-strand extension.  Finally, 
2.25 µl of 20µM 41.30 primer was added and mixed.  The reaction was thermalcycled 
with denaturation conditions of 95ºC for 30 sec, annealing at 45ºC for 30 sec, and 
extension at 72ºC for 60 sec.  A 5 µl aliquot was removed from the reaction at the 4th, 6th, 
8th, 10th, 12th, and 14th cycles. 
For the R30 pool, the mass of 1 double-stranded copy of 1015 molecules is 
1.18x10-4 g; thus 10 double-stranded copies are 1.18x10-3 g.  For 1 µg product produced 
per 100 µl of PCR reaction, this mass would require a 118 ml PCR reaction volume.  
Also, because the total viable sequences is 3.96x1015 molecules, 25.3% of the total 
synthesis would be used as template in the large scale amplification. 
A small scale PCR reaction for the R50 pool was also constructed.  2.25 µl of 20 
µM 24.R50 primer, 3.2 µl of ssDNA R50 pool (281 ng), and 7.5 µl of 4mM dNTPs were 
added to 87.05 µl of water, for a total of 100 µl volume of liquid.  Primer and pool were 
hybridized by denaturing at 65ºC for 5 min and then quickly chilled on ice.  Next, 15 µl 
of 10X PCR buffer, 0.3 µl of Taq DNA polymerase, and 32.25 µl of water were added.  
The reaction was then incubated at 72ºC for 1 hour for first-strand extension.  Finally, 
2.25 µl of 20µM 41.R50 primer was added and mixed.  The reaction was thermalcycled 
with denaturation conditions of 95ºC for 30 sec, annealing at 45ºC for 30 sec, and 
extension at 72ºC for 60 sec.  A 5 µl aliquot was removed from the reaction at the 4th, 6th, 
8th, 10th, 12th, and 14th cycles. 
The small scale amplifications indicated that overamplification started to occur at 
7 cycles of PCR, so 6 cycles was chosen to large scale pool amplification.   
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Large scale pool synthesis 
The large scale PCR reactions were constructed in much the same way as the 
small scale optimization reactions.  The N30 pool master mix was assembled with 39.1 µl 
of 775 µM 24.30 primer, 55 of µl ssDNA N30 pool (1015 extendable strands), 202 µl of 
100mM dATP, 202 µl of 100 mM dCTP, 202 µl of 100 mM dGTP, 202 µl of 100 mM 
dTTP, and 66.431 ml of water.  100 µl of this master mix was added to each microwell, 
covered, and denatured at 65ºC for 5 min and then quickly chilled on ice. 
Next, 47.75 µl of a second master mix was pipetted to each well.  This was 
constructed with 10.1 ml of 10X PCR buffer, 303 µl of Taq DNA polymerase, and 21.75 
ml of water.  After covering and mixing, the plates were incubated at 72ºC for 1 hour to 
facilitate first strand extension.  Finally, 2.25 µl of 20 µM 41.30 primer was added to 
each well, and the plates were thermalcycled 6 rounds at a denaturation condition of 95ºC 
for 30 sec, annealing of 45ºC for 30 sec, and extension of 72ºC for 60 sec. 
The R50 pool master mix was assembled with 73.6 µl of 480.8 µM 24.R50 
primer, 253 of µl ssDNA R50 pool (1015 extendable strands), 236 µl of 100mM dATP, 
236 µl of 100 mM dCTP, 236 µl of 100 mM dGTP, 236 µl of 100 mM dTTP, and 77.396 
ml of water.  100 µl of this master mix was added to each microwell, covered, and 
denatured at 65ºC for 5 min and then quickly chilled on ice. 
Next, 47.75 µl of a second master mix was pipetted to each well.  This was 
constructed with 11.8 ml of 10X PCR buffer, 354 µl of Taq DNA polymerase, and 27.18 
ml of water.  After covering and mixing, the plates were incubated at 72ºC for 1 hour to 
facilitate first strand extension.  Finally, 2.25 µl of 20 µM 41.R50 primer was added to 
each well, and the plates were thermalcycled 6 rounds at a denaturation condition of 95ºC 
for 30 sec, annealing of 45ºC for 30 sec, and extension of 72ºC for 60 sec. 
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PCR reaction aliquots were pooled and ethanol purified with sodium acetate.  
DNA pellets were then suspended in water, and samples were run on a 4% agarose gel to 
quantitate the concentration of the resuspended PCR products.  Next, the dsDNA copies 
of the pool were used as template to generate the RNA form of the random pool. 
A large scale transcription reaction was constructed using AmpliScribe kits 
(Epicentre, Madison, WI).  A 1 ml transcription reaction was assembled for each pool 
with 75 µl of 100 mM ATP, 75 µl of 100 mM CTP, 75 µl of 100 mM GTP, 75 µl of 100 
mM UTP, 100 µl of 100 mM DTT, 100 µl of 10X T7 transcription buffer, 100 µl of T7 
RNA polymerase, and 400 µl of water and template (150 µl of purified PCR product and 
250 µl of water for N30; 350 µl of purified PCR product and 50 µl of water for R50).  
Transcriptions were incubated at 42ºC for 2 hours, then reduced to 37ºC and mixed with 
50 µl of RNase-free DNase I and incubated for 30 minutes to digest template DNA.   
RNA was purified from the transcription reactions by polyacrylamide gel 
electrophoresis on an 8% gel.  The RNA pool was gel eluted as described above for 
purification of the ssDNA pool synthesis purification.  Purified RNA pool was 
quantitated by UV spectroscopy, and aliquoted in arbitrary genome sizes of 2.5x1014 
unique molecules / tube (corresponding to 10.6 µg for N30 pool and 12.8 µg for R50 
pool).    
Isothermal selection 
Robotically manipulated isothermal amplification (3SR) reactions were 
formulated on a previously published protocol[113].  Isothermal amplification was only 
employed for selections against oligo (dT)25 before the N30-specific amplification 
parasite began to ‘take over’ all isothermal reactions.  The partitioning portion of the 
automated selection procedure involving isothermal amplification follows as described in 
the Material and Methods of Chapter 3 for the discontinuous oligo (dT)25 selection. 
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A 2X isothermal reaction buffer was constructed, which dilutes to a 1X mixture of 
40 mM Tris (pH 8.1), 20 mM MgCl2, 25 mM NaCl, 2 mM spermidine, 5 mM DTT, 80 
µg/ml bovine serum albumin, 1 mM dATP, 1 mM dCTP, 1 mM dGTP, 1 mM dTTP, 4 
mM ATP, 4 mM CTP, 4 mM GTP, 4 mM UTP, 250 ng 24.30 primer, and 250 ng 41.30 
primer.  Amplification reactions were assembled on the robotic platform by adding by 50 
µl of 2X isothermal amplification buffer, 43 µl of water-eluted binding species, and 7 µl 
of isothermal amplification enzyme mixture.  The enzyme mixture consisted of 30 U of 
AMV RT (USB, Cleveland, OH), 100 U of T7 RNA polymerase (Stratagene, La Jolla, 
CA), and 4 U of RNase H (Ambion, Austin, TX).   
After assembling the 2X reaction buffer and template, they were mixed by 
repeated aspiration / dispense cycles in a PCR plate, and then the plate containing the 
reactions was sealed by an automated lid mechanism.  Next, the plate was incubated at 
65ºC for 5 minutes and then cooled to room temperature in order to disturb any secondary 
structure that may have interfered with primer binding or strand displacement.  Finally, 
the enzyme mixture is added and mixed, and the isothermal amplification proceeded at 
37ºC for 1 hour.  Typically, the progress of reaction was monitored by addition of 10 µCi 
of radiolabeled α-32P UTP and visualized by polyacrylamide gel electrophoresis. 
In vitro selection 
Selections performed using discontinuous amplification varied in their 
amplification and partitioning protocols.  Therefore, each target’s particular method of 
selection is discussed in its specific section (Chapters 3 -5).   
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Chapter 3:  Proof-of-principle selections 
INTRODUCTION 
The first attempts of automated in vitro selection failed; i.e., ligand-specific 
binding species were not evolved, even if partitioning and amplification functioned 
successfully.  These initial attempts are described in Appendix C.  Because of the relative 
young age of the selection system at this point, we elected to perform ‘proof-of-principle’ 
selections using the most undemanding targets available.   
In order to choose targets with the highest probability of generating aptamers, we 
selected oligonucleobase targets since they require simple hybridization rather than a 
functional secondary structure for binding (hybridization) to the target.  We picked three 
targets:  a polynucleotide, a randomly-chosen oligonucleotide sequence, and the same 
randomly-chosen sequence as a peptide-nucleic acid (PNA).   
The automated in vitro selection system was modified and upgraded until we 
discovered parameters that would reliably generate aptamers to these targets.  These 
simpler selections illustrated that automated selection was entirely possible, and helped to 
establish the parameters for SELECTION version 3.x series (Chapter 2) and more so for 
anti-protein selections in general.   
RESULTS AND DISCUSSION 
Oligo dT selection 
For the first proofing selection, we selected oligo (dT)25 as a target, as magnetic 
beads pre-derivatized with poly-thymidine were commercially available for purification 
of messenger RNA by hybridization of the poly-T sequence with the poly-A tail of the 
message[154].  I performed five rounds of completely automated selection on 
paramagnetic oligo (dT)25 beads[110].  The analytical gel of aliquots taken to monitor the 
progress of amplification is presented in Figure 3-1. 
 
Figure 3-1.  Progress of oligo (dT) selection.  RNA molecules corresponding in size to 
the N30 pool are shown at the left and right; the sizes of the RNA pool and DNA pool are 
indicated with arrows. A fraction (5 µL; 5%) of each RT-PCR (“RT-PCR”) or in vitro 
transcription (“TXN”) reaction was pipetted into separate wells in a microplate during the 
selection. The wells contained an equal volume of sequencing stop dye. At the conclusion 
of the selection, the samples were electrophoresed on a 8% denaturing polyacrylamide 
gel, the gel was exposed to a Phosphor Screen, and the screen was read using a 
Phosphorimager SI (Molecular Dynamics, Sunnyvale,CA). 
The discontinuous amplification protocol yielded DNA and RNA products of the 
appropriate mass without the evolution of artifacts or molecules parasites (Chapter 2).  
However, the third round of selection shows detectable levels of a higher molecular 
weight species.  This larger amplicon continued into the fourth and fifth rounds of 
selection, becoming more prominent.  Sequence analysis of the pool population after the 
last round of selection explained this phenomenon.   
Sequencing showed that the selection was successful; the pool members all 
contained large runs of adenosine residues (Figure 3-2).  The random region of the pool, 
normally 30 nucleotides, had expanded to 44 – 66 residues in length.  The lengthening 
seemed to be due to interaction solely with the ligand, owing to the fact that adenosine 
tracts were 21 – 39 adjacent residues in length.  Additionally, the adenosine tracts were 
typically seen at the middle of the random region, and never at the 5’ end and rarely at 
the 3’ end.   
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Figure 3-2.  Sequences of oligo (dT) aptamers.  The sequences of the random region is 
shown.  Contiguous adenosine runs are highlighted in red text.  The adenosine run length 
and total length of the random sequence tract are shown at the right.  
We believe that the expansion of the random region was due to polymerase 
‘stuttering’.  RNA phage polymerases have been demonstrated to ‘stutter’, or lose the 
current register and move back a few nucleotides when reading templates of 
homonucleotides[155, 156].  As the polymerase slips and polymerizes the portion of the 
template it had just copied, the resultant RNA copy increases in length.   
The rapid transformation in the length of the pool can be viewed as an indication 
of an optimized selection.  This protocol was not only able to yield enough amplicons for 
each round of selection, but also had sufficient stringency to quickly select for the 
‘correct’ species (subpopulations of the pool with poly-A tracts).  Because this ‘easiest of 
selections’ worked so well, we promptly moved up one level in complexity to a non-
homopolymer nucleic acid target. 
Oligo 15 selection 
While successful, the oligo dT selection didn’t directly address specificity due to 
the polymerase slippage mechanism.  Regardless, at least in one case (clone FYL20) we 
enriched for an aptamer with less than 25 adenosine residues.  Additionally, it is unclear 
what length of adenosine run is required for hybridization to the target oligo bead during 
the wash steps.  For these reasons, we decided to perform a selection on a specific 
nucleotide sequence so we could better investigate specificity in automated selection. 
 64
We ordered a biotinylated oligonucleotide as a selection target.  This sequence 
had little neighbor repetition, and was A:T / G:C balanced.  At first, we performed this 
selection with the lithium chloride binding and washer buffer suggested for use with 
mRNA purification with oligo dT beads (Dynal, Olso, Norway), as we did for the above 
selection.  However, we were unable to yield aptamers with a high level of specificity 
(see PNA 15 selection below).  Therefore, we changed the binding and wash buffers to 
SSC, a commonly employed buffer for hybridization in northern and southern 
assays[157].  Use of this buffer yielded fairly specific aptamers after 14 rounds of 
selection (Figure 3-3).   
 
Figure 3-3.  Sequences of oligo 15 aptamers.  The biotinylated target oligonucleotide is 
labeled as “target”.  Regions of perfect complementarity are highlighted in bold red text, 
regions with wobbling complements are highlighted in red text. 
Sequence analysis of the pool after the last round of selection illustrated a nearly 
complete winnowing of the pool to a single individual.  This species, shown in Figure 3-
3, has 13 / 15 perfect reverse complement interactions, with one G:T wobble nearer the 3’ 
portion of the aptamer[158].  This clearly demonstrates that the automated selection 
system is capable of applying sufficient stringency in the partitioning procedures.   
However, a perfect complement was not evolved from the random pool.  At the 
target’s complexity of 415 in a random pool of ~1013 sequences, we might expect 9,000 – 
10,000 individual molecules in the starting pool to contain the perfect 15mer sequence.  It 
may be that our initial random pool was not as diverse as we had believed it to be (this 
selection was performed prior to my large-scale construction of N30 pool discussed in 
Chapter 2, so I cannot confirm the complete history of the pool aliquot used for this 
selection that existed before I joined the laboratory).   
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It is also possible that this target evolved over more perfect hybridizers because it 
is somehow more fit than the competing species.  For instance, T7 RNA polymerase has 
been found to preferentially amplify templates with certain sequence properties not 
possessed by other templates[159-162].  Another explanation could be that the perfect 
hybridizers reannealed to the target oligo during the separation of the water elution and 
aptamer mixture from the beads after capture (see Materials and Methods).   
Previously, such as was done on this selection, the bead / aptamer complexes 
were suspended in water and transferred to the thermalcycler for denaturing by thermal 
melting.  Afterwards, the bead / aptamer slurry was pipetted back to the magnetic particle 
separator, and briefly incubated to separate the beads from the water / aptamer mixture.  
During this time, the liquid temperature would cool to room temperature.  If a small level 
of salt remained on the beads during the water elution, there could be enough to facilitate 
rehybridization.  To avoid this possibility in current selections, we now simply leave the 
beads in the PCR machine after aptamer : target denaturation (Chapter 2). 
PNA 15 selection 
We also performed a selection against a peptide nucleic acid (PNA)[163] 
containing the same sequence as the 15mer oligonucleotide used above.  PNAs hybridize 
using the canonical Watson-Crick hydrogen bonding rules[164], and form duplexes that 
are more stable than oligonucleotide duplexes[165]. Additionally, PNA duplex stability is 
much less salt dependent[165].  A PNA was chosen partially from curiosity, as we were 
intrigued by how a more stable duplex might alter the outcome of the selections.  
However, at this time we began to perform multiple target selection (SELECTION 
version series 3.x) and we desired a target similar but not identical to the 15mer oligo.  
As above, we initially performed this selection using the lithium chloride buffer 
employed in the oligo dT selection.  However, selection in this buffer did not generate 
aptamers with a high amount of sequence specificity (Figure 3-4), much like the selection 
of the 15mer oligo above.   
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s3c28   GGGAGACGACTTCTTTTC
Target
s2c27   
Target ATC
s4c29   GGTAACCAGTAACACAGCAACC
Target A
s7c37   ATAGGGCGGCGGCG
Target ATCAA











Figure 3-4.  Selected sequences of PNA 15 aptamers from lithium buffer selection.  The 
biotinylated target PNA is labeled as “target”.  Regions of perfect complementarity are 
highlighted in bold red text; regions with wobbling complements are highlighted in red 
text.  Lower case residues indicate the static priming region of the pool. 
As seen, the aptamer pool showed no more than 7 ‘perfect’ complementary bases 
with 2 wobbling bases (s3c28 and s7c37), and in some cases as few as 4 (data not 
shown).  Switching the monovalent salt from lithium to sodium, more commonly used in 
in vitro selections, also facilitated the enrichment of better hybridizing aptamers (Figure 
3-5).  Eighteen rounds of selection resulted in a single clone that dominated the pool with 
roughly 80% representation (clone 2).  This clone showed improvement in the number of 
bases it hybridized to over that of the clones evolved from the lithium buffer selection.  
More interestingly, the aptamer is capable of binding to the PNA sequence in two 
different frames.  In the first frame (Alignment 1), the aptamer hybridizes with 10 
Watson-Crick base parings and 3 G:U/T wobbles.  In the second frame (Alignment 2), 
the aptamer hybridizes perfectly with 11 bases. 
Alignment 1
Target      ATCAACACTGCATGT
TAGTTGTGAGTTGTGACACAAAGCGATGClone 2   CC
Alignment 2
Target             A
Clone 2   CCTAGTTGTG
TCAACACTGCATGT
AGTTGTGACACAAAGCGATG  
Figure 3-5.  Sequence of PNA 15 aptamer from SSC buffer selection.  The biotinylated 
target PNA is labeled as “target”.  Regions of perfect complementarity are highlighted in 
bold red text; regions with wobbling complements are highlighted in red text.  This 
aptamer can hybridize to the PNA in two different frames, depicted in Alignment 1 and 2. 
Overall, the PNA selection resulted in enrichment of an aptamer that has less 
perfectly hybridizing residues (10 + 3 wobbles for Alignment 1; 11 for Alignment 2) than 
that of the oligo 15 selection (13 + 1 wobble).  This finding may be mediated considering 
that the aptamer can ‘slide’ along the target and bind in two frames.  It may well be that 
this aptamer with two ‘binding sites’ is more fit than a competing aptamer with a single 
hybridization site of 13, 14, or 15 bases.   To determine if this is the case, future studies 
could be performed using targets of both smaller and larger sequences, thus with smaller 
and larger melting temperatures of the ‘perfect hybridizing’ strand that one would expect 
to be pulled out from a selection.  It is possible that ‘imperfect, multiple sites’ aptamers 
are favored over ‘perfect’ aptamers when the strands are able to displace easily and 
‘slide’ to the next binding site as they might be able to do with a small target (e.g., a 9-
mer or 12-mer).   
CONCLUSIONS 
While still rudimentary, these experiments helped to facilitate the initial selection 
conditions used for anti-protein selections, such as with the alteration where binding 
species were not eluted off beads, but instead directly amplified in the thermalcycler.  
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Also, this was the first instance in which a selection to the same target was repeated twice 
using different selection buffers.  Previously, the tedious nature of manual selections 
prevented researchers from repeating a selection under different conditions after a first set 
of conditions yielded specific aptamers.  Currently, the investigation of different buffers 
on the outcome of a selection is being investigated by student Gwen Stovall.  She has 
previously created an automated protocol that tests the effect of buffers on the initial 
binding of unselected pool (“round zero”) to a given target[127].  She is now executing 
several selections against lysozyme in order to determine whether buffer-to-sequence 
specific effects exist, and to what extent they alter the outcome of what evolves to 
become the most fit binding species. 
The oligo and PNA selections in SSC buffer also marked the first time that more 
than a single target was successfully run on the robot in parallel.  This directly led to the 
3.x version series of selection programs (Chapter 3), in which we first began running 
multiple targets in parallel on a routine basis.  The version series 3.x, taken with the 
selection refinements from version series 4.x (Chapters 2 & 4), created the foundation 
protocols that all current automated selections employ (SELECTION version 5.x series 
and higher).  So, although these proofing selections were against targets of low 
complexity, they were indispensable in refining the procedures used for selection against 
higher complexity targets (Chapters 4 & 5).  
EXPERIMENTAL METHODS 
All liquid and mechanical manipulations were carried out by the Beckman 
Biomek 2000 (Fullerton, CA).  In this chapter, the Biomek was interfaced with a PTC-
200 thermal cycler (MJ Research, Watertown, MA), a magnetic bead separator (MPC-
auto96, Dynal, Lake Success, NY), and a Peltier[166] cooler of our own design via a 
Dimension XPS H266 computer (Dell, Round Rock, TX).  These devices and their 
relative orientations are shown in Figure 3-6, which corresponds to SELECTION version 
2.x series (Chapter 2). 
 
Figure 3-6.  Photograph of selection system at SELECTION version 2.x series.  The 
thermalcycler with automated lid is seen in the upper left portion of the picture.  
Interchangeable pipetting tools are in the upper right.  Radioactive tips from the 
experiment were discarded onto a sheet of plastic wrap covering the thermalcycler into a 
radioactive waste container at the lower left. 
The worksurface of the Biomek 2000 was configured as shown in Figure 3-7.  
The Peltier cooler (“Enzyme Cooler”) held enzymes for the amplification steps; all other 
reagents for the selection, such as the binding buffer, were adjacent to the cooler in a 
microplate (“Reagent Tray”). To prevent evaporation of reagents from the microplate 
trays over extended periods of time, the plates were sealed with Beckman Sample and 
Seal Lids, thin adhesive sheets of aluminum foil that the Biomek can easily puncture with 
its pipette tip when aspirating or dispensing a new liquid.  Bulk quantities of wash buffers 
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were kept in a Biomek Modular Reservoir (“Wash Buffers”).  Tips were sterilized prior 




















Figure 3-7.  Schematic of selection system at SELECTION version 2.x series.  The 
relative positions of labware are indicated by the labeled white boxes.  The left side 
module has been removed to integrate a PTC-200 DNA engine. 
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orks 
cripts.  Communication 
betwee
d as previously described[96, 97].  
n were “41.30”, GAT AAT ACG ACT CAC TAT A
The program directing the Biomek’s movements was written mostly in BioW
version 2.2, with small supplemental BioScript Pro library s
n the MJ Research PTC-200 and the Biomek was mediated by a serial connection 
between the thermal cycler and the computer and by Jeff Cahlik’s (Beckman Coulter) 
“MJR Biomek 2000 Driver” version 1.0.  While the MJR thermalcycler could also have 
been directly interfaced with one of the Biomek’s connection ports, Cahlik’s driver 
allowed suspension of the BioWorks program until the completion of the thermal cycler’s 
run.  This obviated the problem of having to guess how long the thermalcycler might take 
to complete its program. 
Oligo dT selection 
Materials for oligo dT selection 
The random pool RNA library was generate
The primers used for amplificatio GG 
GAA TGG ATC CAC ATC TAC GA (T7 RNA polymerase promoter underlined), and 
“24.30”, AAG CTT CGT CAA GTC TGC AGT GAA.  Magnetic beads conjugated to 
(dT)25 were obtained from Dynal (Lake Success, NY).  Barrier pipetting tips (Beckman, 
Fullerton, CA) were used for all liquid transfers.  The 96-well microplates (Falcon 3911 
 72
 experiment, Dynabeads Oligo(dT)25 (20 µl, corresponding 
in a high-salt binding solution (80 µl; 20 mM Tris-HCl (pH 7.5), 1.0 M 
LiCl, a
nce more before resuspending the beads in 53 
µl of w
Microtest III Flexible Assay Plates) were from Becton Dickinson (Oxnard, CA), except 
for those used in the thermal cycler, which were MJ Multiplate 96 microplates (MJ 
Research, Watertown, MA).  
Selection regime 
At the beginning of the
to 6.6x106 beads) 
nd 2 mM EDTA) were loaded into a well in a microplate on the magnetic bead 
separator.  Roughly 1 µg (≈ 1013 sequences) of a random sequence RNA library (N30; 80 
µl in transcription buffer, see below) was added to the beads.  The binding reaction was 
thoroughly mixed by ten cycles of rapid aspiration and dispensing.  The binding reaction 
was incubated at room temperature for 2.5 min, mixed again (ten cycles), and incubated 
an additional 2.5 min.  At the end of incubation, the MPC-auto96 raised magnets between 
the rows of wells in the microplate and captured the magnetic beads along the side of the 
well.  The supernatant was removed (less than 0.5 µl typically left behind).  The magnets 
were then lowered and the beads were resuspended and washed with 100 µl of low-salt 
wash buffer (10 mM Tris-HCl (pH 7.5), 0.15 M LiCl, and 1 mM EDTA) to remove non-
specifically binding nucleic acid species.   
As before, the beads and buffer were mixed by ten cycles of aspiration and 
dispensing.  The wash step was repeated o
ater.  The bead slurry was transferred to a well in the microplate in the PTC-200 
thermalcycler, the lid of the machine was closed, and the slurry was heated to 65ºC for 
three minutes to dissociate nucleic acid binding species from the derivatized beads.  
During the elution the lid of the thermalcycler was kept at 80ºC.  After the elution step, 
the magnetic bead mixture was transferred back to the magnetic particle separator to 
ensure the complete removal of magnetic beads from the eluate.  In order to amplify the 
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d out in a 
uffer (45 µl) was added to the 51 µl of selected RNA 
eluate. 
scriptase (RT) (Amersham Pharmacia 
Biotech
selected RNA molecules, the eluate (51 µl, purposefully leaving behind a small amount 
of liquid) was transferred to a new well of the microplate on the thermal cycler. 
Reverse transcription and PCR 
Conversion of the selected RNAs into double-stranded DNAs was carrie
single step.  RT-PCR reaction b
 Upon mixing and dilution the amplification reaction contained 10 mM Tris-HCl 
(pH 8.4), 50 mM KCl, 1.5 mM MgCl2, 0.2 mM dNTPs, 5% acetamide, 0.05% Nonidet 
P40, and 0.5 µM each of 5’ and 3’ primers.  To follow the progress of the selection, 5 µCi 
of α-32P labeled dATP was also included in the amplification reaction.  The reaction 
mixture was incubated at 65ºC for 10 min (lid = 80ºC) to facilitate denaturation of 
secondary structures present in the selected RNAs that could inhibit reverse transcription.  
Finally, the temperature of the reaction was reduced to 50ºC and 4 µl of RT-PCR enzyme 
solution was added to the pre-warmed mixture.   
The RT-PCR enzyme solution contained 0.2 U of Display Taq (Promega, 
Madison, WI) and 5 U of AMV reverse tran
, Arlington Heights, IL).  To increase the volume of the enzyme mixture to 4 µl, 
these enzymes were diluted into a solution containing 50% glycerol, 10 mM Tris-HCl 
(pH 8.4), 50 mM KCl, and 1.5 mM MgCl2.  Enzymes were not diluted until the start of 
the experiment and were kept in the Enzyme Cooler (-20ºC).  The addition of the enzyme 
mixture brought the final volume of the RT-PCR reaction to 100 µl.  Reverse 
transcription proceeded at 50ºC for 10 min, and the amplification reaction was then 
thermally cycled (45 sec at 94ºC, 60 sec at 50ºC, and 90 sec at 72ºC) seven times.  At the 
end of the RT-PCR reaction, 10 µl (one-tenth) of the products were transferred to a new 
well of the microplate on the thermalcycler.  
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 was added to the newly amplified DNA 
ng and dilution the transcription reaction contained 40 mM Tris-
HCl (p
n (80 µl) was transferred to a well on the 
agnetic beads (6.6x106 beads) in the high-salt 
buffer 
on, 1 µl of the final 
as used to seed 100 µl of a RT-PCR reaction similar to those 
describ
In vitro transcription 
Transcription reaction buffer (87 µl)
templates.  Upon mixi
H 7.9), 26 mM MgCl2, 0.01% Triton X-100, 2.5 mM spermidine, 5 mM 
dithiothreitol, and 2.5 mM of each NTP. To follow the progress of the selection, 5 µCi of 
α-32P labeled UTP was included in the transcription reaction.  Transcription was initiated 
by the addition of 100 U of T7 RNA Polymerase (Stratagene, La Jolla, CA) and 40 U of 
RNasin (Promega, Madison, WI) in a total volume of 3 µl.  The transcription reaction 
was allowed to proceed at 37ºC for 75 min.   
Additional rounds of selection 
A majority of the transcription reactio
magnetic particle separator that contained m
(80 µl).  The binding reaction was mixed as described above, and separation of 
bound and unbound RNAs proceeded as before.  The entire selection and amplification 
procedure was repeated without change for four additional rounds.  
Sequencing 
At the end of the five cycles of selection and amplificati
transcription reaction w
ed above.  Double-stranded products were cloned into pCR2.1 with Invitrogen's 
(Carlsbad, CA) TA Cloning Kit according to the manufacturer’s instructions.  Individual 
colonies were screened for the presence of insert using a colony PCR protocol[167].  
Purified plasmids containing inserts were then sequenced using Epicentre's (Madison, 
WI) Sequitherm Excel II DNA Sequencing Kit according to the manufacturer’s 
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or these selections are identical to the oligo dT selection as described 
above. 
biotinylated nucleic acid was synthesized by Integrated DNA Technologies 
(Corav
or these selections are identical to the oligo dT selection as described 
above. 
 biotinylated PNA was synthesized and purified by Perspective Biosystems 
(Foster
 G.M., J.C. Cox, and A.D. Ellington, Automated optimization of aptamer 
selection buffer conditions. J. Assoc. Lab. Autom., 2004. 9(3): p. 117-122. 
149. turing 
Polyacrylamide Gel Electrophoresis, in Short protocols in molecular biology, F. 
directions.  Because long runs of a single base were expected, the isothermal (rather than 
thermal cycle) sequencing reaction directions supplied with the kit were employed. 
Oligo 15 selection 
Procedures f
 Like the oligo dT selection, the first selection against the 15-mer oligo used a 
lithium-based binding and wash buffer.  For the second selection against this target, we 
used a ‘high-salt’ binding solution of 1X SSC (300 mM NaCl, 30 mM sodium citrate (pH 
7.5)), and a ‘low-salt’ washing solution of 0.1X SSC (30 mM NaCl, 3 mM sodium citrate 
(pH 7.5)).   
The 
ille, IA) and was purified using standard procedures[149]. 
PNA 15 selection 
Procedures f
 Like the oligo dT selection, the first selection against the 15-mer PNA used a 
lithium-based binding and wash buffer.  For the second selection against this target, we 
used a ‘high-salt’ binding solution of 1X SSC (300 mM NaCl, 30 mM sodium citrate (pH 
7.5)), and a ‘low-salt’ washing solution of 0.1X SSC (30 mM NaCl, 3 mM sodium citrate 
(pH 7.5)). 
The
 City, CA).   
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Chapter 4:  Anti-protein selections 
INTRODUCTION 
Before choosing the actual project that I pursued for this dissertation, I was 
interested in the application of aptamers in two different modes.  First, I was attracted to 
the use of aptamers as reagentless biosensors.  As detailed in Chapter 1, aptamers possess 
large similarity to antibodies, given their high affinity and specificity for target binding.  
Although antibodies in general bind to a target more tightly than a competing aptamer, 
the process of aptamer generation is much more adjustable than that of antibody 
generation.  This inherent ability to impart customizability to synthesized or evolved 
nucleic acid binding species allows aptamers to contend with protein-based 
biosensors[106, 148, 168].   
Secondly, I was fascinated by the ability of aptamers to elucidate and define 
nucleic acid motifs recognized by nucleic acid-binding proteins[169].  (Specific examples 
of ligand sequence definition via in vitro selection are featured in Chapter 1.)  Not only 
have aptamers been employed to find these natural motifs, but in some cases have 
improved upon them, generating nucleic acids that bind better than the wildtype 
element[60].  It is this second route that I eventually chose to focus on, and my specific 
efforts in this direction are presented in Chapter 5.  
Although I was initially unsure of which path I wished to dedicate my doctoral 
research efforts, both paths would require the generation of many aptamers against 
protein targets.  At this time, automated selection had already been established (Chapters 
2 & 3), but I had not yet successfully selected against a protein target.  Therefore, we 
elected to perform several anti-protein selections in order to establish automated selection 
protocols specific to the generation of RNA aptamers to protein targets.    
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RESULTS AND DISCUSSION 
This chapter describes some of the successful anti-protein selections performed on 
the automated selection system.  In particular, selections against the targets CYT-
18[146], MEK1[146], lysozyme[145], Rho[146], and Us11[170] are detailed.  CYT-18 is 
a mitochondrial tyrosyl-tRNA synthetase from the fungus Neurospora crassa, and is 
known to interact with RNA with high affinity[171, 172].  MEK1 is a human MAP 
kinase kinase protein[173] and has not been proven to interact with nucleic acids.   Hen 
egg white lysozyme destroys bacterial cell walls, and also is not known to bind nucleic 
acids.  The transcriptional terminator Rho used here is derived from the thermostable 
Archaebacterium Thermotoga martima, whose homologues are recognized to interact 
with a diverse class of nucleic acid sequences.  US11 is a Herpes Simplex Virus-1 RNA 
binding protein of unclear function that interacts with cellular and viral messages[174].   
Automated selection of anti-protein aptamers 
The progress of a typical automated selection is displayed in Figure 4-1.  
Generally, a small increase in binding is seen in the evolved pool at Round 6 (one day of 
selection).  Further selection to Round 12 usually yields a pool with a significant increase 
in binding (two days of selection).  A third day’s selection to Round 18 is sometimes 
performed, depending on the binding affinity and sequence diversity of the pool.  
Immobilization of the protein target to streptavidin-coated paramagnetic beads is done at 
high concentration on the beads, which causes some nonspecific binding of the native 
pool to the target, especially for nucleic acid binding proteins (see Round 0, Figure 4-1).  
This nonspecific binding can be reduced or alleviated during selections or binding assays 
by employing high-salt washes where the high ionic concentration competes for the 


















High salt wash (2.0M)
 
Figure 4-1.  Improvement of pool binding during automated selection.  Shown are 
binding assays for Rho with unselected pool, the Round 6 selected pool and the Round 12 
selected pool.  The three left sets are RNA only (50 nM).  The three right sets are the 
same amount of RNA (50 nM) in the presence of an equimolar amount of Rho (50 nM).  
Light-purple bars indicate binding assays where the filter was being washed using the 
same concentration of monovalent salt as was used during selection (200 mM KOAc).  
Dark-purple bars represent filters that have been washed with a high salt concentration, 
ten times the concentration used during the actual selection (2 M KOAc). 
As mentioned in Chapter 2, the chemistry used on the automated aptamer 
workstation is optimized to amplify DNA and RNA without the need for ethanol 
precipitation or gel purification.  For instance, in the case of the lysozyme selection, 
eighteen rounds of selection were carried out over three day’s time without any template 
purification and without the generation of higher molecular weight species (Figure 4-2).  
Unexpected products usually indicate over amplification or amplification artifacts (recall 
isothermal amplification in Chapter 2) or failure to optimize the nucleic acid pool or 
























































Figure 4-2.  Amplification products generated during automated in vitro selection.  
Shown here are amplification products that accumulated during 18 rounds of selection 
against lysozyme protein.  Each round of selection has one lane containing radiolabeled 
DNA from reverse transcription / PCR reactions, and one lane containing radiolabeled 
RNA from in vitro transcription reactions.  The higher band in the RT/PCR lane in the 99 
nt DNA template, while the shorter band in the TXN lane is the 80 nt RNA strand.  
Because the template for each reaction is radiolabeled, a small amount of template RNA 
is seen in the RT/PCR lanes, and vice-versa for small amounts of template DNA seen in 





In total, four entire selections were performed against CYT-18, summarized in 
Table 4-1.  First, 10 rounds of manual selection was executed using traditional selection 
methods[108].  Next, the last round of the manual selection (round 10) was used as a 
starting pool for 10 rounds of automated selection, taking the total number of rounds to 
20.  This ‘continuation’ selection was performed as those selections described in Chapter 
3, utilizing simple bead washing as the partitioning method (SELECTION version 3.x 
series).  The third selection against CYT-18 was the same as the second, except all 
twenty rounds was performed by the automated selection system.  Finally, the fourth 
experimental selection was the execution of 20 rounds of selection utilizing the higher 
stringency partitioning method of bead rinsing on a vacuum filtration plate (SELECTION 
version 4.x series).  The selections and sequence data are presented first, followed by 
discussion of which selections generated aptamers that inhibited CYT-18’s activity. 
Method Rounds Partitioning Stringency Winnowing Inhibition 
Manual 1-10 Nitrocellulose Decreasing protein - - 
Automated 11-20 Bead washing Same throughout + + 
Automated 1-20 Bead washing Same throughout - - 
Automated 1-20 Vacuum filtration Same throughout + + 
Table 4-1.  Parameters of in vitro selection against CYT-18.  “Rounds” indicates the 
number of rounds of selections performed in that set.  For the case of “11-20”, these 
rounds of selection were continued on the automated selection workstation after being 
initiated manually (“1-10”).  “Winnowing” refers to an obvious reduction in the 
individual population of the selection pool, and “inhibition” refers to the ability of the 
aptamer pool to inhibit the activity of CYT-18. 
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CYT-18 Selection #1:  Manual selection 
I first performed a manual selection to CYT-18 in order to gain more experience 
of selection in general so that I could apply it to robotic anti-protein selections.  I 
employed standard manual selection techniques from the literature[108].  In particular, I 
continually increased the stringency of each round of selection by increasing the 
RNA:protein ratio, decreasing the total amount of protein, adding tRNA as a nonspecific 
competitor, and increasing the amount of salt in the filter washing steps in stepwise 
fashion(Table 4-2).   
Generally, through the entire manual selection, the amount of RNA competing for 
binding to CYT-18 was 1- to 1000-fold greater.  During the experiment, the amount of 
RNA decreased from 1.25 µM to 627 nM, while the protein concentration fell from 1.25 
µM to 620 pM.  Increasing amounts of monovalent salt were employed to increase the 
stringency of selection during washing of the pool/protein complex on the nitrocellulose 
membrane. The wash buffer contained from 100 mM (the same amount as the binding 
buffer) up to 300 mM KCl.  Also, tRNA was introduced in Rounds 5 – 10 of the manual 
selection to act as a nonspecific competitor for CYT-18 binding at levels of 1-, 10-, or 
100-fold in excess of the CYT-18 concentration.  
The result of 10 rounds of manual selection against CYT-18 produced a pool of 
RNA that bound specifically to CYT-18 (Figure 4-3).  Selection pools from rounds 8-10 
were able to associate with CYT-18 better than the ND1, a Group I intron segment that 
forms the P4-P6 domains of the catalytic intron core[171]. Unselected pool displayed 
little affinity for CYT-18 under assay conditions.  Although continuing the selection from 
Round 8 to Round 10 yielded a modest increase in pool affinity for CYT-18, it 
significantly increased the population of nitrocellulose-binding species.  As such, 
selection was stopped at this point and the pool diversity was assayed. 
Round RNA:Protein [RNA] [Protein] [KCl] in wash [tRNA] 
1 1:1 1.25 µM 1.25 µM 100 mM 0 
2 10:1 1.25 µM 125 nM 200 mM 0 
3 50:1 1.25 µM 25 nM 250 mM 0 
4 100:1 1.25 µM 12.5 nM 300 mM 0 
5 10:1 940 nM 94 nM 100 mM 95 nM 
6 1:1 94 nM 94 nM 100 mM 95 nM 
7 10:1 940 nM 94 nM 100 mM 95 nM 
8 100:1 752 nM 7.5 nM 100 mM 76 nM 
9 1000:1 752 nM 750 pM 100 mM 7.6 nM 
10 1000:1 627 nM 620 pM 250 mM 63 nM 
























Figure 4-3.  CYT-18 manual selection binding assay.  Shown are 50 nM equimolar data 
points for either the nitrocellulose membrane and no protein, or with CYT-18.  ND1 
intron is a positive control RNA known to specifically bind CYT-18 with high affinity.  
Round 0 is unselected random pool.  Errors bars indicate standard deviation. 
 85
Sequence analysis revealed the pool population to be almost equally divided into 
three subgroups (Figure 4-4).  Roughly 1/3 of the selection pool possessed high affinity 
and specificity to CYT-18.  Another 1/3 of the pool had evolved into filter binding 
species, demonstrating a high amount of binding to the nitrocellulose membrane used to 
partition binding species from non-binding species during the course of a manual 
selection.  These species evolved despite aggressive negative selection steps during the 
last rounds of selection, filtering the pool through nitrocellulose once before the partition 
step, and twice afterwards.  Finally, the remaining third of the pool failed to demonstrate 
affinity to CYT-18 or nitrocellulose at the assay conditions used. 
CYT-18 Selection #2:  Robotic continuation of manual selection 
Despite the fact that the Round 10 manually selected CYT-18 aptamer pool binds 
specifically to CYT-18 protein and was selected under highly stringent conditions (refer 
to Table 4-2), the pool population remained very diverse.  Of the aptamers that bound 
specifically to CYT-18, none of them were clonal or contained similar motifs between 
their sequences.  Typically, a very diverse nucleic acid pool is often an indicator that the 
selection has not processed to completion.  Because it was uncertain how many more 
manual selections would be required to achieve sufficient reduction in population, we 
continued the selection of this pool on the robotic selection system. 
Starting with the Round 10 pool obtained from manual selection, we resumed 
selection in an automated fashion, under the simple bead-washing protocols of 
SELECTION version series 2.x (Chapter 2), as was done for the nucleobase targets 
(Chapter 3).  This was facilitated by chemically biotinylating the CYT-18 protein and 
immobilizing it on paramagnetic streptavidin-coated beads.  The final round of this 
continuation selection (Round 20) did produce a significantly winnowed selection pool 
(Figure 4-5). 

























Figure 4-4.  Sequences of CYT-18 selection (manual).  The RNA aptamer sequences cloned from the Round 10 manual 
selection pool are shown above.  The random region of the pool is in black text; the static priming regions are in gray.  The 
aptamers are separated into species that specifically recognize and bind to CYT-18, species that have high affinity for the 





CYT-18HybridR20C07 GGGAATGGATCCACATCTACGAATTC TTCACTGCAGACTTGACGAAGCTT 
CYT-18HybridR20C11 GGGAATGGATCCACATCTACGAATTC TTCACTGCAGACTTGACGAAGCTT 
CYT-18HybridR20C12 GGGAATGGATCCACATCTACGAATTC TTCACTGCAGACTTGACGAAGCTT 
CYT-18HybridR20C16 GGGAATGGNTCCACATCTACGAATTC TTCACTGCAGACTTGACGAAGCTT 










CYT-18HybridR20C05 GGGAATGGATCCACATCTACGAATTC TTCACTGCAGACTTGACGAAGCTT 






CYT-18HybridR20C04 GGGA-TGGATCCACATCTACGAATTC T CA TTCACTGCAGACTTGACGAAGCTT 
CYT-18HybridR20C19 GGGAATGGATCCACATCTACGAATTC - TTCACTGCAGACTTGACGAAGCTT 
CYT-18HybridR20C20 GGGAATGGATCCACATCTACGAATTC - TTCA------ACTTG--CAAGCTT 
 
Family 4 
CYT-18HybridR20C15 GGGAATGGNTCCACATCTACGANTTC A AG CA A CAGCT CG TTCACTGCAGACTTGACGAAGCTT 





CYT-18HybridR20C10 GGGAATGGRTCCACATCTACGAATTCCCTTGAGTGCCTATTAGTAGGACGCCCACTTTCACTGCAGACTTGACGAAGCTT  
Figure 4-5.  Sequences of CYT-18 selection (robotic continuation).  The RNA sequences cloned from ten additional rounds of 
selection on the robotic selection system after the initial manual selection are shown above.  The random region of the pool is 
in black text; the static priming regions are in grey.  The aptamers are separated into families of similarity; many of them are 




GAGATGG TT CG G T TCA G
GAGATGG TT CG G T TCA G
 88
CYT-18 Selection #3:  Complete robotic selection 
Having demonstrated the ability to winnow the pool by many magnitudes and 
generate protein aptamers using a combination of manual selection extended by 
automated selection, we repeated the entire selection wholly on the robotic selection 
system.  We had hoped to recapitulate the results of the ‘hybrid’ manual/automated 
selection, in that we would generate a fully winnowed pool that possessed specific CYT-
18 binding.  However, even after 20 rounds of automated selection, we had evolved a 
pool that at best contained populations exhibiting only modest similarity to one another 
(Figure 4-6).  Additionally, the pool from the last round of selection did not bind as well 
as that of the pool from the last round of the ‘hybrid’ selection.   
CYT-18 Selection #4:  Higher stringency robotic selection 
One of the major differences between the ‘hybrid’ and fully automated selection 
was that the hybrid pool was put through a very stringent selection procedure prior to 
continuation on the automated platform.  This was not the case in the completely 
automated selection, which had not been programmed to increase the stringency of 
binding throughout the course of the selection.  A major reason for this is because at the 
time, we did not have the technology to assay the amount of DNA or RNA being 
generated in the amplification steps (Chapter 2).  Additionally, we were hesitant to 
reduce the amount of protein on the magnetic bead surface below a certain point to 
prevent the evolution of specific bead-binding aptamers (Appendix B).  Finally, at the 
time we were unsure of how to implement higher stringency washing steps with wash 
buffers of different salt concentrations.  Later, I did realize an effective way to implement 
that ability and incorporated individualized wash buffer conditions in SELECTION 
version 6.x series and higher (Chapter 2). 
Potential Family 1 
CYT-18BotR20C09 GGGAATGGATCCACATCTACGAATTCGGGTGT G T T CGC
GGGTGT G T CGCGGC
GGGAGT G T T CG CGG
GGGTG T CG CGC
TA AG TCCCGCA CTTCGCT TTCACTGCAGACTTGACGAAGCTT
CYT-18BotR20C11 GGGAATGGATCCACATCTACGAATTC CA TC CAGTAGCAATCC TTCACTGCAGACTTGACGAAGCTT
CYT-18BotR20C16 GGGAATGGATCCACATCTACGAATTC GC AG CGTGCAG GGTG G TTCACTGCAGACTTGACGAAGCTT
CYT-18BotR20C06 GGGAATGGATCCACATCTACGAATTC AGGATCCAGAATCT GGCG G TTCACTGCAGACTTGACGAAGCT 
 
Potential Family 2 
CYT-18BotR20C12 GGGAATGGATCCACATCTACGAATTC TACGT GTGTG CA C G G CTTCACTGCAGACTTGACGAAG 













CYT-18BotR20C20b GGGAATGGATCCACATCTACGAATTCGTGTCGAGTTACAGGGAATCAACCGCGGGGTTCACTGCAGACTTGACGAAGCTT  
Figure 4-6.  Sequences of CYT-18 selection (wholly automated).  The RNA sequences cloned from Round 20 of a wholly 
automated selection to CYT-18 protein are shown above.  The random region of the pool is in black text; the static priming 
regions are in grey.  The aptamers are separated into families of similarity.  Regions of similarity are highlighted in red bold 
text. 
GTAG AG GA CA GG C G
GTAG AG GA CA GG C G
 89
 90
In order to impart a higher level of stringency during the partitioning of non-
specific species from aptamers that were binding specificity to CYT-18, we modified the 
selection protocols to perform a ‘beads-on-filter’ selection.  Filtration-based partitioning 
methods had been previously shown to be more effective than simple bead capture in 
manual selections[176].  We implemented new methods so that after the nucleic acid pool 
was incubated with beads derivatized with target, the beads/pool mixture was dispensed 
on top of a 96-well filter plate.  Wash buffer is then pipetted on top of and filtered 
through the beads and filter membrane, or used to resuspend the beads off the filter 
membrane or more stringent washing (see Experimental Methods).  Much like the third 
CYT-18 selection, we performed another in vitro selection experiment going through 20 
rounds of completely automated selection using this new procedure.  The result of this 
selection was a highly winnowed selection pool (Figure 4-7).  
Aptamer / ligand competition and inhibition of CYT-18 
We wished to see how analogous robot-evolved aptamers were to those generated 
from traditional manual selections.  We characterized several aptamers from the CYT-18 
selections to determine binding affinity, the ability of aptamers to compete for CYT-18’s 
active site with its natural ligand, and whether evolved aptamers could inhibit protein 
activity.  Binding assays (Figure 4-8) demonstrated that aptamers bound well to CYT-18, 
and in some cases better than the natural ligand, ND1 intron.   
In order to ascertain if the aptamers were binding to the same site as ND1, we 
performed aptamer competition assays (Figure 4-9).  We found that not only could 
aptamers compete with ND1, but that some aptamers actually out-competed the intron for 
the ND1 binding site (Table 4-3).  This is especially remarkable given that the binding of 
ND1 to CYT-18 has been shown to have a dissociation constant of 300 fM[116].
 
Family 1 




CYT-18beadsR20C3   GGGAATGGATCCACATCTACGAATTC TTCACTGCAGACTTGACGAAGCTT 




CYT-18beadsR20C7   GGGAATGGATCCACATCTACGAATTC TTCACTGCAGACTTGACGAAGCT-
CYT-18beadsR20C11  GGGAATGGATCCACATCTACGAATTC TTCACTGCAGACTTGACGAAGCTT
 
Family 3 
CYT-18beadsR20C1   …ATGGATCCACATCTATGAATTCGAGCACGATCAT TACGCGCGG---------TTCACTGCAGACTTGACG…
CYT-18beadsR20C5   …ATGGATCCACATCTACGAATTC---GGCAGATTC ACTGAGAGACGC------TTCACTGCAGACTTGACG…




CYT-18beadsR20C9   GGGAATGGATCCACATCTACGAATTCGACAGCTGACTTGCTTTCTCCACGCGCCGCTTCACTGCAGA-TTGACGAAGCTT 
CYT-18beadsR20C10  GGGAATGGATCCACATCTACGAATTCGGGAACTTAATCCAGGAGCGCACTGCGATGTTCACTGCAGACT-GACGA-GCT- 
CYT-18beadsR20C8   GGGAATGGATCCACATCTACGAATTCGATTGACTTACCAGTATACAGTCCTGGTGCTTCACTGCAGACTTGACGAAGCTT 
CYT-18beadsR20C16  GGGAATGGATCCACATCTACGAATTCGGAACACAAGTTAACACACGTTGCGCGGGGTTCACTGCAGACTTGACGAAGCTT 
CYT-18beadsR20C19  GGGAATGGATCCACATCTACGAATTCGAAAAACAGGAGAACATGAAGTGCCGCGGTGTTCACTGCAGACTTGACGAAGCTT  
Figure 4-7.  Sequences of CYT-18 selection (“beads on filter” method).  The RNA sequences cloned from Round 20 of a 
automated selection to CYT-18 protein using a higher stringency partition protocol are shown above.  The random region of 
the pool is in black text; the static priming regions are in grey.  The aptamers are separated into families of similarity; some of 
them are clonal.  Regions of similarity are highlighted in red bold text.  The overall positioning of the aptamers in Family 3 











































































Figure 4-8.  Binding abilities of selected CYT-18 aptamers.  The amount of 50 nM 
equimolar RNA:protein complexes retained on modified cellulose filters are shown.  
Light-blue bars indicate the amount of aptamer signal seen in the absence of CYT-18; 
dark-blue bars show the CYT-18-dependent aptamer signal.  The four leftmost columns 
are aptamers that do not inhibit CYT-18-assisted splicing, while the middle four sets are 
aptamers that do.  Binding to wildtype RNA ligand, ND1, is shown at right. 
As previously stated, CYT-18 is derived from the mitochondria of the fungus N. 
crassa, and is an necessary cofactor for the catalytic splicing of the ND1 intron[172].  In 
total, five families of aptamers were identified that could completely inhibit the CYT-18 
dependence on intron splicing (Figure 4-10; summarized in Figure 4-11).  Four of the 
aptamer families were evolved from the ‘hybrid’ selection, where the robotic platform 
continued with a diverse pool generated from manual selection.  The other family arose 
during the completely automated selection where the ‘beads-on-filter’ partitioning 
technique was employed in hopes of refining the most specific and best binding 


























Figure 4-9.  Anti-CYT-18 aptamers compete with the natural ligand.  The left portion of 
the gel shows reaction mixtures prior to protein addition.  The higher molecular weight 
band is ND1 (~200 nt), while the lower bands are various aptamers (80 nt).  In addition to 
the five selected aptamers, unselected RNA (Round 0 of the N30 pool) or no RNA were 
included as negative controls. 
 
 
Aptamer name Competitor bound : ND1 bound 
CYT-18HybridR20 C03 2.14 
CYT-18HybridR20 C05 1.26 
CYT-18HybridR20 C12 8.73 
CYT-18HybridR20 C19 7.32 
CYT-18BeadsR20 C11 0.80 
Round 0 (N30 pool) 0.04 
Table 4-3.  CYT-18 aptamer competition ratios.  A phosphorimager was used to determine 
the ratio of aptamer bound RNA : ND1 bound RNA in Figure 4-7; these values are shown 











- + - + - + - + - + - + - +
- + - + - + - + - + - + - + - +
HybridC05 HybridC12 HybridC19
Figure 4-10.  Anti-CYT-18 aptamers inhibit splicing activity.  Aliquots of each splicing 
reaction prior to the addition of GTP magnesium (minus sign) and after addition of the 
mixture (plus sign) are shown.  The higher molecular weight band in unspliced intron 
(~200 nt), while the shorter molecular weight band is spliced intron (~170 nt).  Three 
aptamer families and one outlying aptamers generated from the hybrid selection are 
shown to inhibit CYT-18’s ability to splice Group I introns (Figure 4-3).  One aptamer 
family from the completely automated CYT-18 selection is also seen to inhibit CYT-18’s 
ability to splice (Figure 4-5).  “No aptamer” and “no CYT18” controls exhibit no protein-
independent splicing or aptamer-independent inhibition. 
It is interesting to note that these inhibiting aptamers have much better affinity for 
CYT-18 than the aptamers which do not inhibit splicing (Figure 4-8).  Additionally, these 
aptamers correspond to the ‘robotically-assisted’ selection (#2) and the ‘beads-on-filters’ 
higher stringency selection method (#4).  Aptamers generated in a completely automated 
manner using simple bead washing (CYT-18 selection #3) did not inhibit splicing activity 
whatsoever; neither did manually evolved aptamers (CYT-18 selection #1). 
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Selection #1 (Manual)       Inhibiti
CYT-18AllManR10C01 GCGACGTAACTGGCTTCTGAGTCATTCGAG    















ACACGATCAAGAGAGCAGTTTTGACGCGCC     
ACACGATCAAGAGAGCAGTTTTGACGCGCC
AAGCTACAGTCAATATCAACAAAGGGTTCAG    
AAGCGACAGTCAATATG-ACAAAGGGTTCAG 
AAGCGACAGTCAATATG-ACAAAGGGTTCAG    
GAGATGGATTAGCGCAGATCAGCTTCACGG     no

















CYT-18HybridR20C02 AGTGGGATGAAATCGGCTAGAGGAGTCAGG     no 
CYT-18HybridR20C03 AAGGCTGGCAAGGTCGTTTGTCTGTAGGAAGTTTCAG     yes 
CYT-18HybridR20C10 CCTTGAGTGCCTATTAGTAGGACGCCCACT     no 
 









Selection #4 (‘Beads on filter’)
GGGTGTTAGAGTTCCCGCATCTTCGCTCGC     
GGGTGTCAGTCTCAGTAGCAATCCCGCGGC     no
GGGAGTGCGAGTCGTGCAGTGGTGCGGCGG     
GGGTGAGGATCCAGAATCTTGGCGCGGCGC     
GTAGTACGTAGGTGTGGACACACGGGCGGC     
GTAGCGTAGAGTATGAGAGCCAAGGTCAGG     
 
CYT-18beadsR20C2   
CYT-18beadsR20C3   no 
CYT-18beadsR20C15   
 
CYT-18beadsR20C7   yes 
CYT-18beadsR20C11  
 
CYT-18beadsR20C1   GAGCACGATCAT GG      no 
CYT-18beadsR20C5   GGCAGATTCA       no 
CYT-18beadsR20C4   GTG       no 
GCGTACGCGACTTTCATGCGGCCACAGCGG 
GGCTACGCGACTTTCATGCGGCCACAGCGG      
GGCTATGCGACTTTCATGCGGCCACAGCGG





Figure 4-11.  CYT-18 aptamer inhibition list.  Major aptamer families evolved from 
CYT-18 selections are shown with the static priming regions removed, and similarities 
between families highlighted in red bold text.  Aptamers found to inhibit CYT-18 are 
labeled “yes”, while aptamers that lack the ability to inhibit CYT-18 are labeled “no”. 
 95
Method Rounds Partitioning Stringency 
Manual 1-8 Nitrocellulose Decreasing protein 
Automated 9-14 Vacuum filtration Same throughout 
Table 4-4.  Parameters of in vitro selection against MEK1.  “Rounds” indicates the 
number of rounds of selections performed in that set.  For the case of “9-14”, these 
rounds of selection were continued on the automated selection workstation after being 
initiated manually (“1-8”). 
MEK1 is another example of a manual selection that was continued on the 
aptamer selection robot (Table 4-4).  Student Manjula Rajendran had selected against this 
kinase through eight rounds of manual selection.  While the manual selection did 
generate a pool with affinity for MEK1, there was no observable consensus sequence of 
the pool members (Figure 4-12).  Not only that, but the manual selection had also 
evolved peculiar aptamers containing homonucleotide tracts.  While these aptamers did 
bind to MEK1, they bound with less affinity than the pool overall. 
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MEK1 selection 
I started an automated selection of MEK1 using Manjula Rajendran’s Round 8 
pool as the starting random pool and employed the new ‘beads-on-filter’ protocols 
developed during the CYT-18 selection (SELECTION version 4.x series).  This 
continuation selection was performed as identically as possible to the manual selection, 
using the same selection buffer, amount of protein per selection round, etc.  The end 
result of this selection was a pool with similar affinity for MEK1, but with the emergence 
of two clonal and one non-clonal family (Figure 4-13).  Additionally, the weak-binding 
homonucleotide tract aptamers were not observed in the final pool (Round 14). 
 
Homonucleotide tracts 
mk 8.13   GGGAATGGATCCACATCTACGAATTCAAACAGGGTTGGAGGGGGGGGAGAGAAAAG------------TTCACTGCAGACTTGACGAAGCTT
mk 8.21   GGGAATGGATCCACATCTACGAATTCAAACATAGGGAGGTGGGGGGGGAGTTAAGG------------TTCACTGCAGACTTGACGAAGCTT
mk 8.2    GGGAACGGATCCACATCTACGAATTCTTTTTTTTTTTTTTTTTTTTTGGTGCTACAGTTTTGGCACCGTTCACTGCAGACTTGACGAAGCTT
mk 8.15   GGGAATGGATCCACATCTACGAATTCTTAAAAAAAAAAAAAAGTGGAACCTCTTTTTAACACA-----TTCACTGCAGACTTGACGAAGCTT
mk 8.22   GGGAATGGATCCACATCTACGAATTCAATTTTTTTTTTAGTGGCTATTTGGTCGATCG----------TTCACT-CAGACTTGACGAAGCTT
 
Non-familial members 
mk 8.1    GGGAATGGATCCACATCTACGAATTCGGTGCGAGCTTACATGATCTGCCTCCGTAGTTCACTGCAGACTTGACGAAGCTT 
mk 8.5    GGGAATGGATCCACATCTACGAATTCGATGGGTCCAGAAATATTGCTTATTTGCCCTTCACTGCAGACTTGACGAAGCTT 
mk 8.10   GGGAATGGATCCACATCTACGAATTCGAGATACCCTGCTGATACACTCTCAGATGATTCACTGCAGACTTGACGAAGCTT 
mk 8.12   GGGAATGGATCCACATCTACGAATTCTAATAAAGTGTACACAACAAGTTTCTATTGTTCACTGCAGACTTGACGAAGCTT 
mk 8.16   GGGAATGGATCCACATCTACGAATTCAGAATTACGGGTAGGAGGGTAGGGCTGGGATTCACTGCAGACTTGACGAAGCTT 
mk 8.17   GGGAATGGATCCACATCTACGAATTCGTTGTATACCAACATGACGACGCCGGTTCGTTCACTGCAGACTTGACGAAGCTT 
mk 8.20   GGGAATGGATCCACATCTACGAATTCGTGGGTCTAGAGCTTTTGTGACTCTCGTCCTTCACTGCAGACTTGACGAAGCTT 
mk 8.24   GGGAATGGATCCACATCTACGAATTCGGGAGGTGAGGAGTGGGCTAGTAGATGTGGTTCACTGCAGACTTGACGAAGCTT 
Figure 4-12.  Sequences of MEK1 selection (manual).  Aptamers evolved from a traditional manual selection are shown, with 
the static priming region shaded grey and the random region in black.  Regions of homonucleotide tracts are highlighted in 




mk 14.3   GG-AATGGATCCACATCTACGAATGC TTCACTGCAGACTTGACGAAGCTT 
 
Family 2
mk 14.1   GGGAATGGATCCACATCTACGAATTCGCTAATACGAGCTGCTAATAACTATAATAA
GCTAATACGAGCTGCTAATAACTATAATAA
 
mk 14.5   GGGAATGGATCCACATCTACGAATGC TTCACTGCAGACTTGACGAAGCTT 






mk 14.2   GGGAATGGATCCACATCTACGAATTC-----AGCGCATAAC G T GTTCACTGCAGACTTGACGAAGCTT 
mk 14.14  GGGAATGGATCCACATCTACGAATTC-------TGCAGGCT G ATTCACTGCAGACTTGACGAAGCTT 









mk 14.4   GGGAATGGATCCACATCTACGAATTCGCACTATATTTAGTGCTGGGAGTCGGATYATTCACTGCAGACTTGACGAAGCTT 
mk 14.6   GGGA-TGGATCCACATCTACGAATTCAAGCATGCAGTGGCATAACTACAATAACAATTCACTGCAGACTTGACGAAGCTT 
mk 14.8   GGGAATGGATCCACATCTACGAATTCTTTAATCTTTGGGTCGGGTTGACTCGTTGCTTCACTGCAGACTTGACGAAGCT- 
mk 14.9   GGGAATGGATCCACATCTACGAATTCGGAACATAGCATACTGCATCCCTCCATCTATTCACTGCAGACTTGACGAAGCTT 
mk 14.10  GGGAATGGATCCACATCTACGAATTCGTGTGCAAGATAAACCCACAGCGTTGCTC-TTCACTGCAGACTTGACGAAGCTT 
mk 14.11  GGGAATGGATCCACATCTACGAATTCTTTAGCTCCGAATATTGGAGATAGTCATACTTCACTGCAGACTTGACGAAGCTT 
mk 14.12  GGGAATGGATCCCCATCTACGAAT-CAAGAATSCCACCAAGACACGGTTCAAACTGTTCACTGCAGACTTGACGAAGCTT 
mk 14.17  GGGAATGGATCCACATCTACGAATTCTAAGAATAAGAGGGCGAAAAGCCCCGTGCGTTCACTGCAGACTTGACGAAGCTT  
Figure 4-13.  Sequences of MEK1 selection (robotic continuation).  Aptamers evolved from the continuation of a traditional 
manual selection on the automated selection system are shown, with the static priming region shaded grey and the random 
region in black.  Regions of similarity are highlighted in bold red text.  Sequences courtesy of Manjula Rajendran. 
Lysozyme selection 
Despite the fact that hen egg-white lysozyme is not recognized as a nucleic acid 
binding protein, it has several other values that makes it a desirable ‘test’ target for anti-
protein selections.  Lysozyme is commercially available with high purity at low cost, it is 
relatively stable, and has an overall positive charge, as do most nucleic acid binding 
proteins.  Twelve rounds of ‘beads-on-filter’ selection was performed against lysozyme. 
Lysozyme aptamers characterization 
The nucleic acid pool from the last round of selection (Round 12) was cloned and 
sequenced.  Analysis showed that the selection pool had been largely winnowed to only 
six individual sequences (Figure 4-14), with one individual (Clone 1) comprising the 
simple majority of the population.  This accounts for an enrichment of better than 1012-
fold, given that the initial random pool had a diversity of approximately 1.1x1014 unique 







Clone 1. ATCAGGGCTAAAGAGTGCAGAGTTACTTAG 
  20/33 clones = 61% of sequences 
 
Clone 2. GGTGATCATGGCAGTGTACGCGGGCGGAC
  4/33 clones = 12% of sequences 
 
Clone 3. GGTTGTGAAGATTGGGAGCGTCGTGGCTA
  3/33 clones = 9% of sequences 
 
Clone 4. GTAAATCGTCGACAGGAATTGGCGGGCCG
  3/33 clones = 9% of sequences 
  
Clone 5. GAATTGCGACAGTCGGGACATGTCGCGAG
  2/33 clones = 6% of sequences 
 
Clone 6. GGAATGAGTGCCCTGCAAGCGAGGGCTAG
  1/33 clones = 3% of sequences  
Figure 4-14.  Sequences of lysozyme selection.  Shown are the clonal families remaining 
after 12 rounds of selection.  Only the random region (30 nt) is shown.  The approximate 
population of each clone is given as a percentage. 
Next, clones were assayed for binding ability.  Due to the positive charge of 
lysozyme, the initial unselected random pool demonstrated fair affinity for the protein 
when assayed in the selection buffer.  However, we employed more stringent assay 
conditions for evaluating binding which scarcely reduced the binding of the evolved 
clones while eliminating the vast majority of non-specific binding from the initial random 
pool (refer to Experimental Methods).  In the higher stringency buffer, Clone 1 decreased 
only 9% in signal from 74.6% to 68.1% bound, while native pool signal decreased 96% 
in signal from 19.6% to 0.8% bound.  Binding abilities under higher stringency 


























Figure 4-15.  Binding abilities of lysozyme aptamers.  The binding abilities for the 
lysozyme aptamers are shown under higher stringency assay conditions.  Light-green bars 
illustrate percent binding of 500 nM aptamer in the absence of protein, while dark-green 
bars show percent binding in the presence of 500 nM lysozyme.  Clones 2-6 were assayed 
for binding to biotinylated lysozyme, while Clone 1 was assayed for both ‘plain’ and 
biotinylated lysozyme.  Error bars show standard deviation of triplicate data points. 
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In this selection, the most populous clone (Clone 1, 66% of the population) was 
also the one demonstrating highest binding affinity.  Under stringent assay conditions, 
Clone 1 bound lysozyme 87-fold better than the unselected pool (Round 0).  In fact, with 
the exception of Clone 4 (9% of the population), all clones showed much higher affinity 
for lysozyme that the initial random nucleic acid pool.  Additionally, all clones except 
Clone 2 (12% of the population) exhibited strong protein-dependent responses in binding 
signal.  This is a good indicator that the steps we employed to minimize the accumulation 
of filter binding species was successful.   
While the selection was performed against biotinylated lysozyme, the best 
aptamer (Clone 1) actually revealed higher binding affinity for ‘plain’ lysozyme over 
unbiotinylated lysozyme (Figure 4-16).  The complex of Clone 1 with unmodified 
lysozyme was determined to have a dissociation constant of 31 nM, while the same 
aptamer complexed with the chemically biotinylated form of lysozyme had a dissociation 
constant of 65 nM.  Given that the major specie of this selection did not evolve to 
specifically recognize the biotin moiety of the selection target proved encouraging that 
future automated aptamers selections would yield binding species that specifically 
recognized the target rather than the target’s immobilization chemistry.  This has been 
demonstrated for other automated selections as well, such as U1A (Chapter 5). 
Aptamer inhibition of lysozyme 
Lysozyme is an enzyme well known for its ability to damage bacterial cells walls, 
ultimately causing lysis of the cell.  As with the CYT-18 aptamers, we wished to 
determine whether robotically-generated aptamers could again inhibit the natural function 
of a protein.  Thus, we employed a standard lysozyme activity assay[177, 178] in the 
presence of the best binding clone and also unselected random pool, monitoring the 









































































































































































Figure 4-16.  Clone 1 : lysozyme dissociation constant curves.  Shown on the left is the 
multiple concentration binding curve of Clone 1 aptamer for ‘plain’ lysozyme, and on the 
right for biotinylated lysozyme.  Data points (red) are shown with errors bars illustrating 
the standard deviation of triplicate data points.  The curve fit for y=(a*x)/(b+x) is shown 
(blue line) and provides a dissociation constant for ‘plain’ lysozyme of 31 nM (R2 = 9.70) 
and for biotinylated lysozyme of 65 nM (R2 = 9.84). 
The change in absorbance (450 nm) of a Micrococcus culture was used to monitor 
the extent of lysozyme activity.  When lysozyme destroys bacterial cell walls, the 
resultant debris is too small to obscure light which causes a decrease in the absorbance of 
the culture[178].  Indeed, the incubation of lysozyme with Micrococcus cells caused a 
decrease in the absorbance of the cell culture (Figure 4-17; green line).  However, 
incubation of lysozyme with the bacteria cells in the presence of a 10-fold excess of 
Clone 1 completely abolished lysozyme activity during the assay (Figure 4-17; blue line).  
Conversely, a control reaction where the same amount of unselected random pool (Round 























Cells + lysozyme + Family 1
Cells + lysozyme + Round 0
Figure 4-17.  Anti-lysozyme aptamer inhibits lysozyme.  The cytolytic effect of lysozyme 
is plotted as a function of the decrease of a cell culture over time.  Cells only (black) 
maintain their absorbance while cells incubated with lysozyme (green) lose absorbance.  
Cells that are incubated with lysozyme and the Clone 1 aptamer (blue) demonstrate no 
discernable decrease in absorbance while cells incubated with the same amount of native 
pool (red) are efficiently lysed. 
Rho selection 
Eighteen rounds of selection were performed against the Rho protein, isolated 
from the Archebacterium Thermatoga maritima, in collaboration with Alan Friedman’s 
laboratory at Purdue University.  Rho is a nucleic acid binding protein that causes 
protein-dependent transcriptional termination via interaction with sequences that are 
poorly defined but cytosine rich[179].  A previous manual selection had been performed 
by Schneider et al. on Rho isolated from the Eubacterium E. coli[180].  The authors had 
found that the best binding species had predominately high C:G ratios, implying an 
unstructured recognition sequence due to the large amount of unpaired cytosines.  We 
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wanted to see how automated selection methods fare in comparison to manual 
techniques, and set out to determine whether the aptamer selection robot would generate 
a pool of similar sequence bias, or if the generation of distinct aptamer families would 
arise as they did for the previously described anti-protein selections. 
The nucleotide distribution frequencies for each six rounds of selection are 
provided in Table 4-5.  The first six rounds of selection (Figure 4-18) yielded a pool with 
a C:G ratio  of 1.4 : 1, and the next six selection cycles (Round 12; Figure 4-19) saw an 
increase of C:G ratio to 2.2 : 1.  While another six cycles of selection (Round 18; Figure 
4-20) was carried out using increasingly higher salt concentrations in the wash buffer, the 
cytosine richness failed to increase past a C:G ratio of 2.2 : 1.   
 
Population Round 0 Round 6 Round 12 Round 18 
C:G ratio < 1 85% 23% 0% 0% 
C:G ratio = 1 0% 4% 7% 0% 
C:G ratio > 1 15% 73% 93% 100% 
C:G ratio > 2 0% 37% 75% 62% 
Overall C:G ratio 0.7 : 1 1.4 : 1 2.2 : 1 2.2 : 1 
     
A:T ratio < 1 31% 15% 18% 14% 
A:T ratio = 1 23% 8% 7% 7% 
A:T ratio > 1 46% 77% 75% 83% 
A:T ratio > 2 8% 35% 43% 38% 
Overall A:T ratio 1.0 : 1 1.6 : 1 1.8 : 1 1.5 : 1 
Table 4-5.  Nucleotide distribution of anti-Rho aptamers.  The calculated base ratios are 
derived from the random sequence region of the aptamers. 
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The application of higher stringency wash buffers had proved a valid technique in 
past anti-protein selections.  While it did not elicit an increase in the overall C:G ratio of 
the selection pool, it did facilitate the generation of clonal aptamer families containing a 
consensus sequence of (T)CACCT.  Aptamers with this consensus were observed at 
lower frequency in the Round 6 and 12 pools, but did not begin to predominate until the 
higher salt washes employed in Rounds 13-18.  Overall, this caused the ratio of binding 
species with a C:G ratio > 1 to rise from 93% to 100%, but conversely decreased the 
number of aptamers with the higher C:G ratio > 2 to fall from 75% to 65%. 
Unlike the manual selection against Rho from E. coli performed by Schneider et 
al., our selections also demonstrated a non-random distribution of unpaired adenosine 
residues as well.  The first six rounds of selection gave way to a pool with an A:G ratio of 
1.6 : 1.  This ratio enlarged during the next six rounds of selection (Round 12) to 1.8 : 1.  
However, the employment of the high stringency wash buffers in Rounds 13-18 resulted 
in an overall decrease in A:G ratio to 1.5 :1.  As above with the C:G ratio of the pool, the 
use of high salt washing buffers increased the number of aptamers with A:G > 1 from 
75% to 83%, but decreased the number of aptamers where A:G > 2 from 43% to 38%.  
The evolved aptamers also exhibited high affinities for Rho, increasing their 
binding strength as the selection progressed through rounds.  Aptamers isolated from the 
Round 6 pool were determined to possess dissociation constants in the range of 45 – 80 
nM.  Six additional rounds to the Round 12 pool yielded clones with dissociation 
constants of 4 – 48 nM.  Another six rounds with increasingly stringent wash buffer 
conditions resulted in species that bound with dissociation constants between 1 – 10 nM.  
The improvement in pool binding seems to correspond with the overall increase in the 
cytosine richness of the pools and the winnowing of diversity to produce familial clones 















Figure 4-18.  Sequences of Rho selection (Round 6).  Aptamer sequences derived from the 6th round of selection against Rho 
are shown.  Static priming regions are in grey text; the random region of the aptamer is black text.  Cytosines have been 
highlighted in red text, and the (T)CACCT motif sequence is emphasized by a yellow box.  The A:T and C:G ratios are given. 
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                                                                                              A:T     C:G
“(T)CACCT” sequences 
RhoR06C11  GGGAATGGATCCACATCTACGAATTCGC C C CC C TC CAT AATA A TAG TGGGTAAG GT TTCACTGCAGACTTGACGAAGCTT   8:7     8:7
RhoR06C13  GGGAATGGATCCACATCTACGAATTC A T AA AGG A TT TTCACTGCAGACTTGACGAAGCTT   7:10   10:3 
 
Non-familial sequences 
RhoR06C01  GGGAATGGATCCACATCTACGAATTCG TAGAG AA GTAT T GG GA TTTCACTGCAGACTTGACGAAGCTA   6:5    12:7
RhoR06C02  GGGAATGGATCCACATCTACGAATTC TG TGG G AAA CTTCACTGCAGACTTGACGAAGCTT   8:6     8:8
RhoR06C03  GGGAATGGATCCACATCTACGAATTCGTAAA GAAATGGGA GGATAAAAAGGGTTCACTGCAGACTTGACGAAGCTT  13:4     2:11
RhoR06C04  GGGAATGGATCCACATCTACGAATTCAAGATAG TAAA TA AT AAGGG GATTCACTGCAGACTTGACGAAGCTT  13:4     7:6
RhoR06C05  GGGAATGGATCCACATCTACGAATTCAAAGAAT A AGA GT A AATTCACTGCAGACTTGACGAAGCTT  13:2     9:6
RhoR06C06  GGGAATGGATCCACATCTACGAATTCGAAAT T TA TTTAGG A TTCACTGCAGACTTGACGAAGCTT   9:7    10:4
RhoR06C07  GGGAATGGATCCACATCTACGAATTCAG GGGG A AATAGT T A T G TTTACTGCAGACTTGACGAAGCTT   9:4    10:7
RhoR06C08  GGGAATGGATCCACATCTACGAATTCGTGA T GTT AAG T GA TTCACTGCAGACTTGACGAAGCTA   5:8    11:6
RhoR06C09  GGGAATGGATCCACATCTACGAATTCGT G A TAG TTCACTGCAGACTTGACGAAGCTT   9:5    13:3
RhoR06C10  GGGAATGGATCCACATCTACGAATTCGAA A TGA A TTCACTGCAGACTTGACGAAGCTT  11:6    10:3
RhoR06C12  GGGAATGGATCCACATCTACGAATTCGGGGT TAAT A AA GGGG TTCACTGCAGACTTGACGAAGCTT  10:5    6:9 
RhoR06C15  GGGAATGGATCCACATCTACGAATTCGGGA AGA GT A G A GGAA TTCACTGCAGACTTGA----GCTT   8:1    10:11
RhoR06C16  GGGAATGGATCCA--TCTACGAATTC AT ATTA AA AGTT GG TTCACTGCAGACTTGACGAAGCTA   8:9     9:4
RhoR06C17  GGGAATGGATCCACATCTACGAATTC GAGAT AGGTA TT AT GATTCACTGCAGACTTGACGAAGCTA   8:6    11:5
RhoR06C18  GGGAATGGATCCACATCTACGAATTC GAG AG TTTAA G TTCACTGCAGACTTGACGAAGCTA  11:5     8:6
RhoR06C19  GGGAATGGATCCACATCTACGAATTCGAATA GAAA TTG G TTCACTGCAGACTTGACGAAGCTT  11:5    10:4
RhoR06C24  GGGAATGGATCCACATCTACGAATTC A T T TG TA TA A AA TTCACTGCAGACTTGACGAAGCTT   8:8    12:2
RhoR06C25  GGGAATGGATCCACATCTACGAATTC GGAAGTG T TAGA GT TTCACTGCAGACTTGACGAAGCTT   9:4     6:11
RhoR06C26  GGGAATGGATCCCCATCTACGAATTCGGGAG AA A A AG GG TTTCACTGCAGACTTGACGAAGCTT   7:2    13:8
RhoR06C27  GGGAATGGATCCACATCTACGAATTC GAGA AAAT GTTCACTGCAGACTTGACGAAGCTT   5:8    12:5
RhoR06C28  GGGAATGGATCCACATCTACGAATTC A TAG GGA TTCACTGCAGACTTGACGAAGCTT  10:7     8:5
RhoR06C29  GGGAATGGATCCACATCTACGAATTC G AGATTAG GTT TGGATTAAAG TTCACTGCAGACTTGACGAAGCTA   7:7     7:9
RhoR06C30  GGGAATGGATCCACATCTACGAATTCGGAGAT AGG AA GGGAGGGG TAAGA TTCACTGCAGACTTGACGAAGCTT  10:3    4:13
RhoR06C31  GGGAATGGATCCACATCTACGAATTC GA G T TAAAT GT A GTTCACTGCAGACTTGACGAAGCTT   7:4    12:7
GTATTC CTT C CC C CC CACTT
C C C CCCC C CC CC
GAG CTGTC CAAACC CGTTA C
C CTG
C C CAC CC C
CC AGAGC CCGC CC C
C C CC TAAC CACCGCC
C C C C CC C CAAC CA
C CCC C C TTGTC ACCCC
CATCACCCAAATC CCCC C ATCAC
CAT CCT CATAACGCTC CCATCA
CAATA C CATC ACG C
CG C C CAGC CC CGC C
C AATC C TCCTCTC C CG
CCC C CCAC C CTACC
AAG CAACC CCGCT C TAAAC
C CCATATAAC CCCACC C
CC C C C GC CC AC TTTACC C
AAG CGCAGCC GGA CC A
C CCGCCCTACC C CC C C
CC CTCGCCTCCTTGCTCTTC C
GATC CTTTATCAA CCATCAAGC C
C C CC CGGC C
C AC C C T
C C CGC CGGCCACAC C C C
                                                                                        1.6:1    1.4:1    
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                                                                                                 A:T     C:G 
“(T)CACCT” sequences 
RhoR12C01  GGGAATGGATCCACATCTACGAATTCGTC CC CC CC C C CC CA T G AGT ATT TGT TG AA---TTCACTGCAGACTTGACGAAGCTT   5:8    12:5 
RhoR12C15  GGGAATGGATCCACATCTACGAATTCGT A T AGT TG AGA ---TTCACTGCAGACTTGACGAAGCTT   7:4    14:5 C CC CACC AAC CGCCCC CC
RhoR12C12  GGGAATGGATCCACATCTACGAATTCG AA T AGTA ---TTCACTGCAGACTTGACGAAGCTT   8:4    12:5 C CACC C CAACGCCGACCGCTTC
RhoR12C19  GGGAATGGATCCACATCTACGAATTCG G A TTA A TA TTG TTGG ---TTCACTGCAGACTTGACGAAGCTT   5:7    12:6 C CGCAC CC C C CC C C
RhoR12C26  GGGAATGGATCCACATCTACGAATTC TTG GT GA T A ATG ---TTCACTGCAGACTTGACGAAGCTT   7:6    12:5 GAA C C CCACACCTC C CC C
RhoR12C02  GGGAATGGATCCACATCTACGAATTCAATNAAA TA TTAAT AA A T G ---TTCACTGCAGACTTGACGAAGCTT  11:6    10:2 CC CCG C C CC C C
RhoR12C04  GGGAATGGATCCACATCTACGAATTCG AA T TAT TTA GG G T ---TTCACTGCAGACTTGACGAAGCTT   5:6    14:5 
 
Non-familial sequences 
RhoR12C03  GGGAATGGATCCACATCTACGAATTCAGA AG AAA A A GGG TA---TTCACTGCAGACTTGACGAAGCTT  10:2    12:6 
RhoR12C05  GGGAATGGATCCACATCTACGAATTCTAG TG G T A G ---TTCACTGCAGACTTGACGAAGCTT   6:6    12:6 
RhoR12C06  GGGAATGGATCCACATCTACGAATTCA TTGGA AA T A A ---TTCACTGCAGACTTGACGAAGCTT  10:5     9:5 
RhoR12C11  GGGAATGGATCCACATCTACGAATTC TAT AAGGGA A ---TTCACTGCAGACTTGACGAAGCTT   9:5    10:6 
RhoR12C13  GGGAATGGATCCACATCTACGAATTCAGGAAG AATT A ATA AG AG ---TTCACTGCAGACTTGACGAAGCTT  10:3    10:7 
RhoR12C14  GGGAATGGATCCACATCTACGAATTCAAAT A AG AAGTA TT ---TTCACTGCAGACTTGACGAAGCTT  11:4    12:3 
RhoR12C17  GGGAATGGATCCACATCTACGAATTCTA TG AAT TAT --TTCACTGCAGACTTGACGAAGCTT   8:9    11:3 
RhoR12C18  GGGAATGGATCCACATCTACGAATTCGGT AT A G G ---TTCACTGCAGACTTGACGAAGCTT   6:8     8:8 
RhoR12C20  GGGAATGGATCCACATCTACGAATTCA T A AA T GA G ---TTCACTGCAGACTTGACGAAGCTT   8:6    12:4 
RhoR12C21  GGGAATGGATCCACATCTACGAATTCA A AG GA A G ---TTCACTGCAGACTTGACGAAGCTT  11:3    12:4 
RhoR12C22  GGGAATGGATCCACATCTACGAAT-CA A A TAAAAA A GA GG GAA---TTCACTGCAGACTTGACGAAGCTT  14:1    11:4 
RhoR12C23  GGGAATGGATCCACATCTACGAATTC TTA A AAG TTA ---TTCACTGCAGACTTGACGAAGCTT   8:5    12:5 
RhoR12C25  GGGAATGGATCCACATCTACGAATTCAGA AG A AA GG ---TTCACTGCAGACTTGACGAAGCTT  11:4     9:6 
RhoR12C27  GGGAATGGATCCACATCTACGAATTCTG A GAA ---TTCACTGCAGACTTGACGAAGCTT   8:3    14:4 
RhoR12C28  GGGAATGGATCCACCTCTACGAATTCAG AA GAT AG TTGG ATG ---TTCACTGCAGACTTGACGAAGCTT   8:6     9:7 
RhoR12C29  GGGAATGGATCCACATCTACGAATTCGAATGA A A AA A G AAT A ---TTCACTGCAGACTTGACGAAGCTT  12:2    12:4 
RhoR12C30  GGGAATGGATCCACATCTACGAATTCG TA A GAA TA TA A G G ---TTCACTGCAGACTTGACGAAGCTT   9:6    11:4 
RhoR12C31  GGGAATGGATCCACATCTACGAATTC ATATA TG A GT AAATTCACTGCAGACTTGACGAAGCTT  13:5    10:5 
RhoR12C32  GGGA-TGGATCCACATCTACGAATTCA ATTAGAA A A G ---TTCACTGCAGACTTGACGAAGCTT  11:3    12:4 
RhoR12C33  GGGAATGGATCCACATCTACGAATTC GG T TTA A A TT G G ---TTCACTGCAGACTTGACGAAGCTA   4:7    13:6 
RhoR12C36  GGGAATGGATCCACATCTACGAATTCGGGA AAAA GGTAG G ---TTCACTGCAGACTTGACGAAGCTT   9:5     8:8
C GC CC C CCC CC CACC C
C C CACC C CTCC CGCC
C CC CTCATAAGCCGC CAT CC C
C CAGAATG CTA C C CCCGC-
CGC CT CATACAATC CGCCGC
C C CC CC CC CGCG
C C CC CCC CAGCACACC
CTATC CTC CCGACC CTACAGC
C C CGTATCTTACCTC C GGATAG
C CGGATT C C CATCTACC CCC C
C C CCAGAACCC CTATATC CAC C
C CC CA CC C ACC CC
GAAC CC C CACTC CCGGCGCC
C CTA C CAGATTCACTC CACG
CCCATCC CCAACC TCCCACAGGCC
CC CA C C CTATC CGC
C C CC GC CCAC CC C C
CC CCTT C C C TCAA C C C
GTACGAAAACAC C CC CCGC C
CATC CC C CACGACACGCC C
C GGCC C CC C CTC CAT CC C
CGTC CTCATATCAC C C  
                                                                                    1.8:1   2.2:1             
Figure 4-19.  Sequences of Rho selection (Round 12).  Aptamer sequences derived from the 12th round of selection against 
Rho are shown.  Static priming regions are in grey text; the random region of the aptamer is black text.  Cytosines have been 
highlighted in red text, and the (T)CACCT motif sequence is emphasized by a yellow box.  The A:T and C:G ratios are given. 
                                                                                                 A:T     C:G 
“(T)CACCT” sequences 
RhoR18C08  GGGAATGGATCCACATCTACGAATTCAC C C C C C CC C CAATA TTA GT AAA T A TG TG G---TTCACTGCAGACTTGACGAAGCTT   9:7    10:4 
RhoR18C11  GGGAATGGATCCACATCTACGAATTCA AATA TTA GT AAA T A TG TG G---TTCACTGCAGACTTGACGAAGCTT   9:7    10:4 C C C C C C CC C C
RhoR18C17  GGGAATGGATCCATATCTACGAATTCA AATA TTA GT AAA T A TG TG G---TTCACTGCAGACTTGACGAAGCTT   9:7    10:4 
 
C C C C C C CC C C
RhoR18C25  GGGAATGGATCCACATCTACGAATTCGA A A TA GT T A TGT TGA---TTCACTGCAGACTTGACGAAGCTT   6:7    12:5 TC C CCGC C CC C CC C
RhoR18C28  GGGAATGGATCCACATCTACGAATTCGA A A TA GT T A TGT TGA---TTCACTGCAGACTTGACGAAGCTT   6:7    12:5 
 
TC C CCGC C CC C CC C
RhoR18C02  GGGAATGGATCCACATCTACGAATTCAA G TAGT A T A TG A ---TTCACTGCAGACTTGACGAAGCTT   9:4    14:3 AC CC C CC ACC CAC CC CC
RhoR18C14  GGGAATGGATCCACATCTACGAATTCAA G TAGT A T A TG A ---TTCACTGCAGACTTGACGAAGCTT   9:4    14:3 
 
AC CC C CC ACC CAC CC CC
RhoR18C05  GGGAATGGATCCACATCTACGAATTCGA TA AAGTG A T AGAT ---TTCACTGCAGACTTGACGAAGCTT   9:4    11:6 GC CC CCAC CC ACGC C
RhoR18C16  GGGAATGGATCCACATCTACGAATTCGA TA AAGTG A T AGAT ---TTCACTGCAGACTTGACGAAGCTT   9:4    11:6 GC CC CCAC CC ACGC C
RhoR18C29  GGGAATGGATCCACATCTACGAATTCGA TA AAGTG A T AGAT ---TTCACTGCAGACTTGACGAAGCTT   9:4    11:6 
 
RhoR18C07  GGGAATGGATCCACATCTACGAA--- GT AG A T TG A-----------TTCACTGCAGACTTGACGAAGCTT   5:3    10:4 
 
Non-familial sequences 
RhoR18C03  GGGAATGGATCCACATCTACGAATCCA ATG TA GGAGAGTT A ATG AA---TTCACTGCAGACTTGACGAAGCTT   9:6     8:7 
RhoR18C04  GGGAATGGATCCACATCTACGAATTC A GT AT T ---TTCACTGCAGACTTGACGAAGCTT   6:9    11:4 
RhoR18C06  GGGAATGGATCCACATCTACGAATTCGG G TAGT A AGT A ---TTCACTGCAGACTTGACGAAGCTT   9:4    11:6 
RhoR18C09  GGGAATGGATCCACATCTACGAATTCA TA AAGTA AA TG G---TTCACTGCAGACTTGACGAAGCTT  11:5    10:4 
RhoR18C10  GGGAATGGATCCACATCTACGAATTCATAG AAGTA AA AG AGAT ---TTCACTGCAGACTTGACGAAGCTT  12:3     9:6 
RhoR18C12  GGGAATGGATCCACATCTACGAATTCTA T A TAT AT ---TTCACTGCAGACTTGACGAAGCTT   5:9    11:5 
RhoR18C15  GGGAATGGATCCACATCTACGAATTCG AT AAGTAT TAT AGAG ---TTCACTGCAGACTTGACAAAACTT   7:6    10:5 
RhoR18C18  GGGAATGGATCCACATCTACGAATTC GAGT TG T AAAGTGT A---TTCACTGCAGACTTGACGAAGCTT   6:6    11:7 
RhoR18C19  GGGAATGGATCCACATCTACGAATTCGA AAA AATAA A A TA GG GG---TTCACTGCAGACTTGACGAAGCTT  12:4     9:5 
RhoR18C20  GGGAATGGATCCACATCTACGAATTC TAGTAT A AG A TTCACTGCAGACTTGACGAAGCTT   7:6    16:4 
RhoR18C21  GGGAATGGATCCACATCTACGAATTCAA A GTTAAG TT TG ---TTCACTGCAGACTTGACGAAGCTT   9:6    11:4 
RhoR18C22  GGGAATGGATCCACATCTACGAATTCA GTAAAAGT AT GGTA---TTCACTGCAGACTTGACGAAGCTA  10:6     8:6 
RhoR18C23  GGGAATGGATCCACATCTACGAATTCG TGA TT GA AA AG---TTCACTGCAGACTTGACGAAGCTT   8:5    12:5 
RhoR18C24  GGGAATGGATCCACATCTACGAATTCG T TAT TTA GG ATA---TTCACTGCAGACTTGACGAAGCTT   9:8     9:4 
RhoR18C26  GGGAATGGATCCACATCTAGGAATTCGAAAG TG AG TT AT AGT GG---TTCACTGCAGACTTGACGAAGCTT   8:5     9:8 
RhoR18C30  GGGAATGGATCTACATCTACGAATTCAT TTGT ATTAGTG AG---TTCACTGCAGACTTGACGAAGCTT   9:9     7:5 
RhoR18C31  GGGAATGGATCCACATCTACGAATTC ATAAGTTGT AAG AG A---TTCACTGCAGACTTGACGAAGCTT   9:6    10:5 
RhoR18C32  GGGAATGGATCCACATCTACGAATTCAA AAT G ---TTCACTGCAGACTTGACGAAGCTT  10:6    12:2
CAC C GCCC CC AC C
C C TC C CGCC C
GTACTTACTAC C CAC CTGTC CGCC
AC CC CACATACC C GCC CA
ATAGC CACC CCTACC C C
CACGAGC CC CC C C
CTCAG CGTC C CCGTGCTGCC C
C C CC CGC CCTCC--
CGCC C CC CACCG CTC
C C C CATC C C CTC
CTGC C CATCCCGACCTCC CCCC C
GC CCCTC CC ACCAC CAA
CGTCAC CATC CACGC
CCAAGC CCC C ACCTC TCC
ATACAA CATC C CCGCC C
C C CC CC GAAC CC
CAAGT CTCACC CAAC
CAC C CCC CCTACTGC
AC CCACTACACTACCTATC CCGTC  
                                                                                         1.5:1   2.2:1 
GC CC CCAC CC ACGC C
       
Figure 4-20.  Sequences of Rho selection (Round 18).  Aptamer sequences derived from the 18th round of selection against 
Rho are shown.  Static priming regions are in grey text; the random region of the aptamer is black text.  Cytosines have been 
highlighted in red text, and the (T)CACCT motif sequence is emphasized by a yellow box.  The A:T and C:G ratios are given.
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The manual selection against E. coli Rho produced aptamers with C content much 
higher than those seen in our selection; in fact, some of their aptamers had no guanosine 
bases in their random regions.  Our collaborator theorizes that this may be due to the 
difference in genome composition between Eubacteria and Archebacteria (Alan 
Friedman, personal communication).  He bases this on a small dataset investigation of 
Rho-dependent terminators in T. maritima, finding an average C:G ratio of 2 : 1[181], 
and the fact that E. coli depends on Rho-dependent termination much more than T. 
maritima[182].  
US11 selection 
The definitive function of US11 remains unclear and several different purposes 
have been experimentally supported.  It has been implicated as interacting with kinesin 
for axonal transport[183],  catalyzing the degradation of major histocompatibility 
complexes by endoplasmic reticulum dislocation[184], preventing apoptosis by binding 
to and inactivating the dsRNA-dependent protein kinase R (PKR)[185], and regulation of 
expression of a viral membrane protein (UL34) by interaction with its mRNA[174, 186].  
It has been shown that US11 may regulate another RNA, 12/14, which encodes the UL12, 
UL13, and UL14 gene products[187].  More interestingly, it has been demonstrated to 
bind to the HIV-1 Rev response element (RRE) and transactivate expression of the env 
gene product[188].  US11 has also been shown to bind and facilitate the expression of 
Env for the HIV-related virus, HTLV-1[188, 189]. 
Twelve rounds of selection were performed against the US11 protein, isolated 
from Herpes Simplex Virus-1, in collaboration with Donald Coen’s laboratory at Harvard 
Medical School.  The result of this selection was a highly winnowed aptamer pool that 
contained a conserved motif of TTCGCAATYCTGCAYTG (“Y” indicating a pyrimidine 
(C/T), Figure 4-21). 
 
Figure 4-21.  Sequences of US11 selection.  Aptamers evolved after twelve rounds of selection are shown.  The static priming 
region is shaded grey; regions of high similarity are highlighted in bold red text.  The conserved consensus sequence is listed at 
the top of the aptamers (Y = pyrimidine, C or T).
CONSENSUS:                             TTCGCAAT CTGCA -TGY Y
 
US11R12C21  GGGAATGGATCCACATCTACGAA---- C C- GCTAGAACGACAACTG--TTCACTGCAG-CTTGACGAAGCTT 
US11R12C31  GGGAATGGATCCACATCTACGAA---- C C- GCTAGAACGACAACTG--TTCACTGCAGACTTGACGAAGCTT 
US11R12C19  GGGAATGGATCCACATCTACGAA---- C C- GCTAGAACGACAACTG--TTCACTGCAGACTTGACGAAGCTT 
US11R12C23  GGGAATGGATCCACATCTACGAA---- C T- TATAGCATCGTATGAC--TTCACTGCAGACTTGACGAAGCTT 
US11R12C15  GGGAATGGATCCACATCTACGAA---- C T- TATAGCATCGTATGAC--TTCACTGCAGACTTGACGAAGCTT 
US11R12C16  GGGAATGGATCCACATCTACGAA---- C T- TATAGCATCGTATGAC--TTCACTGCAGACTTGACGAAGCTT 
US11R12C26  GGGAATGGATCCACATCTACGAA---- C T- TATAGCATCGTATGAC--TTCACTGCAGACTTGACGAAGCTT 
US11R12C17  GGGAATGGATCCACATCTACGAA---- C T- AACTTCTCACTAAAAC--TTCACTGCAGACTTGACGAAGCTT 
US11R12C13 GGGAATGGATCCACATCTACGAA---- C T T- AACTTCTCACTAAAAC--TTCACTGCAGACTTGACGAAGCTT 
US11R12C GGGAATGGATCCACATCTACGAA---- T T C- AAATAGACGCCGTTGT--TTCACTGCAGACTTGACGAAGCTT 
US11R12C03  GGGAATGGATCCACATCTACGAA---- TT T C- AAATAGACGCCGTTGT--TTCACTGCAGACTTGACGAAGCTT 
US11R12C22  GGGTATGGATCCACATCTACGAATTCC C G- CAGGTGACCTTC------TTCACTGCAGACTTG-CGAAGCTT 
US11R12C08  GGGAATGGATCCACATCTACGAATTCC C T G- CAGGTGACCTTC------TTCACTGCAGACTTGACGAAGCTA 
US11R12C32  GGGAATGGATCCACATCTACGAATTTC C T G- CAGGTGACCTTC------TTCACTGCAGACTTGACGAAGCTT 
US11R12C27  GGGAATGGATCCACATCTACGAA---- T C- ATAGTTAACTCGCTCC--TTCACTGCAGACTTGACGAAGCTT 
US11R12C25  GGGAATGGATCCACATCTACGAA---- T T C- ATAGTTAACTCGCTCC--TTCACTGCAGACTTGACGAAGCTA 
US11R12C07  GGGAATGGATCCACATCTACGAA---- T T- CATGACATGACTG-GACGTTCACTGCAGACTTGACGAAGCTT 
US11R12C28  GGGAATGGATCCACATCTACGAA---- - T T- CATGACATGACTGTGACGTTCACTGCAGACTTGACGAAGCTT 
US11R12C06  GGGAATGGATCCACATCTACGAA---- - T T- CATGACCACGCTG-GATGTTCACTGCAGACTTGACGAAGCTT 
US11R12C20  GGGAATGGATCCACATCTACGAA---- T T- TACTGCATCGGAGCT---TTCACTGCAGACTTGACGAAGCTT
US11R12C14  GGGAATGGATCCACATCTACGAA---- C T- CAAAATCACCAACGGTT--TTCACTGCAGACTTGACGAAGCTT
US11R12C02  GGGAATGGATCCACATCTACGAA---- C TATGTCAACATCACGA--TTCACTGCAGACTTGACGAAGCTT 









  TTCGACAT CTG A TG
10  TTCGCAAT TTG A TG
TTCGCAAT TG A TG
TTCGCAAT CTTCA TG
TTCGCAAT CT CA TG
TTCGCAAT CT CA TG
TTCGTAAT CTGCA TG
TTCG AAT CTGCA TG
TTCGCA-T CTGCA TG
TTCGCA T CTGCA TG
TTCGCA T CTGCA TG
TTCGTAAG TTGTA TG  




The consensus motif is largely present in the entire population of the selection 
pool that was sequenced.  There are two bases where specificity is limited to either 
pyrimidine nucleotide.  At the first Y position (TTCGCAATYCTGCAYTG), 65 % (15 of 
23 aptamers) had cytosine; the other 35% (8 of 23) instead had uracil.  The second Y 
position (TTCGCAATYCTGCAYTG) is seen to have cytosine in 30% (7 of 23) of the 
population, 52% uracil (12 of 23), and 18% (4 of 23) of adenine or guanine.  All aptamers 
are predicted to fold into a highly conserved secondary structure (Figure 4-22).   
 
Figure 4-22.  Predicted structure of US11 aptamers.  The secondary structure of the 
conserved aptamer family as predicted by mfold[190] is shown here.  Black text indicates 
bases from the random region of the aptamer; grey text indicates bases derived from the 
3’ static priming region, primer 24.30.  Double hydrogen bonds (A:T pairs) are inferred 
by blue dots while triple hydrogen bonds (C:G pairs) are indicated with red dots. “Y” 
represents either pyrimidine base. 
All aptamers were seen to possess the bulged adenosine base branched between 
the guanine and cytosine bases near the 3’ end of the aptamer.  Most individual aptamers 
folded such that they contained two internal bulge-loops, one spanning two bases on each 
strand, the other spanning one base each strand.  The first bulge-loop was most often UY 
on the 5’ end, and was constrained to AC on the 3’ end from the static priming region.  
The second bulge-loop was most often Y, with the 3’ primer again constraining the 
opposing base to C.  Binding experiments performed by our collaborator indicate that 
these aptamers bind US11 specifically, and with an approximate dissociation constant of 
60 nM[170].   
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As stated, US11 is capable of binding the Rev response element of HIV-1.  It is 
thus interesting to note the similarity between the US11 aptamer pool and Stem IIB of the 
RRE that defines the minimal Rev binding element (RBE).  The wildtype HIV RBE is 
depicted in Figure 4-23, with bases identical to the aptamer family highlighted.  The 
bulged adenosine and the two base pairs on either side are seen in both structures.  
Because this conserved element of the RBE was evolved from a US11 selection, it may 
represent the binding element by which US11 is capable of association with HIV RRE. 
 
Figure 4-23.  Minimal Rev binding element of HIV-1.  Illustrated here is the secondary 
structure of Stem IIB of HIV RRE, with the minimal RBE necessary for Rev binding 
indicated by the blue box[191, 192].  Only canonical Watson-Crick base-pairing is 
shown.  Bases of the RBE identical to that of the US11 aptamer family are highlighted in 
red text.  
Because of their similar functions, US11 has been likened to the Tat protein of 
HIV[186].  Like US11, Tat binds highly double-stranded RNA sequences.  Specifically, 
Tat is recognized as associating with the Tat-responsive region (TAR) of HIV RNA[193].  
Also like US11, Tat bound to TAR RNA has been identified as specific inactivator of 
PKR to mitigate host immune response[194].  A comparison of TAR RNA with that of 
the US11 aptamer family shows some similarity, but less that that seen with comparison 
to HIV RBE (Figure 4-24).  Here, the bulged adenine is conserved with one set of 
identical base-pairings on either side of it, rather than two seen for HIV RBE.  However, 
the base pairing next to the guanine prior to the bulged adenine is still an A:T pairing.  
Likewise, the base-pairing after the cytosine directly following the bulged adenosine is 
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still a C:G pairing.  Several viruses have evolved mechanisms to circumvent activation of 
PKR[195], which halts cellular translation and ultimately leads to cell death[196].  
Because both US11 and Tat bind RNA and interact with PKR, it is possible that this 
conserved core represents a minimal element necessary for interaction with the RNA 
binding domain of PKR.   
 
Figure 4-24.  Tat-responsive element of HIV-1.  Illustrated here is the Tat responsive 
element (TAR) of HIV-1.  Bases of the TAR identical to that of the US11 aptamer family 
are highlighted in red text.  In the evolved US11 aptamers, the base-pairings directly on 
either side of the red conserved regions are inverted. 
This hypothesis is further supported by examination of another Herpesviridae, 
Epstein-Barr virus (EBV).  EBV contains a highly-structured RNA, EBER, which binds 
to and participates in the inactivation of PKR in conjugation with the SM protein of 
EBV[197, 198].  A minimal PKR binding element of the EBER has been elucidated by 
researchers[199], and again shows similarity to the US11 aptamer family (Figure 4-25).   
 
Figure 4-25.  Minimal EBV EBER element for PKR binding.  Shown here is the minimal 
structural RNA element required for association of the EBER with PKR.  Bases of this 
element identical to that of the US11 aptamer family are highlighted in red text.  
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In fact, the SM protein of EBV has high similarity to HSV-1 US11.  The C-
terminus of both proteins consists of a novel RXP triplet motif[200] that is necessary for 
specific RNA binding[174, 189, 197].  An investigator has suggested on the basis of this 
that the RXP motif may be a conserved motif of the Herpesviridae specific for PKR 
inactivation[197].  However, considering that this motif can also bind HIV RBE RNA 
and has similarity to the HIV TAR sequence which is required for HIV inactivation of 
PKR, it may be that the RXP triplet motif is a convergently evolved motif for viral RNA 
processing.  That is, the arginine-rich motif (ARM) segments of HIV and HTLV seem to 
possibly have the same specificity as RXP-repeats segments of Herpesviridae.   
We have just elucidated this possible connection, and as such, are beginning to 
decide how best to proceed at this point.  Possibly, other laboratory members will test 
cross reactivity of HIV RNA binding proteins with Herpesviridae RNA and vice-versa.  
Additionally, we may determine the specific bases of the RBE which is required for 
binding to US11 in order to see if they truly overlap with those critical for Rev binding.  
Ultimately, it will be most remarkable to determine if two different protein motifs do 
indeed have specificity for the same nucleic acid sequence, and the molecular mechanism 
behind the recognition. 
CONCLUSIONS 
These anti-protein selections clearly demonstrate the ability of our robotic 
selection system to develop aptamers that are comparable to those generated manually.  
With the described automated methods, we have evolved aptamers with high affinities 
(e.g., 1 nM dissociation constant for certain Rho aptamers, and potentially < 300 fM 
dissociation constant for certain CYT-18 aptamers).  And like manual selections, we have 
been able to utilize automated selection as a tool to explore sequence specificity (as in the 
cases of the Rho and US11 selections).  This application of aptamer selection to 
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investigate sequence specificity potentially provides good support for the use of 
automated selection for specificity studies, and is further sustained by the selection 
against wildtype U1A presented in Chapter 5. 
Furthermore, we have shown robot-generated aptamers to mimic another property 
of some manually evolved aptamers.  In the cases of the CYT-18 and lysozyme 
selections, we have yielded binding species capable of disruption of the native function of 
the protein target.  This phenomenon is often seen with manual selections as well and is 
consistent with many anti-protein selections that seem to preferentially ‘target’ allosteric 
or active sites of the target protein[201].   These exhibitions of affinity, specificity, and 
interference suggest good efficacy for downstream applications of robotically-created 
aptamers.  
The initial anti-protein selections, specifically the CYT-18 selection, was pivotal 
for the development of SELECTION version 4.x series, in which higher stringency wash 
conditions were employed in order to yield winnowed selection pools with high binding 
affinities.  All the new procedures implemented up to this point in the series 4.x were 
reproduced in a multi-well format in order to create SELECTION version 5.x series for 
multiple target selection in parallel.  Unlike SELECTION version 3.x series which was 
our original attempt at eight target selections in parallel, this revised version fared much 
better at aptamer production, largely due to the enhancements derived from the series 4.x 
alterations (Chapter 2).   
In fact, all selection programs that are now run are based from the 5.x series 
design.  In order to simplify training of new students and increase the modularity of the 
system, all selections are executed in this higher throughput manner under the auspices of 
performing eight targets in parallel regardless of the actual number of targets being 
selected against.  While this results in waste of disposable pipette tips, this encourages the 
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use of control steps.  For instance, robot ‘runners’ will often load empty selection lanes 
with colored dye to more easily monitor liquid manipulation and movement.  Another 
habitually repeated control step is to perform a lysozyme selection along with the ‘real’ 
target selection any time we make major changes to the selection procedures.  This 
allows us to easily separate ‘target’ or chemical failures from robotic ones.  We regularly 
choose lysozyme as a positive control and as a training tool, as it is inexpensive and 
frequently yields aptamers, even for students new to the process of in vitro selection.   
Additionally, the use of a single program for any number of targets (one to eight) 
obviated the need to track and alter several programs each time a change was made to the 
automated selection protocol.  Again, this created a situation whereby students could 
more easily learn to utilize the automated selection system while reducing potential 
human error in programming.   
Implications of automated selection for future research 
In point of fact, the robotic selection platform that we have created has been used 
by a number of researchers in the Ellington laboratory for several small molecule, 
peptide, protein, and bacterial spore targets (summarized in Appendix D).  Some of these 
have been successful while many have not for various reasons (refer to Appendix C).  
Regardless, the automated selection system has generated aptamers of equal quality as 
those evolved in manual selections.  This in itself is a major feat.   
Laboratory robotics have become very reliable for the execution of standard, 
established procedures benefiting of a technician.  For instance, a human being can 
reliably perform plasmid preps of bacterial cultures with a very high level of success; the 
same is true of a laboratory robot[84, 85].  A bench technician or robot programmer can 
be provided with a step-by-step protocol which will result in reproducible production of 
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plasmid preps.  Because every step to successful, standard plasmid prep can be explained 
to a person, it can be programmed and executed on a robot. 
The major difficulty with the automation of in vitro selection is that there is no 
standard protocol to follow that typically provides success a majority of the time.  While 
there are certainly published procedures[100, 176], each selection performed manually at 
the bench is highly customized and adjusted at each round of selection.  Worse, each 
target possesses its own specific characteristics that affect a generalized selection 
protocol.  For instance, a protein with a pI < 7 may need to be selected in a lower pH 
buffer for enough of the nucleic acid pool to bind to the target, obviating charge-charge 
repulsions.   
Many people attempt in vitro selection and either are not successful at the first try, 
or not successful at all.  Our laboratory is fairly experienced with in vitro selection 
techniques, having produced RNA aptamers[60], DNA aptamers[202], modified nucleic 
acid aptamers[203], signaling aptamers[204], molecular beacons[205], etc.  Additionally, 
we have trained members of several other research laboratories on in vitro selection 
techniques as well as published several in vitro selection protocols[100, 107, 108, 176, 
206].  Despite our available pool of expertise, we have encountered selection targets 
which have eluded our ability to generate specific aptamers against them.  A case in point 
is our efforts to generate aptamers to Bacillus spores and Bacillus anthracis exosporium.  
While discussed elsewhere (Appendix C), I performed eight entire selections in an 
attempt to evolve specific aptamers.  In addition, several automated DNA aptamer 
selections were performed by student Letha Sooter, and manual DNA aptamer selections 
were executed by student Seth Cockrum.  Despite a total of more than a dozen in vitro 
selection experiments, we were unable to produce Bacillus aptamers, even with the 
manual, human approach.  A simple ‘checklist’ for routinely successful aptamer 
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production does not exist, as do protocols for DNA sequencing, plasmid preparation, 
restriction endonuclease digestion, etc.  Typically, once the ‘kinks’ are worked out of 
such systems, the procedures become highly reliable.  Such a simplified protocol simply 
does not exist for aptamer selection. 
In vitro selection still remains an art, with tenuous variables including but not 
limited to the diversity of the pool[207, 208], static priming regions of the pool[99], type 
of nucleic acid used, selection buffer[209-214], wash buffer, elution buffer, method of 
target immobilization, concentrations of pool and target, length of time of pool : target 
interaction, use and type of nonspecific competitors, etc.  Generally, some of these values 
are attuned at each round of selection, with binding affinity assayed each few rounds.  
Additionally, nucleic acid is often purified during the course of a manual selection in 
order to prevent the accumulation of ‘over-PCR’ products or PCR artifacts.  We lack the 
ability to perform on-the-fly adjustments due to limitations in the software and hardware 
characteristics of the robotics platform.  
Thus, we believe that it is no small feat that we have been able to accomplish in 
vitro selection in a fully automated robotics system.  We have constructed and refined a 
robotic system that can produce aptamers without some of the processes available to the 
human bench researcher (e.g., nucleic acid purification, pool : target concentration 
optimization, etc.), despite that in vitro selection is still an art.  In fact, we are in the 
process of using this tool as a way to convert in vitro selection from an art to a more 
reproducible science.   
Due to the tedious and lengthy nature of manual selections, the effect of several 
selection variables has not been investigated.  For instance, there is very little data 
concerning the effect of the use of one particular binding buffer over another in the 
course of a selection.  Various combinations of lithium, sodium, potassium, magnesium, 
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calcium and zinc have been used in Tris, HEPES, MES, and phosphate buffers at various 
pHs.  Due to the reproducible and speedy nature of the robotic system, student Gwen 
Stovall is currently investigating the outcome of different buffer conditions in selections 
against the same target.  Likewise, student Fang En Lee is a examining the effect of pool 
diversity on the result of selection experiments, by performing several identical selections 
with different and unique sub-aliquots of a pool synthesis.  The answers that these 
experiments provide will likely enable us to define certain variables that greatly affect the 
course of selection experiments, ultimately facilitating higher percentages of successful 
selections. 
Not only that, but the simple speed increase gained in automated selection 
facilitates levels of experimentation that would not be possible within the career of a 
graduate student otherwise.  For instance, robotic selection has facilitated this body of 
work resulting in the investigation of several mutants of an RNA binding protein 
(Chapter 6). As an example, when I joined Dr. Ellington’s laboratory, it was not 
uncommon for a doctoral student to graduate after performing three successful selections.  
Now, three selections are considered an almost trivial amount of work.  In fact, an 
undergraduate student (Patrick Goertz) recently performed three successful selections in 
short order as a training exercise to learn in vitro selection[128]. 
EXPERIMENTAL METHODS 
Targets and target preparation 
CYT-18 protein was provided by Alan Lambowitz’ group at the University of 
Texas at Austin, and was prepared according to standard procedures[116].  MEK1 was 
purchased from Santa Cruz Biotechnology (Santa Cruz, CA).  Lysozyme was purchased 
from Sigma-Aldrich (St. Louis, MO).  Rho was obtained from Alan Friedman’s group at 
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Purdue University.  US11 was supplied by Donald Coen’s group at Harvard Medical 
School. 
Proteins were biotinylated and immobilized on magnetic beads.  If necessary, 
protein samples were first dialyzed to remove Tris buffer using Slide-A-Lyzer dialysis 
cassettes (Pierce, Rockford, IL).  Proteins (approximately 1 nmol) were chemically 
biotinylated by incubation with sulfo-NHS-LC-biotin (12 nmol; Pierce) in 3 ml of 10 mM 
HEPES, pH 7.5-8.0, 100 mM KOAc.  After the reaction had proceeded for two hours on 
ice, unincorporated biotin was removed using a 10DG chromatography desalting column 
(Bio-Rad, Hercules, CA).  Finally, biotinylated proteins were loaded onto strepavidin-
coated Dynabeads (roughly 150 pmol protein per 1.8 mg of beads; Dynal, Lake Success, 
NY). 
In vitro selection 
Robotic workstation configuration   
The entire selection was carried out on a Biomek 2000 Laboratory Automation 
Workstation (Beckman Coulter, Fullerton, CA), shown in Figure 4-26.  Control of the 
robot was governed directly by Bioworks 3.1c (Beckman Coulter).  The robot’s 
worksurface is integrated with a PTC-200 thermalcycler (MJ Research, Waltham, MA) in 
a remote dock position, a MPC auto-96 magnetic particle separator (Dynal), a modified 
Multiscreen vacuum filtration manifold (Millipore, Bedford, MA), and a ‘homemade’ 
enzyme cooler.  The enzyme cooler exchanges heat via a recirculating liquid bath and is 
capable of holding 96 wells of enzyme solution at –20°C indefinitely.  A Stacker 
Carousel (Beckman Coulter) funnels fresh pipette tips to the workstation as needed. 
Automated partitioning of binding species  
At the start of a round of the selection, the workstation pipetted RNA pool to 400 
µg of Dynabeads with biotinylated lysozyme bound to the beads’ strepavidin-derivitized 
surface.  In the first round, the amount of RNA pool applied was 5 µg (ca. 1.1x1014 
unique sequences).  At all other rounds, the amount of RNA pool applied was one-fifth of 
the preceding RNA transcription reaction (20 µL).  In general, this meant approximately 
one to three micrograms of RNA pool, but values likely varied between rounds.  The 
RNA pool was dispensed directly onto the beads equilibrated in selection buffer (20 mM 
Tris (pH 7.5), 100 mM NaCl, 5 mM MgCl2; 80 µL).  The RNA pool and bead mixture 
(100 µL) was incubated for 3 min, thoroughly mixed by pipette aspiration, and incubated 
for a further 3 min. 
Figure 4-26.  Photograph of selection system at SELECTION version 4.x series.  
Depicted is a photograph of the entire automated in vitro selection system while at 
version 4.x series.  Shown is a Beckman Coulter Biomek 2000 robot integrated with a 
thermalcycler, magnetic particle separator, vacuum filtration manifold, pipette tip 




After incubation, the bead and RNA mixture was resuspended by mixing, and 
transferred to the Multiscreen vacuum manifold containing a Millipore HV (PVDF) filter 
plate.  The beads were placed on the membrane surface, and the liquid was siphoned 
through the membrane.  Non-binding RNA species were partitioned away from the bound 
RNA associated with the lysozyme by vacuum filtration.  The beads were then washed 
with 250 µL of selection buffer, and resuspended on the filter plate in another 250 µL 
without vacuum.  That solution was again filtered, and the wash process proceeded once 
more for a total of two bead resuspensions in 1 mL of wash buffer. 
Automated RT-PCR cycling 
The RNA bound to the washed beads was used as a template for a RT-PCR 
reaction.  After washing, the beads were suspended in pure water, and transferred to the 
thermal cycler (51 µL).  Binding species were eluted from their targets by holding the 
mixture at high temperature (98ºC) for 3 min.  Afterwards, 45 µL RT-PCR reaction 
buffer (final concentrations were 10 mM Tris (pH 8.4), 50 mM KCl, 1.5 mM MgCl2, 0.2 
mM dNTPs, 5% acetamide, 0.05% Nonidet P40, and 0.5 µM each of 5’ and 3’ primers) 
was added.  If the amplified DNA was to be radiolabeled, 5 µCi of α-32P-labeled dATP 
was also added to the reaction. 
After addition of reaction buffer, the mixture was incubated at 65ºC for 10 min to 
disrupt the structures of selected RNAs.  The RT-PCR enzyme mixture (4µL) was then 
pipetted from the enzyme cooler.  The mixture contained 5 U of AMV reverse 
transcriptase (Amersham Pharmacia Biotech, Arlington Heights, IL), and 0.2 U of 
Display Taq (Display Systems, Vista, CA).  To minimize the high pipetting error 
associated with the pipette transfer of small amounts of 50% glycerol solutions (<1 µL), 
the enzymes are diluted together in a solution of 50% glycerol, 10 mM Tris (pH 8.4), 50 
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mM KCl, and 1.5 mM MgCl2 prior to the selection run.  The enzyme mixture was mixed 
with the RT-PCR reaction mixture by pipette aspiration. 
Next, the automated lid on the thermalcycler closed and warmed to 110ºC.  
Reverse transcription was allowed to proceed for 10 min at 50ºC, at which time PCR 
cycling began.  The amplification reaction was cycled (45 s at 94ºC, 60 s at 50ºC, and 90 
s at 72ºC) either for a total of 20 cycles (selection rounds 1-6) or 16 cycles (selection 
rounds 7-12). After cycling was complete, 10% of the reaction was mixed with an equal 
volume of stop dye for future gel analysis, and 50% of the reaction was placed in a 
separate microplate for archival purposes. 
Automated in vitro transcription 
10% of the RT-PCR mixture (10 µL) was used as template to generate RNA for 
the next round of selection.  The DNA template was mixed with 87 µL RNA transcription 
buffer (final concentrations were 40 mM Tris (pH 7.9), 26 mM MgCl2, 5 mM 
dithiothreitol, and 2.5 mM of each NTP).  If the RNA produced was to be radiolabeled, 5 
µCi of α-32P-labeled UTP was also added to the reaction.  After mixing, 40 U of RNasin 
(Promega, Madison, WI) ribonuclease inhibitor and 100 U of T7 RNA polymerase 
(Stratagene, La Jolla, CA) were added and well-mixed.  The final volume of the reaction 
was 100 µL and the reaction proceeded for 75 min at 37ºC.  At the conclusion of the 
reaction, 10% was mixed with an equal volume of stop dye for gel analysis.   
Sequence analysis 
DNA generated from the automated selection was ligated into a thymidine-
overhang vector using a TA Cloning Kit (Invitrogen, Carlsbad, CA).  Individual 
transformants were grown overnight in LB, and DNA isolated using a Plasmid Mini Kit 
(Qiagen, Valencia, CA).  To obtain the sequence of CYT-18 and lysozyme aptamers, the 
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plasmids were cycle-sequenced using a Sequitherm Excel II DNA Sequencing Kit 
(Epicentre, Madison, WI). MEK1, Rho, and US11 aptamers were sequenced in an 
automated fashion using the Dye Terminator Cycle Sequencing Kit (Beckman Coulter) in 
conjunction with a CEQ 2000 XL capillary DNA sequencer (Beckman Coulter). 
Dissociation determination 
Individual aptamers were assayed for the binding activity as previously 
described[108] using a Minifold I filtration manifold (Schleicher & Schuell, Keene, NH) 
that sandwiched a Protran pure nitrocellulose membrane (Schleicher & Schuell) and a 
Hybond-N+ nylon transfer membrane (Amersham Pharmacia Biotech).  Binding 
reactions were filtered through the filtration manifold and washed with a high salt 
solution (20 mM Tris (pH 7.5), 1 M NaCl, 5 mM MgCl2) to disrupt nonspecific 
electrostatic interactions between the positively charged lysozyme molecules and 
negative phosphate backbone of the RNA molecules[108, 175].  Percentages of bound 
nucleic acids were computed using a PhosphorImager SI (Amersham Pharmacia 
Biotech).  Dissociation constants were determined by assaying the binding ability of 
limiting amounts of aptamer over a wide range of protein concentrations (6.8 pM - 1.3 
µM).  The log of protein concentrations versus the amount of aptamer bound was fit to 
the equation y = a*x / (b+x) and directly yielded dissociation constants.  
Inhibition and competition assays 
CYT-18 competition assay 
A standard assay for competition between nucleic acid ligands that bind to CYT-
18 has previously been described[215, 216].  In short, 50 pmol of a given aptamer and 50 
pmol of a natural ligand (the ND1 Group I intron) were incubated with 10 pmol of 
purified CYT-18 in a volume of 100 µl for 60 minutes at room temperature.  Both RNAs 
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were body-labeled with 5 µCi α-32P UTP (Perkin Elmer, Boston, MA).  After incubation, 
20% of the binding reaction was saved to calculate the initial amount of radiolabel 
present in each reaction.  The remaining 80% was then passed through a nitrocellulose 
filter and washed to remove unbound nucleic acid.  The RNA bound to the protein was 
eluted by boiling the filter twice in elution buffer[108], extracted once with 
phenol:chloroform, and precipitated with isopropanol.  Finally, radiolabeled RNAs were 
separated from one another on a 6% denaturing polyacrylamide gel and quantitated using 
a Phosphorimager. 
CYT-18 inhibition assay 
Assays to determine the amount of Group I intron splicing inhibition in the 
presence of specific aptamers were adapted from previous methods[217].  In summary, 
CYT-18 (10 pmol) was incubated with a similar amount of ND1 (10 pmol, body-labeled 
with 5 µCi α-32P UTP) and ten times the amount of aptamer (100 pmol) in TMK buffer 
(100 µl of 20 mM Tris pH 7.5, 100 mM KCl, 5 mM MgCl2).  10% of the volume was 
taken out prior to initiation of the reaction for a ‘time zero’ sample.  Reactions were then 
catalyzed by adding 10 µl of a 10 mM GTP, 10 mM MgCl2 mixture.  After 25 minutes 
incubation at room temperature, a second 10 µl sample was drawn for analysis.  Both 
‘time zero’ and ‘25 min’ samples were immediately mixed with 2 µl of 0.5 mM EDTA, 
phenol:chloroform extracted, and ethanol precipitated.  Spliced and unspliced RNA 
molecules were separated on a 6% denaturing polyacrylamide gel. 
Lysozyme inhibition assay 
To evaluate the effect of aptamers on the function of lysozyme in vitro, lysozyme 
activity was assayed using a standard method[177, 178].  In short, lyophilized 
Micrococcus lysodeikticus (ATCC #4698) cells (Sigma-Aldrich) were suspended in 
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selection buffer at an O.D. (450 nm) of about 0.9.  An aliquot (250 µL) of suspended 
cells was placed in a microplate tray in which either nothing, lysozyme, RNA, or 
combination of lysozyme and RNA was added, for a total volume of 300 µL.  Wells with 
enzyme received 1 µg lysozyme, and RNA was added at a 10x molar ratio to that of 
lysozyme.  Assay wells were measured for their absorbance at 450 nm for 1 hr in real-
time in a FL600 microplate reader (Bio-Tek Instruments, Winooski, VT). 
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Chapter 5:  U1A selection 
INTRODUCTION 
An in vitro selection against U1A was performed to validate its use as a model 
protein for specificity selections.  This selection yielded aptamers whose secondary 
structures are modeled to fold into the wildtype binding elements of U1A.  Base identity 
of the aptamer sequences recapitulates data from structural studies concerning critical 
RNA : protein contacts of the complex.  Additionally, some evolved aptamers bound 
U1A with higher affinity than that of the wildtype element. 
In this Chapter, we also introduce the concept of “gene to aptamer”, whereby the 
entire in vitro selection experiment begins with the gene sequence of a desired protein 
target as the starting point.  PCR gene assembly is used to create an expression construct 
of the protein gene, which is then expressed in a coupled transcription and translation 
system in cell lysates.  This method facilitates rapid construction and expression of gene 
sequences in a manner that allows tagging of the protein with biotin for simple 
purification and immobilization to streptavidin-coated beads for automated in vitro 
selection.  This process is easily customizable, and is ideal for producing several mutants 
of a given protein (Chapter 6).  
RESULTS AND DISCUSSION 
“Gene to protein” – Creation of U1A protein 
Our previous anti-protein selections[110, 145, 146](Chapter 4) have been targeted 
against purified proteins.  However, we wished to develop a platform that was amenable 
to the rapid production of several proteins for metabolome, proteome, or mutational 
studies.  Without a simple and rapid method of purification, the ultimate utility of 
aptamers as a platform for biosensors or specificity analysis would be reduced[106].  
Previous anti-protein selections (Chapter 4) were performed by chemically biotinylating 
the protein target for conjugation to streptavidin beads[145, 146].  Unfortunately, 
chemical biotinylation generally generates a population of molecules with differing 
amounts of biotinylation at different conjugation sites, typically at primary amine groups 
on a protein (i.e., most often the N-terminus and available lysine residues).  Thus, 
multiple different epitopes are present during selection.  A biotinylation tag obviates this 
problem, and a relatively homogenous set of epitopes should be present during the 
selection.   
Additionally, chemical biotinylation may block an active or allosteric site of a 
protein, while specific biotinylation at the either the T- or C-terminus is less likely to 
interfere with function.  For instance, while first determining optimal biotinylation 
chemistry for some of our protein targets, I discovered that standard biotinylation 
protocols drastically reduced the functionality of lysozyme (Figure 5-1). 
 
Figure 5-1.  Inhibition of lysozyme activity by chemical biotinylation.  This assay is 
similar to that described in Figure 4-17 (Chapter 4).  Shown are the absorbances of cell 
cultures incubated with lysozyme (blue line) that has been biotinylated with an 8-fold 
excess of biotinylation reagent (left) and a 2.5-fold excess of reagent (right).  A negative 
control (grey line) shows no lysis in the absence of lysozyme; a positive control (red line) 
demonstrates the activity of unbiotinylated lysozyme.  Typical biotinylation procedures 
call for an 8 – 12-fold excess of biotinylation reagent to protein (Pierce). 
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Therefore, we have attempted to increase the speed of protein generation and 
purification via coupled in vitro transcription and translation (TnT).  Such a system can 
provide testable or usable protein the same day that a DNA template is created.  
Moreover, we have worked in conjunction with Andrew Hayhurst, recently of the 
Georgiou laboratory, to enhance the basic TnT expression system for further labeling of 
the template product.  In order to make the proteins easy and quick to purify, as well as 
preparing them for immobilization for robotic selection, we have introduced a 
biotinylation leader tag during the in vitro synthesis procedure.  
We examined a large number of prokaryotic- and eukaryotic-based commercially 
available kits.  Ultimately, we found that the Roche RTS 100 E. coli HY kit worked well 
with the automated selection procedures we had previously established, and had some of 
the highest expression yields for our templates.  In order to biotinylate translated proteins, 
templates were modified (Figure 5-2) so that translated proteins would contain an amino 
terminal peptide tag (MAGGLNDIFEAQKIEWHEDTGGSS) that is an efficient 
substrate for biotin protein ligase (BPL), the product of the birA gene [218-220].  The ε-
amino group of a single lysine residue in the BPL recognition peptide becomes 
covalently linked to biotin[221].  Existing BPL present in fresh or commercially 
purchased E. coli lysates proved insufficient to efficiently biotinylate target proteins, as 
demonstrated by Andrew Hayhurst[71].  Regardless, biotin ligase can either be co-
translated or exogenously added as a reagent.  Initially, (in this Chapter) we co-translated 
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Figure 5-2.  Scheme for in vitro transcription, translation, and biotinylation.  Splice-
overlap extension was used to assemble 5’ and 3’ fragments onto genes of interest.  The 
5’ fragment contains a T7 promoter and biotin protein ligase (BPL) recognition sequence 
(“biotag”).  The 3’ fragment contains the gene for BPL (birA) and a T7 terminator.  
Transcription generates a dicistronic message that when translated yields a ‘biotagged’ 
gene of interest and function BPL.  Free biotin is covalently attached to the gene of 
interest by BPL and the tagged protein is purified from the reaction by capture with 
streptavidin. 
“Gene to aptamer” – Selection against U1A 
Like the other selections presented here (Chapters 2-4), biotinylated protein 
targets are loaded onto streptavidin beads, and incubated with RNA libraries.  Bound 
RNA molecules are partitioned from unbound by filtration; the use of beads facilitates 
robotic manipulation (Chapter 4).  The beads are directly transferred into a thermalcycler, 
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and RNA is prepared for the next round of selection by a combination of reverse 
transcription, PCR, and in vitro transcription.  
As the U1A selection progressed, the DNA and RNA pools produced at each 
round were examined by denaturing gel electrophoresis (Figure 4).  The lengths of the 
DNA and RNA molecules were remarkably uniform, especially given that the number of 
cycles and incubation times used for DNA and RNA amplification were pre-set.  The 
consistent sizes of amplification products is in part a result of our prior optimization of 
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Figure 5-3.  Nucleic acid products during automated U1A selection.  Radioactive reaction 
products from RT-PCR and transcription reactions during automated selection were 
resolved on denaturing polyacrylamide gels.  RNA (80 nt) and DNA (99 nt) products are 
indicated by green and blue arrows, respectively.  The round numbers are listed above the 
lanes. 
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was increased by increasing the salt concentration from 100 mM during the first twelve 
rounds (two days) of selection to 300 mM at Round 13.  It is interesting to note that the 
amount of RNA that is amplified following this round seems to drop, just as though the 
increase in stringency reduced the amount of pool that survives the selection.  A further 
increase in stringency was introduced at Round 15 by increasing the salt concentration to 
600 mM.   
Filter-binding assays were employed to detect significant changes in the affinities 
of selected pools for U1A (Figure 5-4).  The initial pool showed significant binding to 
U1A, likely due to electrostatic interactions with the highly charged target protein [108, 
175] (+7.2 at pH 7).  Binding assays were therefore also carried out at higher salt 
concentrations (1 M) to reduce this non-specific background binding signal.  Six rounds 
of automated selection yielded no significant increase in apparent affinity, but a further 
six yielded an appreciable increase in signal (1.7-fold increase in binding signal even in 
the presence of high salt).  The final six rounds, carried out under increasingly stringent 
conditions, yielded additional improvements in pool binding (3.1-fold increase in binding 
signal even in the presence of high salt).  All binding assays were performed using a his-
tagged U1A isolated from E. coli, rather than the biotin-tagged U1A generated by in vitro 
translation and biotinylation.  The fact that binding did not appear to be dependent upon 
the type of tag present suggested that binding was specific for the RNP.  It is interesting 
that no aptamers were isolated against BCCP, given that this protein was also always 
present as a target.  It is likely that RNP is a better target for selection than BCCP.  When 
‘mock’ selections were carried out without the gene for U1A, aptamers against BCCP 

















Normal salt wash (0.1M)
High salt wash (1.0 M)
 
Figure 5-4.  Progress of automated U1A selection.  Binding assays are shown for Rounds 
0, 6, 12, and 18 of the selection.  The first column (light blue) shows the fraction of RNA 
captured in a standard binding assay.  The second column (dark blue) shows the fraction 
of RNA captured with a high salt wash was used to remove non-specifically bound RNA. 
Anti-U1A aptamers resemble natural binding sequences 
The natural RNA ligands of the U1A RNP have been well-characterized.  Hairpin 
II of U1 snRNA is a short stem topped by a G:C base pair and a loop with the sequence 5' 
AUUGCACUCC (Figure 5-5a).  The bolded heptamer sequence has been shown to be 
critical for binding to U1A; for instance, G9 makes hydrophobic contacts with Arg52, 
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and hydrogen-bonding interactions with Arg52, Leu49, Asn15, and Lys50 of U1A  [70, 
222].  The other six bases form similar hydrophobic, hydrogen bonding, and stacking 
interactions with other peptide backbone and side chain positions in the U1A protein [35, 
222].  The last three bases (UCC) do not physically interact with the protein and act 
primarily as a spacer to close the loop [35, 72, 74, 223].  In addition, the U1A protein 
interacts in a similar manner with the 3’ UTR of its own messenger RNA [224, 225], 
autoregulating its own expression by inhibiting polyadenylation and cleavage [30, 35, 
226]. (Figure 5-5b).  However, in this instance the canonical heptamer sequence is 
presented as an internal loop (Box 2), rather than a hairpin loop.  Following binding of 
one U1A monomer to the Box 2 internal loop, a second U1A monomer is recruited to 
bind to an adjacent internal loop containing a variant of the canonical heptamer, 
AUUGUAC (Box 1).   
Aptamers from Rounds 6, 12, and 18 were cloned and sequenced.  Aptamer 
sequences that contained the canonical heptamer were seen at the sixth round of 
selection:  8% (1 of 12 clones) contained a perfect match to the heptamer, while 42% (5 
of 12 clones) had imperfect matches to this sequence (Figure 5-6).  After another six 
rounds of selection the sequence diversity of the pool was further reduced, and most 
individuals (79%, 11 of 14 clones) possessed the heptamer or near-perfect matches (14%, 
2 of 14 clones; Figure 5-7).  Further selection with increasing stringency yielded a pool 
where 87% of sequences (26 of 30 clones) contained the heptamer (Figure 5-8) and the 
remaining 13% (4 of 30 clones) had near-perfect matches (Figure 5-9).  No sequences 









































































































Figure 5-5.  Anti-U1A aptamers resemble natural binding sequences.  (A) U1 snRNA 
hairpin II; (B) the 3’ UTR of U1 mRNA.  The heptamer sequence critical for recognition 
by U1A is highlighted with a black bar.  The 3’ UTR of U1 mRNA (B) contains a second 
heptamer sequence (Box 1) that contains a base change (AUUGUAC) at the fifth 
nucleotide. The critical C:G base-pair that closes stem II and that precedes Box II is in 
bold.  The adenosine found in the internal loop region of the 3’ UTR is also in bold.  (C) 
Aptamer Family 1, drawn in a manner similar to (A); (D) Aptamer Family 2, drawn in a 
manner similar to (B).  Residues contributed by the primer-binding sites are shown as 
dark yellow. 
















UIA-R06C02  GGGAAUGGAUCCACAUCUACGAAUUCGAGACUGAAUACUCCGAGCGGCCCAAUAAGUUCACUGCAGACUUGACGAAGCUU  
Figure 5-6.  Sequences of U1A selection (Round 6).  Aptamers evolved to U1A after six rounds of robotic selection are shown.  
The static priming region is in grey text; the random region of the aptamer is in black text.  Perfect matches to the U1A snRNA 
heptamer are highlighted in bold red text shaded in a grey box; near perfect heptamer sequences are shaded in a grey box. 
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Perfect matches (79%) 
UIA-R12C06  GGGAAUGGAUCCACAUCUACGAAUUCGAACAGGCUGUUUUGGACAUUGCACUACCGUUCACUGCAGACUUGACGAAGCUU 
UIA-R12C08  GGGAAUGGAUCCACAUCUACGAACUCGAACAGGCUGUUUUGGAC UACCGUUCACUGCAGACUUGACGAAGCUU 
 
AUUGCAC
U1A-R12C02  GGGAAUGGAUCCACAUCUACGAAUUCC CUGACGAUGUGGACAGAAUGGC-UUCACUGCAGACUUGACGAAGCUUAUUGCAC
U1A-R12C18  GGGAAUGGAUCCACAUCUACGAAUUC AUAUCGCCUGGCUUGCGCUUCACUGCAGACUUGACGAAGCUUACGGGCAUUGCAC
UIA-R12C10  GGGAAUGGAUCCACAUCUACGAAUUCCGGAAUAAGC AGUCGUAGACACU-UUCACUGCAGACUUGACGAAGCUUAUUGCAC
U1A-R12C15  GGGAAUGGAUCCACAUCUACGAAUUCGGGGGAACUAGC ACAGUCGUCAC-UUCACUGCAGACUUGACGAAGCUUAUUGCAC
UIA-R12C01  GGGAAUGGAUCCACAUCUACGAAUUCGGGAGAACAGCUU UGUCAAGAUA-UUCACUGCAGACUUGACGAAGCUUAUUGCAC
UIA-R12C02  GGGAAUGGAUCCACAUCUACGAAUUCGGCGCUGAUACCAAC ACAUCGAC-UUCACUGCAGACUUGACGAAGCUUAUUGCAC
UIA-R12C03  GGGAAUGGAUCCACAUCUACGAAUUCAACGUUACUUGCUUC AUAAGUCA-UUCACUGCAGACUUGACGAAGCUUAUUGCAC
UIA-R12C05  GGGAAUGGAUCCACAUCUACGAAUUCACAAUUGUACACCCGUAGUC AGC-UUCACUGCAGACUUGACGAAGCUUAUUGCAC





U1A-R12C06  GGGAAUGGAUCCACAUCUACGAAUUCGGAGGGUCAAGCUGCUUGCACUGGUGAUGAUUCACUGCAGACUUGACGAAGCUU 
UIA-R12C04  GGGAAUGGAUCCACAUCUACGAAUUCGCUUGCACAUCCCACAUAUUUCGCUGUUCGUUCACUGCAGACUUGACGAAGCUU 
 
Other sequences (7%) 
U1A-R12C16  GGGAAUGGAUCCACAUCUACGAAUUCACAGCACGUCCCCAGAACGCUCCUGCCGAUUCACUGCAGACUUGACGAAGCUU  
Figure 5-7.  Sequences of U1A selection (Round 12).  Aptamers evolved to U1A after twelve rounds of robotic selection are 
shown.  The static priming region is in grey text; the random region of the aptamer is in black text.  Perfect matches to the 





Family 1 (33%) 
UIA-R18C08  GGGAAUGGAUCCACAUCUACGAAUUCGAACAGGCUGUUUUGGACAUUGCACUACCGUUCACUGCAGACUUGACGAAGCUU
UIA-R18C19  GGGAAUGGAUCCACAUCUACGAAUUCGAACAGGCUGUUUUGGAC UACCGUUCACUGCAGACUUGACGAAGCUUAUUGCAC
U1A-R18C31  GGGAAUGGAUCCACAUCUACGAAUUCGAACAGGCUGUUUUGGAC UACCGUUCACUGCAGACUUGACGAAGCUU
 
AUUGCAC
U1A-R18C25  GGGAAUGGAUCCACAUCUACGAAUUCUACGAGUAGCUUCAUGAAC ACGGUUCACUGCAGACUUGACGAAGCUUAUUGCAC
U1A-R18C07  GGGAAUGGAUCCACAUCUACGAAUUCUACGAGUAGCUUCAUGAAC ACGGUUCACUGCAGACUUGACGAAGCUU
 
AUUGCAC
UIA-R18C13  GGGAAUGGAUCCACAUCUACGAAUUCGCGUCAUAAGAGGUUGAAC UACGUUCACUGCAGACUUGACGAAGCUUAUUGCAC
U1A-R18C14  GGGAAUGGAUCCACAUCUACGAAUUCGCGUCAUAAGMGGUUGAAC UACGUUCACUGCAGACUUGACGAAGCUA
 
AUUGCAC
UIA-R18C02  GGGAAUGGAUCCACAUCUACGAAUUCAAGCGCUGAGGUUGAGAAC UACGUUCACUGCAGACUUGACGAAGCUUAUUGCAC
UIA-R18C05  GGGAAUGGAUCCACAUCUACGAAUUCAAGCGCUGAGGUUGAGAAC UACGUUCACUGCAGACUUGACGAAGCUU
 
AUUGCAC





U1A-R18C03  GGGAAUGGAUCCACAUCUACGAAUUCGGACGUUAUGAUCAAGUC GCAGGUUCACUGCAGAC-UGACGAAGCUUAUUGCAC
UIA-R18C04  GGGAAUGGAUCCACAUCUACGAAUCCGGACGUUAAGAUCAAGUC GCGGGUUCACUGCAGACUUGACGAAGCUUAUUGCAC
U1A-R18C26  GGGAAUGGAUCCACAUCUACGAAUUCGGACGUUAAGAUCAAGUC GCAGGUUCACUGCAGACUUGACGAAGCUAAUUGCAC
UIA-R18C83  GGGAAUGGAUCCACAUCUACGAAUUCGGACGUUAAGAUCAAGUC GCAGGUUCACUGCAGACUUGACGAAGCUUAUUGCAC
UIA-R18C79  GGGAAUGGAUCCACAUCUACGAAUUCGGACGUUAAGAUCAAGUC GCAGGUUCACUGCAGACUUGACGAAGCUUAUUGCAC
UIA-R18C01  GGGAAUGGAUCCACAUCUACGAAUUCGGACGUUAAGAUCAAGUC GCAGGUUCACUGCAGACUUGACGAAGCUUAUUGCAC
U1A-R18C11  GGGAAUGGAUCCACAUCUACGAAUUCGGACGUUAAGAUCAAGUC GCAGGUUCACUGCAGACUUGACGAAGCUUAUUGCAC  
Figure 5-8.  Sequences of U1A selection (Round 18, familial).  Familial aptamers evolved to U1A after eighteen rounds of 
robotic selection are shown.  The static priming region is in grey text; the random region of the aptamer is in black text.  
Perfect matches to the U1A snRNA heptamer are highlighted in bold red text shaded in a grey box; near perfect heptamer 
sequences are shaded in a grey box.  The C:G base pair that closes the U1 snRNA hairpin II loop (Family 1) and the precedes 
Box II of the 3’-UTR U1 mRNA (Family 2) is shown in blue.  The adenosine found in the internal loop region of the 3’-UTR 
U1 mRNA (Family 2) is shown in green. 
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Other perfect matches (30%) 
U1A-R18C88  GGGAAUGGAUCCACAUCUACGAAUUCAUUGCACUUAGAAUUCGGGACGAAGCGCGGUUCACUGCAGACUUGACGAAGCUU
UIA-R18C06  GGGAAUGGAUCCACAUCUACGAAUUC AAACGAGUUCAGACAGGAGGCGCUUCACUGCAGACUUGACGAAGCUUAUUGCAC
UIA-R18C16  GGGAAUGGAUCCACAUCUACGAAUUCC UUAGGAAUCAGCAGCGGCCAGGUUCACUGCAGACUUGACGAAGCUUAUUGCAC
U1A-R18C38  GGGAAUGGAUCCACAUCUACGAAUUCAC ACCAGUGUAUCGUAUGCCGCUUCACUGCAGACUUGACGAAGCUUUAUUGCAC
U1A-R18C21  GGGAAUGGAUCCACAUCUACGAAUUCGCUC UUCGAGCGAACCCUCGGGCUUCACUGCAGACUUGACGAAGCUUAUUGCAC
UIA-R18C15  GGGAAUGGAUCCACAUCUACGAAUUCAUAACGCC UACGGCGUUCGCUGCUUCACUGCAGACUUGACGAAGCUUAUUGCAC
UIA-R18C10  GGGAAUGGAUCCACAUCUACGAAUUCCGGAAUAAGC AAUCGUCGACACUUUCACUGCAGACUUGACGAAGCUUAUUGCAC
UIA-R18C17  GGGAAUGGAUCCACAUCUACGAAUUCAAGAAUGCAAGAGGAGC UACGACUUCACUGCAGACUUGACGAAGCUUAUUGCAC






UIA-R18C47  GGGAAUGGAUCCACAUCUACGA-UUCACUCAUAGCACAACGGGUGACAGGCACAGGUUCACUGCAGACUUGACGAAGCUU  
Figure 5-9.  Sequences of U1A selection (Round 18, non-familial).  Non-familial aptamers evolved to U1A after eighteen 
rounds of robotic selection are shown.  The static priming region is in grey text; the random region of the aptamer is in black 
text.  Perfect matches to the U1A snRNA heptamer are highlighted in bold red text shaded in a grey box; near perfect heptamer 
sequences are shaded in a grey box.  The C:G base pair that closes the U1 snRNA hairpin II loop (Family 1) and the precedes 




Predictions of the secondary structures of individual aptamers are consistent with 
the hypothesis that Family 1 mimics the wild-type U1 snRNA hairpin II, while Family II 
is instead structurally similar to the 3’ UTR of U1A mRNA (Figure 5-5c & 5-5d).  It 
should be noted that aptamers that are not in Family 1 or Family 2 may still generally 
resemble the wild-type ligands.  For example, many of the aptamers listed as ‘other 
perfect matches’ (Figure 5-9) can readily be folded to form hairpin II-like structures. 
Interestingly, all residues that have previously been shown by structural or 
functional analyses to be important for hydrophobic, stacking, or hydrogen bonding 
interactions were conserved in the selected aptamers.  Conversely, residues that are 
known to not be important for interactions with U1A were not conserved.  The degree to 
which features of natural ligands have been recapitulated by in vitro selection is 
remarkable.  A C:G base-pair closes the loop in the wild-type U1 snRNA hairpin, and has 
been shown to be crucial for binding an arginine residue in U1A.  Disruption of this base-
pair and this interaction eliminates U1 snRNA binding to U1A [29, 64].  All aptamers in 
Family 1 are predicted to form a typical stem-loop structure closed by the requisite C:G 
base-pair.  Conversely, the remaining base-pairs in the stem interact non-specifically with 
positively charged residues in U1A [30, 35, 70].  Because of this the identity of the base-
pairs in the stem have been found to be irrelevant to U1A binding, and in fact no 
particular base-pairs predominate in the predicted stem structures of the Family 1 
aptamers.  Similarly, the last 3 residues (UCC) of the 10 residue hairpin loop of the wild-
type U1 snRNA do not physically interact with the protein [35].  Family 1 aptamers all 
have 3-4 dissimilar (non-conserved) residues in these same positions.  The variability in 
overall loop length was expected, given that it has previously been shown that the 
insertion of a single residue into the loop has little effect on protein-binding [223].  
Conversely, no loops shorter than 10 residues were seen.  In this regard, it has previously 
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been shown that a nine residue loop lacking one of the three otherwise non-conserved 
residues has a thousand-fold less affinity for U1A.  The removal of another residue 
decreases binding an additional ten-fold, while the creation of a 7 residue loop ultimately 
decreases the Kd by 100,000-fold [223].   
In the wild-type 3’-UTR the canonical AUUGCAC and loop-closing C:G base-
pair again form hydrogen bonds and hydrophobic interactions with U1A [70, 222], and as 
stated before Family 2 aptamers retain all critical sequence and structural features.  In 
addition, in the 3’ UTR a single adenosine residue (A24) on the opposite side of the 
internal loop has been shown to form essential hydrogen bonding and stacking 
interactions with serine, valine, and arginine residues in U1A [70, 222].  Aptamers in 
Family 2 can in fact be folded as to present a single adenosine residue opposite the 
conserved heptamer.   
The wild-type RNA ligands of the U1A protein are known to bind with high-
affinity (Kd values of 10-11 – 10-8 M, depending on pH, and monovalent and divalent salt 
concentrations) [223].  Under our assay conditions, the minimized, 21 nt wild-type U1 
snRNA hairpin II structure forms a complex with U1A with a Kd of 11 nM.  Most 
aptamers were found to have Kd values in the low nanomolar range (Table 5-1).  Family 
1 aptamers, those most akin to hairpin II, have Kd values as low as 4.5 nM.  Interestingly, 
at least one member of Family 1, clone 09, has a much higher Kd value (69 nM).  This 
aptamer is also predicted to form a hairpin-like structure, just as the other family 
members are.  The fact that its Kd deviates significantly suggests that subtle changes in 
the presentation of the heptamer motif can be extremely important for binding.  Family 2 
aptamers bind U1A slightly worse than Family 1, with the majority aptamer forming a 
complex with a Kd of 17 nM.  As expected, sequences with ‘near perfect’ motifs bound 
much less well than sequences that conformed to the natural ligands. 
Grouping Aptamer Kd (nM) Std. Dev. 
Family 1 08, 19, 31 4.9 0.9 
 07, 25 4.7 0.8 
 13, 14 10 1.7 
 02, 05 4.5 0.5 
 09 69 5.9 
Family 2 01, 11, 26, 79, 83 17 1.0 
 03 33 4.5 
 04 30 2.9 
“Other perfects” 16 69 7.5 
 21 6.8 0.7 
 28 10 0.8 
“Near perfects” 77 91 7.8 
 18 20 3.5 
Controls U1 snRNA stem II 11 0.6 
 Round 0 pool 101 8.7 
Table 5-1.  Dissociation constants of U1A aptamers.  The numbers under “Aptamer” 
refer to the clone numbers from Round 18 (Figures 5-8 & 5-9).  Binding assays were 
performed in triplicate to determine standard deviation. 
The selection of the natural binding sequences was not completely unexpected.  A 
previous manual selection had been performed against the U1A protein by Tsai et al. 
[72].  The authors carried out selection experiments starting from three randomized pools.  
The first two pools contained the wild-type U1 snRNA stem structure topped by a 
randomized loop region of 10 or 13 nt.  The third pool contained 25 randomized 
nucleotides flanked by primer sequences, similar to our N30 pool.  Both the constrained 
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and unconstrained pools generated aptamers containing the canonical heptamer sequence.  
However, the aptamers generated from the third pool by these manual selection 
procedures exhibited poor binding to U1A protein in gel-shift experiments (100-fold less 
affinity than with wild-type ligand).   In keeping with this observation, the manually-
selected aptamers did not mimic the wild-type sequences as well as those generated by 
automated selection; for example, they did not contain the C:G base-pair closing the U1 
snRNA loop.  Similarly, none of the aptamers selected from the unconstrained pool was 
predicted to fold into either U1 snRNA-like or U1A 3’-UTR mRNA-like structures.  
While additional rounds of manual selection might of course have improved the selected 
populations, these would have been prohibitively tedious.  The fact that multiple rounds 
of automated selection can be carried out within days allows the sequences, structures, 
and affinities of aptamers to be finely tuned. 
CONCLUSIONS 
Our results confirm that it may be possible to use in vitro selection to decipher 
specific interactions between multiple different nucleic acid binding proteins and their 
corresponding cellular RNA sequences.  In vitro selection has previously been used to 
identify or define a variety of natural nucleic acid binding sequences[169].  Some 
examples illustrating this are provided in Chapter 1. 
In this light, is interesting to note that our selection produced two aptamer 
families that closely corresponded to the two natural RNA binding elements of U1A.  
The fact that the natural sequences and structures were extracted from a completely 
random sequence library is remarkable, and has additional important implications for the 
specificity of interactions between U1A and its natural targets.  One measure of 
specificity is what set of sequences a given protein will preferentially recognize.  In the 
case of U1A, the natural ligands are apparently globally optimal, at least within the 
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context of a sequence space of roughly 30 residues.  Indeed, the U1A protein can even 
finely distinguish between ligands that superficially resemble one another in terms of 
critical sequences and structures, since different Family 1 members can have Kd values 
that vary by an order of magnitude.  These results imply both that the U1A protein has 
structured its RNA binding domain in such a way that it can reject sequences and 
structures that are not exactly like the natural ligands, and that the natural ligands have 
been derived by a search of a sequence space that is much larger than the size of the 
genomes in which they are ensconced.  This is one of the first examples of natural 
optimality in a sequence space of this size.  Given these results, we feel that in vitro 
selection of U1A mutants will provide realistic insights into the true specificity 
determinants of RNP domains. 
EXPERIMENTAL METHODS 
Automated in vitro selection was carried against U1A.  In short, N30 was used as 
the starting pool and was incubated in 1x Selection Binding Buffer (20 mM Tris, pH 7.5; 
100 mM KOAc, and 5 mM MgCl2) with biotinylated protein immobilized on 200 µg 
streptavidin beads (sufficient to bind 4 – 8 x 1012 biotinylated antibody molecules).  
RNA:protein complexes were filtered from free RNA and weakly bound species were 
removed by washing with 4 x 250 µl of 1x SBB.  Bound RNA molecules were eluted in 
water at 97ºC for 3 minutes.  RNA for additional rounds of selection was generated by 
reverse transcription, PCR, and in vitro transcription (using primers 41.30 and 24.30).  
All of reactions were carried out sequentially on a Beckman-Coulter (Fullerton, CA) 
Biomek 2000 automated laboratory workstation that had been specially modified and 
programmed to interface with a PCR machine (MJ Research, Waltham, MA) and a 
filtration plate device (Millipore)(Figure 5-10). 
 
 
Figure 5-10.  Schematic of selection system at SELECTION version 7.x series.  This 
illustration shows a schematic of the robotic worksurface used for automated in vitro 
selection of U1A.  Plate names are in bold text, and manufacturer and consumable type is 
in normal text.  A green “D” denotes a data connection on the worksurface.  Likewise, 
“P” denotes a physical connection onto the worksurface from off-board, and “E” denotes 
an electrical connection to that location. 
Eighteen rounds of selection were performed against biotinylated U1A.  In the 
first twelve rounds of selection 20 cycles of PCR were carried out, while in the last six 
rounds this number was decreased to 16 cycles to prevent overamplifcation of the 
selected pool; these parameters had been empirically determined during previous 
automated selection experiments[145].  In the first twelve rounds of selections, the wash 
buffer was 1x SBB.  In last six rounds of selection, the stringency of the selection was 
increased by progressively increasing monovalent salt concentration, as detailed in Table 
5-2.   
The progress of selection was monitored every six rounds (6, 12, and 18) by 
placing α-32P radiolabeled ribo- and deoxyribonucleotides in the amplification reactions 
and resolving amplification products by gel electrophoresis.  The automated protocol 
included a provision to archive aliquots of the reverse transcription (10 µl, 10% of the 
total reaction) and in vitro transcription (10 µl, 10% of the total reaction) reactions.  After  
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the automated protocol had run its course, the aliquots 
(in standard stop dye) were run on 8% acrylamide 
(19:1 acrylamide:bisacrylamide), 7 M urea denaturing 
gels.  Decade RNA Markers (Ambion) were used as 
size standards.  The gels were visualized using a 
PhosphorImager SI (Amersham Pharmacia Biotech).  
In addition, single-point binding assays were carried 
out with equimolar concentrations of protein and 
RNA samples (50 nM), as described below.   
























Table 5-2.  Conditions for the 
automated selection of anti-
U1A aptamers.  The binding 
ability of the pool was assayed 
at 0, 6, 12, and 18 rounds 
(highlighted in bold text). 
Template Construction 
The N-terminal RNA binding domain of U1A 
was synthesized from fifteen oligonucleotides using a 
PCR-based assembly method[227].  The sequence of 
U1A was derived from Genbank accession M60784, 
modified to include the same mutations (Y31H and 
Q36R) that were present in the protein crystallized by 
Oubridge et al.[35].  The assembled gene was sub-
cloned into pET28a, yielding a gene encoding a 
fusion protein with an N-terminal 6x histidine tag.  
This was placed into an expression vector to create 
pJH-hisU1A.  The sequence of the final construct was 
verified. 
The assembled U1A gene fragment was used 
to generate a template for in vitro transcription and 
translation (TnT) reactions.  Specifically, ‘splice-
 151
 152
overlap extension’ (SOE) PCR[228] was used to attach sequences necessary to direct 
high level expression and quantitative biotinylation of U1A during in vitro coupled 
transcription-translation reactions (refer to Figure 5-2).  The primers used during these 
experiments are described in Table 5-3.   
The 5’ region for SOE PCR is roughly 150 bp in length.  The T7 gene 10 
promoter and translation initiation region (TIR) is included to enhance transcript stability 
and translation[229, 230].  Protein synthesis is then initiated with a 24 amino acid biotin 
acceptor peptide sequence (“biotag”, MAGGLNDIFEAQKIEWHEDTGGSS)[231].  A 
megaprimer containing both the TIR and the biotag was generated using primer AHX10, 
primer AHX47, and the E. coli biotinylation and expression plasmid pDW363[232].  The 
3’ region is roughly 1050 bp in length.  The birA gene is followed by the major 
transcription terminator signal for T7 RNA polymerase to enhance transcript 
stability[229].  A megaprimer containing birA and the transcription terminator was 
generated using primer AHX33, primer AHX29, and pDW363.  The assembled U1A 
gene was PCR-amplified with primers (U1A.biotag, U1A.t0) that added overlap regions 
complementary to both megaprimers.  The 3’ assembly junction creates a opal 
termination codon followed by a functional RBS for birA[232].  SOE assembly was 
carried out with the two ‘rescue’ primers AHX31 and AHX30.   
In vitro transcription and translation 
The U1A-birA construct was transcribed and translated in vitro using the RTS 100 
E. coli HY kit (Roche Diagnostics, Basel, Switzerland).  In order to generate sufficient 
protein for the entire course of an automated selection experiment a quadruple-sized 
reaction (200 µl) was carried out starting with 2 µg of DNA template.  Biotin (14 µM 
final concentration) was also added at the start of the combined transcription and 
translation (TnT) reaction.  The reaction was incubated at 30ºC for 6 hours, followed by 













M13 F GGTTTTCCCAGTCACGAC 
M13 R AGCGGATAACAATTTCACAC 
-47 seq CGCCAGGGTTTTCCCAGTCACGAC 
Table 5-3.  Primers listed in the Experimental Methods section of Chapter 5.  Priming 
sequences are shown 5’→3’. 
incubation at 4ºC for roughly 4 hours.  Unincorporated biotin was removed by passing 
the entire reaction though a Bio-Spin 6 chromatography column (Bio-Rad Laboratories).  
The purified, biotinylated protein sample was incubated with 2.4 mg strepavidin-coated 
magnetic Dynabeads (Dynal, Oslo, Norway) in the presence of 1x Selection Binding 
Buffer (1x SBB; 20 mM Tris, pH 7.5; 100 mM KOAc, and 5 mM MgCl2) for 15 minutes.   
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Beads were thoroughly washed five times in 500 µl selection buffer to remove any non-
biotinylated protein. 
Protein expression and biotinylation were verified by electroblotting and Western 
blot analysis using strepavidin-conjugated alkaline phosphatase as a reporter for 
biotinylated proteins (Figure 5-11).  Aliquots of the TnT reaction (5 µl) were placed in 1 
µl β-mercaptoethanol, 10 µl water, and 4 µl 5x SDS-PAGE loading dye (250 mM Tris 
HCl, pH 6.8; 50% glycerol, 2.5% SDS, 142 mM βME, 0.05% bromophenol blue) and 
heat-denatured by boiling for five minutes.  Half of the denatured sample (10 µl) was 
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Figure 5-11.  Detection of translated, biotinylated U1A.  Expression of biotinylated 
U1A was assayed by Western blot analysis.  Biotinylated protein size standards are in 
the first lane.  The second lane shows a no template control, while the third and fourth 
lane show controls with gene products that were not biotinylated.  The fifth lane 
contains an aliquot from an in vitro transcription and translation reaction with the 
biotagged U1A gene.  The arrow indicates the translated, biotinylated U1A gene 
product.  The ca. 20kDa band seen in all control and experimental lanes is thought to be 
biotin carboxy-carrier protein (BCCP), the single biotinylated protein in E. coli. 
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a MiniPROTEAN-3 gel rig (Bio-Rad Laboratories).  The gel was run until the 
bromophenol blue dye reached the bottom (roughly 30 min @ 200V).  The gel was 
electroblotted onto Trans-Blot nitrocellulose (Bio-Rad Laboratories) in a Mini Trans-Blot 
Electrophoretic Transfer Cell (Bio-Rad Laboratories) in electroblotting buffer (pH 9.9, 10 
mM NaHCO3, 3 mM NaCO3, 30% methanol) for 90 minutes at 350 mA.  The blot was 
blocked with 1x Tris-buffered saline and Tween-20 (TBST) for 30 minutes at room 
temperature with gentle agitation.  Next, the blot was incubated with 3 µl alkaline 
phosphatase-conjugated strepavidin (Promega, Madison, WI) in fresh 1x TBST buffer 
(15 ml) for 30 minutes with mild agitation.  Unbound alkaline phosphatase was removed 
with 3x washes of 1x TBST (15 ml, 5 minutes each).  Finally, the blot was briefly rinsed 
with deionized water and placed in 15 ml of Western Blue Stabilized Substrate for 
alkaline phosphatase (Promega) for 1-5 minutes. 
Sequence analysis 
Aliquots (1 µl of a 50 µl archive) of RT-PCR reactions from a given round of 
selection were further amplified and then ligated into a thymidine-overhang vector (TA 
Cloning Kit, Invitrogen).  Templates for sequencing reactions were generated from 
individual colonies via 50 µl colony PCR reactions[167] and standard M13 sequencing 
primers flanking the insertion site of the thymidine-overhang vector (primers M13 
forward and M13 reverse).  The PCR products were purified away from primers, salt, and 
enzyme using a MultiScreen96-PCR cleanup plate (Millipore).  Aliquots of the colony 
PCR reactions (5 µl) were developed on a 4% agarose gel to verify the insertion of 
aptamers into vectors.   
Cycle sequencing reactions were performed using a CEQ DTCS Quick Start Kit 
(Beckman-Coulter) and the vendor’s modified M13 sequencing primer (primer -47 seq).  
Reaction assembly and cycling conditions were performed largely as described in the 
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vendor’s instructions.  Approximately 100 fmol of purified colony PCR products were 
used as templates, and reactions were performed with half of the master mix 
concentration recommended in the instructions in order to minimize reagent use (4 µl of 
master mix in a 20 µl sequencing reaction, rather than 8 µl).  Unincorporated dye was 
removed by size exclusion chromatography, as described in a Beckman-Coulter 
Technical Application Information Bulletin, T-1874A (http://www.beckman.com/ 
Literature/BioResearch/T-1874A.pdf).  Briefly, 45 µl of dry Sephadex G50 (Amersham 
Pharmacia Biotech) was placed into each well of a MultiScreen HV plate using a 
MultiScreen 45 µl Column Leader (Millipore).  The Sephadex chromatography resin was 
allowed to hydrate in 300 µl of water for three hours at room temperature.  After 
incubation, the resin was packed by centrifugation for 5 minutes at 1,100 g.  The columns 
were rinsed once with 150 µl water and packed again at the same speed for the same 
time.  The 20 µl sequencing reactions were loaded onto the tops of the columns using a 
multichannel micropipettor, and spun again for 5 minutes at 1,100 g.  Purified samples 
were recovered from a CEQ Sample microplate (Beckman-Coulter) that had been placed 
below the chromatography plates before centrifugation.  Recovered samples were dried 
under vacuum at room temperature.  Pellets were resuspended in 40 µl deionized 
formamide and developed on a CEQ 2000XL 8-channel capillary DNA sequencer 
(Beckman-Coulter).  Aptamer secondary structures were predicted using RNAstructure 
3.6 by Mathews, Zuker, and Turner [190]. 
Cellular expression of U1A 
The plasmid pJH-hisU1A was transformed into BL21 cells (Stratagene).  A 1 ml 
starter culture grown from a single plasmid was used to inoculate 50 ml of fresh LB.  The 
culture was grown to an OD600 of roughly 0.6 at 37ºC and protein expression was induced 
by the addition of IPTG to a final concentration of 840 µM.  The induced culture was 
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grown for an additional three hours at 37ºC.  Cells were pelleted at 5,000 g and lysed in 
B-PER (Pierce), DNase (10 U; Invitrogen), and 10 mM MgCl2 in a total volume of 5 ml.  
After incubation at room temperature for 15 min, cellular debris was pelleted at 13,000 g.  
The supernatant was further purified by nickel-chelation chromatography.  IMAC resin (2 
ml; Amersham Pharmacia Biotech) was equilibrated with 4 ml of water, followed by 4 ml 
of charging buffer (50 mM NiCl2).  The column was equilibrated with 10 ml protein 
binding buffer (1x PBB; 50 mM Tris, pH 7.5, 100 mM NaCl, 5 mM imidazole).  
Clarified supernatant (ca. 15 ml) was loaded and the column was washed with 4 ml of 1x 
PBB and 15 ml of wash buffer (50 mM Tris, pH 7.5, 100 mM NaCl, 50 mM imidazole).  
The U1A protein was eluted by the addition of 3 ml of elution buffer (50 mM Tris, pH 
7.5, 100 mM NaCl, 500 mM imidazole); 500 µl fractions were collected for gel analysis.  
Fractions containing significant amounts of U1A were pooled and dialyzed in 50 mM 
Tris, pH 7.5, 100 mM NaCl with four buffer exchanges of 500 ml every three hours at 
4ºC in order to remove imidazole from the prep.  Finally, the absorbance at 280 nm was 
used to determine protein concentration (extinction coefficient = 5,442 M-1 cm-1). 
Dissociation determination 
Plasmids containing individual aptamers were used to generate transcription 
templates via PCR.  Transcription reactions were carried out with an AmpliScribe T7 
RNA transcription kit (Epicentre, Madison, WI) according to the manufacturer’s 
instructions except that incubation was at 42ºC rather than 37ºC.  Aptamers were purified 
on denaturing polyacrylamide gels[149], dephosphorylated, and radiolabeled with γ-32P 
ATP[108].  Radiolabeled RNA was extracted with phenol:chloroform (1:1) and 
unincorporated nucleotides were removed using size exclusion spin columns (Princeton 
Separations, Adelphia, NJ).   
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Nitrocellulose filter-binding assays were employed to determine the dissociation 
constants of aptamer:protein complexes[108].  A standard protocol was automated using 
the Biomek 2000 automated laboratory workstation and a modified Minifold I filtration 
manifold (Schleicher and Schuell, Keene, NH).  RNA samples in 1x SSB were thermally 
equilibrated at 25ºC for 30 minutes.  The RNA concentration for binding reactions was 
kept constant at a final concentration of 200 pM while the concentration of U1A ranged 
from 1 µM down to 17 pM (11 different concentrations).  Equal volumes (60 µl) of RNA 
and U1A were incubated together for 30 minutes at room temperature in 1x SBB.  The 
binding reactions (100 µl) were filtered through a sandwich of Protran pure nitrocellulose 
(Schleicher & Schuell) and Hybond N+ nylon transfer membrane (Amersham Pharmacia 
Biotech) that had been assembled in the modified Minifold I vacuum manifold.  The 
filters were washed 3 times with 125 µl of 1x SBB.  The amount of radiolabeled RNA 
captured from a reaction onto the nitrocellulose membrane was quanititated using a 
PhosphorImager SI (Amersham Pharmacia Biotech).  The log of U1A concentration was 
plotted against the amount of RNA bound.  Data were fit to the equation y = (a·b) / (b+x) 
+ C where “C” is the fraction of RNA bound to the nitrocellulose at zero protein 
concentration, “b” is the maximum fraction bound, “x” is the fraction of RNA bound to 
U1A, and “a” is the dissociation constant for the RNA:protein complex.  Assays were 
performed in triplicate and standard deviations were calculated.  The 21 nt synthetic RNA 
(AAUCCAUUGCACUCCGGAUUU) previously employed in structural studies of the 
U1A protein was used as a positive control[35]. 
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Chapter 6:  mutant U1A selections 
INTRODUCTION 
We have built an automated aptamer selection robot (Chapter 2) that is capable of 
performing in vitro selection experiments[110] (Chapter 3).  Moreover, we have 
demonstrated the ability of the system to generate anti-protein aptamers with both high 
affinity and specificity[145, 146] (Chapter 4).  This system has also proven to be able to 
elucidate the natural sequence and structural specificity of a nucleic acid binding 
protein[71] (Chapter 5).  Thus, we believe that this automated in vitro selection system 
may be applied toward the elucidation of binding codes of RNP domains (Chapter 1) 
derived from the selections of mutant RNP proteins.  
I have designed 28 point mutants of the U1A protein based upon structural, 
functional, and hypothetical data from the literature.  Of those, I have been successful in 
creating 23 of the constructs and sequence verifying 21 of them.  I have performed 18 
rounds of in vitro selection against these 21 verified mutants, detailed in this Chapter. 
Mutation rationale 
Mutations being made to the U1A protein are classified below by examining the 
relational classes of mutations, and by considering each individual interaction and its 
contacts which may lead into multiple relational classes.  Experimental data has 
highlighted residues which can or can not be changed in order to bind U1A cognate 
RNA.  This body of data infers individual residues that may be responsible for conferring 
U1A’s exquisite specificity despite the highly conserved ribonucleoprotein-domains 
(RNP domains) that are crucial for binding in all RNP-domain nucleic acid binding 
proteins. 
Mutations by class 
There are currently seven groupings of mutational classes being investigated, 
summarized in Table 6-1.  The first class, U1A-specific residues, examines mutations 
made to amino acid residues that are not conserved across RNP-domain nucleic acid 
binding proteins and are largely specific to U1A[70, 233].  Owing to the fact that RNP 
domains are strongly evolutionarily conserved yet also highly specific for their cognate 
sequences and are not ‘promiscuous’ suggests that these residues are “likely to be the true 
specificity determinants of U1A”[70].  N15, E19, L44 and Q85 residues fall into this 
category[70](Figure 6-1).  
Mutational class Residues 
Non-conserved residues N15, E19, L44, Q85 
‘Critical G’ interactions N15, E19, L49, K50, Q54 
‘Critical A’ interactions L49, K50, M51, R52, T89 
C:G stem-loop contacts L49, M51, R52 
C-terminus contacts to CAC bases T89, D90, D92 
Hydrophobic ‘finger-lock’ contacts I93, I94, M97 
DEZYMER predictions N15, E19, M51, T89 
Uncategorized mutations T11, G53, F56 
Table 6-1.  U1A mutations sorted by class.  This table lists the categories by which 
residue mutations can be sorted.  For instance, N15, E19, L44 and Q85 have been 
implicated as being residues that are not conserved throughout similar RNP-domain 
proteins. 
The second and third groupings look at the so-called ‘critical guanosine’ and 
‘critical adenosine’ interacting amino acid residues (Figure 6-2 and 6-3, respectively).  Of 
the specific heptamer sequence that U1A has high specificity for, five of those seven 
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nucleotides can be changed with only a modest increase in Kds (10 to 20-fold)[65, 78].  
However, base changes of the guanosine (G9) or the second adenosine (A11) of the 
heptamer cause large increases in Kd of 1,000-fold or more[43, 65].  Amino acid residues 
that interact with these two ‘critical’ nucleotides in both the U1 snRNA hairpin II and of 
the 3’ UTR of U1A mRNA have been explored by structural methods and mapped[29, 
35, 70].  These residues are chosen for mutation in order to investigate amino acid : 
nucleotide specificity.  Residues included in this set are N15, E19 L49 K50, and Q54 for 
the guanosine contacts, and L49, K50, M51, R52, and T89 for the adenosine constants. 
The fourth class inspects those amino acids that make direct contact with the C:G 
base pairing that ends the stem before both the U1 snRNA hairpin II and U1A 3’ UTR 
mRNA open into a loop (Figure 6-4).  Disruption of these amino acids eliminates specific 
cognate binding to U1A, and includes amino acids from the RNP1 element, L49, M51, 
and R52 [29, 64, 70, 222]. 
The fifth class examines C-terminus residue contacts with the CAC portion of the 
RNA loop (Figure 6-5).  Residues 88-92 possess a significantly high amount of 
interaction with the CAC base run of the heptamer sequence[35, 222], and has been 
suggested as a source of specificity for U1A’s cognate RNA sequence[234].  Single 
mutations of Asp90Asn and Asp92Asn, as well as the double mutation of Asp90Asn / 
Asp92Asn, are designed.  It was hoped that mutating residues from hydrogen bond 
acceptors to hydrogen donors may elicit a specificity change from cytosine to uracil.  
The sixth class analyzes the hydrophobic amino acids of helix C (I93, I94, and 
M97) that comprise the end of the U1A protein (Figure 6-6).  Structural studies have 
shown that this helix acts as a ‘finger’ that closes over the RNA loop after binding and 
‘locks’ by forming contacts with other amino acids (His10, Leu41, I58, and Val62[234]).  
It has been suggested that this not only decreases the Kd of the complex, but also 








Figure 6-1.  U1A mutations relating to non-conserved residues.  U1A (green) bound to 
cognate RNA (blue) is rendered based upon the crystal structure.  The two highly 
conserved RNP2 & RNP1 elements are colored orange.  The residues of U1A that are not 
conserved in homologous RNP-domain proteins are colored red and are labeled with 
white arrows. A linear representation of U1A is depicted at the bottom of this Figure 
demonstrating the relative positions of secondary structures (green boxes) and the highly 
conserved RNP elements (orange boxes).  Residues targeted for mutation within this class 
are identified on the linear representation with red arrows. 
β1 α1 β2 β3 α2 β4 αC
RNP 2 RNP 1N C
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Figure 6-2.  U1A mutations relating to ‘critical G’ residues.  U1A (green) bound to 
cognate RNA (blue) is rendered based upon the crystal structure.  The two highly 
conserved RNP2 & RNP1 elements are colored orange.  The residues of U1A that are 
involved in contacting the critical guanosine are colored red and are labeled with white 
arrows.  The critical guanosine is colored cyan.  A linear representation of U1A is 
depicted at the bottom of this Figure demonstrating the relative positions of secondary 
structures (green boxes) and the highly conserved RNP elements (orange boxes).  
Residues targeted for mutation within this class are identified on the linear representation 
with red arrows. 
β1 α1 β2 β3 α2 β4 αC















Figure 6-3.  U1A mutations relating to ‘critical A’ residues.  U1A (green) bound to 
cognate RNA (blue) is rendered based upon the crystal structure.  The two highly 
conserved RNP2 & RNP1 elements are colored orange.  The residues of U1A that are 
involved in contacting the critical adenosine are colored red and are labeled with white 
arrows.  The critical adenosine is colored cyan.  A linear representation of U1A is 
depicted at the bottom of this Figure demonstrating the relative positions of secondary 
structures (green boxes) and the highly conserved RNP elements (orange boxes).  
Residues targeted for mutation within this class are identified on the linear representation 
with red arrows. 
β1 α1 β2 β3 α2 β4 αC









Figure 6-4.  U1A mutations relating to C:G stem-closing residues.  U1A (green) bound to 
cognate RNA (blue) is rendered based upon the crystal structure.  The two highly 
conserved RNP2 & RNP1 elements are colored orange.  The residues of U1A that are 
involved in making contacts to the C:G base pairing that closes the loop and begins the 
stem are colored red and are labeled with white arrows.  The C:G base pairing is colored 
cyan.  A linear representation of U1A is depicted at the bottom of this Figure 
demonstrating the relative positions of secondary structures (green boxes) and the highly 
conserved RNP elements (orange boxes).  Residues targeted for mutation within this 
class are identified on the linear representation with red arrows. 
β1 α1 β2 β3 α2 β4 αC
RNP 2 RNP 1N C
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Figure 6-5.  U1A mutations relating to CAC loop contacts.  U1A (green) bound to 
cognate RNA (blue) is rendered based upon the crystal structure.  The two highly 
conserved RNP2 & RNP1 elements are colored orange.  The residues of U1A that are 
involved in making contacts to the CAC base run in the loop are colored red and are 
labeled with white arrows.  The CAC base run itself is colored cyan.  A linear 
representation of U1A is depicted at the bottom of this Figure demonstrating the relative 
positions of secondary structures (green boxes) and the highly conserved RNP elements 
(orange boxes).  Residues targeted for mutation within this class are identified on the 
linear representation with red arrows. 
β1 α1 β2 β3 α2 β4 αC
RNP 2 RNP 1N C
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Figure 6-6.  U1A mutations relating to hydrophobic contacts on αC.  U1A (green) bound 
to cognate RNA (blue) is rendered based upon the crystal structure.  The two highly 
conserved RNP2 & RNP1 elements are colored orange.  The residues of the third α-helix 
of U1A (αC) that ‘clamp’ over the cognate RNA once it associates with U1A are colored 
red and are labeled with white arrows.  The dashed arrow indicates a residue that is 
visually obscured in this rendering, located on the opposite face of the protein.  A linear 
representation of U1A is depicted at the bottom of this Figure demonstrating the relative 
positions of secondary structures (green boxes) and the highly conserved RNP elements 
(orange boxes).  Residues targeted for mutation within this class are identified on the 
linear representation with red arrows. 
β1 α1 β2 β3 α2 β4 αC
RNP 2 RNP 1N C
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The seventh class contains mutations designed to create a specificity swap as 
indicated by the computer program DEZYMER[235].  The software package is capable 
of determining a series of mutations within a protein causing structural changes which 
result in a specificity change of the natural binding characteristics of the protein.  For 
instance, DEZYMER has predicted mutations that transformed maltose-binding protein 
into a zinc-binding protein[236] as well as altered it to specifically bind several small 
molecules and amino acids[237], including dynamite and serotonin[238].  DEZYMER 
has even been able to imbue maltose-binding protein with catalytic activity by predicting 
mutations that gave it the functionality of triose phosphate isomerase[239]. 
The current embodiment of DEZYMER is limited to polymers containing a 
peptide backbone.  Former student Jay Hesselberth received the program from the 
Hellinga laboratory at Duke University and configured DEZYMER so that it could model 
phosphate-backbone polymers.  Using the crystal structure of U1A bound to its cognate 
RNA, we changed the critical guanosine (G9) to the other three nitrogenous RNA bases 
and used DEZYMER to predict residue changes which might elicit specific binding to the 
replaced nucleotide.  We also did the same procedure for the critical adenosine base 
(A11), instructing DEZYMER to try new amino acids at many of the mutation positions 
listed above. 
As a sort of control, we also processed the wildtype RNA sequence through 
DEZYMER to see which residues it would predict to be different from the wildtype.  A 
majority of the time, the program chose residues different than the natural sequence, 
usually arginine and lysine residues to nonspecifically interact with the negative 
backbone.  This was not especially surprising given that this was not only the first 
implementation of nucleic acids in DEZYMER, but our laboratory’s first use of the 
software at all.   
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Regardless, there were a couple of specificity changes suggested by DEZYMER 
that did not revolve around simply increasing the pI of the protein.  It advised that a 
specificity change of G9C might be accomplished by a N15F or E19N mutation (Figure 
6-7).  Likewise, it proposed that an A11C swap might occur from a M51S or T89R 
mutation (Figure 6-8).  We have picked these four changes as our seventh set of 
mutations in order to examine this first application of DEZYMER with nucleic acids.   
Finally, there are two other interesting ‘uncategorized’ residues that will be 
examined as well.  One example is Thr11.  This residue has been shown to make contact 
with Ser91, and it has been suggested that this interaction is significant in its function in 
facilitating the orientation of the hydrophobic C-terminus in interaction with the rest of 
the complex[35, 62].   
Also of interest is Phe56.  While a simple majority of RNP proteins possess 
phenylalanine at this position over other aromatic residues found at this position, this 
phenylalanine residue is conserved in U1A in nearly all species, with occasional species 
possessing tryptophan, but none found with histidine or tyrosine[76].  Despite this 
finding, mutations of Phe56 to other aromatic residues (tryptophan, tyrosine, and 
histidine) resulted in either no change or up to a 10-fold increase in Kd with the wildtype 
cognate sequence[43].  Conversely, mutation of Phe56 to leucine or alanine caused large 
increases in Kd of 1,000-fold and 6,600-fold, respectively[43, 74]. Selections against 
mutants with and without substituted aromatic residues at this position can help yield 
species-specific specificity data. 
Lastly is Gly53, which serves to function as a hinge between two β-strands within 
U1A.  Increasing the steric bulk of this residue to alanine worsens the Kd by 200-fold; 
increasing it further to valine worsens it by 1,600-fold[240].  Also, the valine mutant 
loses salt dependence of RNA binding but retains specificity with its poor affinity[240].
 
Figure 6-7.  U1A mutations predicted by DEZYMER for a G9C specificity swap.  U1A 
(green) bound to cognate RNA (blue) is rendered based upon the crystal structure.  The 
two highly conserved RNP2 & RNP1 elements are colored orange.  The two critical 
bases for wildtype binding (G9 and A11) are highlighted in cyan.  G9 is indicated with a 
cyan arrow.  The residues predicted by DEZYMER to cause a specificity swap of G9C 
(N15F or E19N) are colored red and are labeled with white arrows.  A linear 
representation of U1A is depicted at the bottom of this Figure demonstrating the relative 
positions of secondary structures (green boxes) and the highly conserved RNP elements 
(orange boxes).  Residues targeted for mutation within this class are identified on the 
linear representation with red arrows.
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Figure 6-8.  U1A mutations predicted by DEZYMER for a A11C specificity swap.  U1A 
(green) bound to cognate RNA (blue) is rendered based upon the crystal structure.  The 
two highly conserved RNP2 & RNP1 elements are colored orange.  The two critical 
bases for wildtype binding (G9 and A11) are highlighted in cyan.  A11 is indicated with a 
cyan arrow.  The residues predicted by DEZYMER to cause a specificity swap of A11C 
(M51S or T89R) are colored red and are labeled with white arrows.  A linear 
representation of U1A is depicted at the bottom of this Figure demonstrating the relative 
positions of secondary structures (green boxes) and the highly conserved RNP elements 
(orange boxes).  Residues targeted for mutation within this class are identified on the 
linear representation with red arrows. 
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Figure 6-9.  U1A mutations that are ‘uncategorized’.  U1A (green) bound to cognate 
RNA (blue) is rendered based upon the crystal structure.  The two highly conserved 
RNP2 & RNP1 elements are colored orange.  Thr11, which may function in aligning the 
C-terminal tail to the cognate RNA is colored red and indicated by a dashed white arrow.  
F56, which functions in aromatic stacking with the cognate RNA and found in most 
species, is colored red and indicated by a solid white arrow.  G53, important for 
functioning as a hinge between secondary structures, is also colored red and labeled with 
a white arrow.  A linear representation of U1A is depicted at the bottom of this Figure 
demonstrating the relative positions of secondary structures (green boxes) and the highly 
conserved RNP elements (orange boxes).  Residues targeted for mutation within this 
class are identified on the linear representation with red arrows. 
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Mutations by residue 
For convenience, the rationale of mutation choice is sorted here by residue. 
Thr11 
This position has been experimentally shown to be a critical residue for cognate 
binding.  A conservative mutation of T11V eliminates binding of U1A to wildtype 
RNA[64].  Experiments have shown that an even more conservative change of T11I 
increases the apparent Kd by 7,500-fold[62].  I have constructed a T11V U1A mutant for 
in vitro selection. 
Asn15 
This residue is not conserved throughout RNP domains, and is largely specific to 
U1A[70, 233].  Additionally, this amino acid has been selected as it makes contact with 
the critical guanine base in wildtype RNA[70].  Experiments have shown that Asn15 is 
crucial for cognate binding.  A mutation of N15V abolishes binding of U1A to wildtype 
RNA[75].  Finally, this position is indicated by DEZYMER as potentially causing a 
specificity swap in the recognition of wildtype RNA of G9C if mutated to phenylalanine.  
I have constructed N15V and N15F U1A mutants for in vitro selection. 
Glu19 
This residue is not conserved throughout RNP domains, and is largely specific to 
U1A[70, 233].  To test the effect of this residue on wildtype cognate recognition, I have 
changed this position from a hydrogen-bond accepter to a hydrogen-bond donor by 
constructing an E19N U1A mutant.  Additionally, DEZYMER has selected this same 




This residue is not conserved throughout RNP domains, and is largely specific to 
U1A[70, 233].  Additionally, this amino acid has been selected as it makes contact with 
the critical guanine base in wildtype RNA[70].  To test the effect of this residue on 
wildtype cognate recognition, I have removed the functional group from this position by 
constructing a L44G U1A mutant. 
Leu49 
This residue has been selected as it makes contact with the critical guanine base in 
wildtype RNA[70].  Also, this position also interacts with the critical adenosine base as 
well as the C:G base pair found at the opening of the loop[234].  This amino acid has 
been experimentally proven to be critical for wildtype RNA binding.  A phage-display 
experiment has demonstrated the importance of leucine at this position.  The only other 
residue which was found to bind cognate RNA at this position was methionine, which 
caused a 5-fold increase in the Kd[241].  I have constructed a L49M U1A mutant for in 
vitro selection. 
Arg50 
 Arginine at this position makes extensive contact with the critical guanosine[70]; 
additionally, it also does so with the critical adenosine[70]. This residue has been 
exhibited to play a large role in binding and specificity recognition of cognate RNA.  A 
mutation of K50A has resulted in a 10-fold increase in the Kd with wildtype RNA[73].  A 
R50K mutant had been designed but not successfully created in time for this dissertation. 
Met51 
This amino acid has been chosen as it makes contact with the critical guanine base 
in wildtype RNA[70].  Also, this residue interacts with the critical adenosine base as well 
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as the C:G base pair found at the opening of the loop[234].  Further experimental 
evidence has shown that a mutation to alanine only worsens the Kd by 7-fold, but may 
greatly effect recognition specificity[73].  Finally, DEZYMER has selected this same 
position as potentially causing a specificity swap in the recognition of wildtype RNA of 
A11C with a substitution to serine.  I have constructed a M51S U1A mutant for in vitro 
selection; a M51A mutant had been designed but not fully sequence verified in time for 
this dissertation. 
Arg52 
This amino acid on the edge of RNP1 has been experimentally demonstrated as a 
critical residue for cognate binding.  A R52Q mutation was shown to eliminate U1A 
recognition of wildtype RNA[29, 64].  Other research has illustrated that a conservative 
mutation of R52K only reduces cognate RNA binding by 3-fold[70].  Also, this position 
contacts the critical adenosine base as well as the C:G base pair found at the opening of 
the loop[234].  I have constructed R52Q and R52K U1A mutants for in vitro selection. 
Gly53 
Glycine at this position is just prior to β3, functioning as a hinge between β2 and 
β3 strands.  A mutation of this residue to alanine increases the Kd for wildtype RNA by 
200-fold; a mutation to valine is seen to worsen the Kd by 1,600-fold[240].  Furthermore, 
the binding mode of G53V is known to be salt-independent but still is capable of 
maintaining recognition[240].  I have constructed G53A and G53V U1A mutants for in 
vitro selection. 
Gln54 
This residue has been experimentally shown to be an important residue to 
binding.  A mutation at this position to phenylalanine increases the Kd for wildtype RNA 
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binding by 10 – 100-fold[64].  Additionally, this amino acid has been selected as it makes 
contact with the critical guanine base in wildtype RNA[70].  I have constructed a Q54F 
U1A mutant for in vitro selection. 
Phe56 
This amino acid is another position that has been experimentally illustrated to be 
important for cognate binding.  Data has shown that mutating this important aromatic-
stacking residue to leucine increases the Kd for wildtype RNA by 1,000-fold[43].  
Another mutation to alanine exhibits a worse Kd than that, increased by 6,600-fold when 
compared to wildtype U1A[74].  I have constructed F56L and F56A U1A mutants for in 
vitro selection.  Additionally, I have also substituted other aromatic residues at this 
position in order to investigate whether this residue imparts specificity, or if its sole 
function is to provide base stacking in the RNP1 domain for affinity function (U1A 
mutants F56W, F56Y, and F56H). 
Gln85 
This residue is not conserved throughout RNP domains, and is largely specific to 
U1A[70, 233].  To test the effect of this residue on wildtype cognate recognition, I have 
changed this position from a hydrogen-bond donor to a hydrogen-bond accepter by 
designing a Q85E U1A mutant.  This construct had been created but not fully sequence 
verified in time for this dissertation. 
Thr89 
This amino acid has been chosen as it makes contact with the critical guanine base 
in wildtype RNA[70].  Furthermore, this position is of the run of five residues of the C-
terminal region of U1A that heavily interacts with the 10CAC12 nucleotide segment of 
the loop[35, 222].  Also, DEZYMER has selected this same position as potentially 
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causing a specificity swap in the recognition of wildtype RNA of A11C with a 
substitution to lysine.  I have constructed a T89K U1A mutant for in vitro selection. 
Asp90 
This location is of the run of five amino acids of the C-terminal region of U1A 
that heavily interacts with the 10CAC12 nucleotide segment of the loop[35, 222].  Here 
we attempt a purely rational mutation by changing this residue from a hydrogen-bond 
accepter to a hydrogen-bond donor in order to elicit a specificity change from cytosine to 
uracil.  I have constructed a D92N U1A mutant for in vitro selection. 
Asp92 
This residue is of the run of five positions of the C-terminal region of U1A that 
heavily interacts with the 10CAC12 nucleotide segment of the loop[35, 222].  Again, we 
attempt a purely rational mutation by changing this residue from a hydrogen-bond 
accepter to a hydrogen-bond donor in order to elicit a specificity change from cytosine to 
uracil.  I have constructed a D92N U1A mutant for in vitro selection.  Additionally, this 
mutation has been combined with the one above to create a D90N, D92N double-mutant 
U1A for in vitro selection. 
Iil93 
This position is one of the amino acids that comprise the hydrophobic ‘finger’ of 
αC that functions to lock in the cognate RNA after initial association with U1A[234].  In 
order to investigate the potential this position has over specificity function, an I93T 
mutation had been designed but not successfully created in time for this dissertation. 
Iil94 
Like its neighboring position above, this amino acid is also one of the amino acids 
that comprise the hydrophobic ‘finger’ of αC that functions to lock in the cognate RNA 
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after initial association with U1A[234].  In order to examine the potential this residue has 
over specificity function, an I94T mutation had been designed but not successfully 
created in time for this dissertation. 
Met97 
This final residue is also one of the amino acids that comprise the hydrophobic 
‘finger’ of αC that functions to lock in the cognate RNA after initial association with 
U1A[234].  In order to probe the potential this residue has over specificity function, an 
M97Q mutation had been designed but not successfully created in time for this 
dissertation. 
RESULTS AND DISCUSSION 
Thr11 (to Val) 
Despite the fact that this mutant has been shown to eliminate binding to wildtype 
RNA, the canonical heptamer remained the dominate clone of this selection, indicating 
that is still may be the ‘best match’ for this mutant.  However, this is one of the few 
mutants where changes in sequence specificity may be mapped directly to the 3’ portion 
of the heptamer.  Uridine was observed in one or both of the last two positions (A11 and 
C12) in 37% (7 of 19) of the population (Figure 6-10).  Thr11 forms a hydrogen bond 
with Ser91[69], one of the run of five amino acids of the C-terminal region of U1A that 
heavily interacts with the 10CAC12 nucleotide segment of the loop[35, 222].  Disruption 
of the hydrogen bound with this mutation implies that this short run of residues may 
impart a large effect of specificity, as suggested by others[69] based upon aptamer 
diversity.   
Some of the swap clones are predicted to fold into secondary structures that 
directly mimic U1 snRNA hairpin II (e.g., D3).  However, some of the swap clones are
 
Figure 6-10.  Sequences of U1A mutant T11V selection.  The static priming region is in grey text; the random region of the 
aptamer is in black text.  Heptamer motifs containing a direct match to the wildtype heptamer are in red text; differences from 













D3 GGGAAUGGAUCCACAUCUACGAAUUCGGACACGCCAC U ACCGUGGCCCUCUUCACUGCAGACUUGACGAAGCUU






































predicted to fold into a hairpin II-like structure lacking either one or two unconserved 
nucleotides at the 3’ portion of the loop (e.g., B1 and A2, respectively).  While the 
identity of the last three nucleotides of the loop are unimportant, three or more 
nucleotides must follow the heptamer for wildtype U1A to sterically interact with the 
loop[71, 223].  Wildtype U1A has shown to bind a 9-mer loop with 500-fold less affinity 
and an 8-mer loop with 7,500-fold less affinity[223].  However, the fact that the 
Thr11Val mutation eliminates binding for wildtype RNA may mitigate this finding in 
some fashion. 
Asn15 (to Val, Phe) 
This residue seemed to be a likely determinate of specificity given its large ‘role’ 
in U1A.  Not only is this not conserved in U1A homologues[70, 233], but this residue 
makes extensive contact with the critical guanosine[70].   In fact, DEZYMER had 
predicted that a mutation at this position would cause a specificity change from 
guanosine to cytosine.   
The N15V mutant had been previously shown to eradicate binding to wildtype 
RNA, and sequence analysis of the evolved pool shows very little wildtype heptamer 
(>6%, 1 of 17 sequences).  In fact, the majority of the population (71%, 12 of 17 
members) contained a heptamer sequence of CUUACAC (changes from wildtype 
underlined)(Figure 6-11).  Replacing asparagine with valine elicited a recognition change 
of the critical guanosine (G9) to adenosine.  Also, the first adenosine (A6) was seen to be 
replaced by cytidine in the evolved aptamers.   
The DEZYMER predicted mutation, N15F, also yielded a conserved aptamer 
family demonstrating a change in specificity (Figure 6-12).  However, while DEZYMER 
suggested this mutation would correspond to a G9C swap, we instead observed an A11C 


















C8 GGGAAUGGAUCCACAUCUACGAAUUC--CACACGUCGCCGGAC A CACCGCCGG-------UUCACUGCAGACUUGACGAAGCUU
E8 GGGAAUGGAUCCACAUCUACGAAUUC--CACACGUCGCCGGAC A CACCGCCGG-------UUCACUGCAGACUUGACGAAGCUU
F5 GGGAAUGGAUCCACAUCUACGAAUUC--CACACGUCGCCGGAC A CACCGCCGG-------UUCACUGCAGACUUGACGAAGCUU
A6 GGGAAUGGAUCCACAUCUACGAAUUC--CACACGUCGCCGGAC A CACCGCCGG-------UUCACUGCAGACUUGACGAAGCUU
A7 GGGAAUGGAUCCACAUCUACGAAUUC--CACACGUCGCCGGAC A CACCGCCGG-------UUCACUGCAGACUUGACGAAGCUU
D7 GGGAAUGGAUCCACAUCUACGAAUUC--CACACGUCGCCGGAC A CACCGCCGG-------UUCACUGCAGACUUGACGAAGCUU
E7 GGGAAUGGAUCCACAUCUACGAAUUC--CACACGUCGCCGGAC A CACCGCCGG--------UUCACUGCAGACUUGACGAAGCUU
 
B5 GGGAAUGGAUCCACAUCUACGAAUUC-------AAUAGCG-CC A -ACCCUGCGCUCACGCUUCACUGCAGACUUGACGAAGCUU
C7 GGGAAUGGAUCCACAUCUACGAAUUC------ACUUAGCG-CC A -ACCCUGCGCUCAGC-UUCACUGCAGACUUGACGAAGCUU
G7 GGGAAUGGAUCCACAUCUACGAAUUC------ACCAAGCGACC A -ACCCAGUCGCGGC--UUCACUGCAGACUUGACGAAGCUU
 
F7 GGGAAUGGAUCCACAUCUACGAAUUCAACCACCUGCCAACGCC A UCCCGCG---------UUCACUGCAGACUUGACGAAGCUU
 
AUUGCAC motif (wildtype) 
F6 GGGAAUGGAUCCACAUCUACGAAUUCCUCAGACACAC AUCCGUGUGGGCUUCACUGCAGACUUGACGAAGCUU 
 
AAUACAC motif 





B7 GGGAAUGGAUCCACAUCUACGAAUUCACAGCCCGAUGAUAAAUGCCGGGCCAAUGCUUCACUGCAGACUUGACGAAGCUU  
Figure 6-11.  Sequences of U1A mutant N15V selection.  The static priming region is in grey text; the random region of the 
aptamer is in black text.  Heptamer motifs containing a direct match to the wildtype heptamer are in red text; differences from 
the wildtype are shown in blue. 















AUUGCAC A UGC C
ACGCGGUCAUUGCAC UCCGA UGC C
A GCAC
UCCCCGAGUCCGUUCACUGCAGACUUGACGAAGCUU 
H3 GGGAAUGGAUCCACAUCUACGAAUUCGAAGUGGCACGC UAACCGCGGCCUUCACUGCAGACUUGACGAAGCUU 
F1 GGGAAUGGAUCCACAUCUACGAAUUCACAAAUAGACGCUC CACCGGGCGUUCACUGCAGACUUGACGAAGCUU 
A2 GGGAAUGGAUCCACAUCUACGCAAUUCGCCUCGCUAAGGCC GACCGGCCCUUCACUGCAGACUUGACGAAGCUU 
F3 GGGAAUGGAUCCACAUCUACGAAUUCAGAACGGUCAAAGAAC ACCCGGUUCACUGCAGACUUGACGAAGCUU 
 
AAUGCCC motif 
E1 GGGAAUGGAUCCACAUCUACGAAUUCACACAGCCGGAUGAUA A C GGUAGCCUUCACUGCAGACUUGACGAAGCUU 
C2 GGGAAUGGAUCCACAUCUACGAAUUCACACAGCCGGAUGAUA A C GGUAGCCUUCACUGCAGACUUGACGAAGCUU 
E2 GGGAAUGGAUCCACAUCUACGAAUUCACACAGCCGGAUGAUA A C GGUAGCCUUCACUGCAGACUUGACGAAGCUU 
G3 GGGAAUGGAUCCACAUCUACGAAUUCACACAGCCGGAUGAUA A C GGUAGCCUUCACUGCAGACUUGACGAAGCUU 
D4 GGGAAUGGAUCCACAUCUACGAAUUCACACAGCCGGAUGAUA A C GGUAGCCUUCACUGCAGACUUGACGAAGCUU 
H4 GGGAAUGGAUCCACAUCUACGAAUUCACACAGCCGGAUGAUA A C GGUAGCCUUCACUGCAGACUUGACGAAGCUU 
C3 GGGAAUGGAUCCACAUCUACGAAUUCACACAGCCGGAUGAUA A C GGUAGCCUUCACUGCAGACUUGACGAAGCUU 
B3 GGGAAUGGAUCCACAUCUACGAAUUCACACAGCCGGAUGAUA A C GGUAGCCUUCACUGCAGACUUGACGAAGCUU 
 
A3 GGGAAUGGAUCCACAUCUACGAAUUCACUAUC CA C UAUGAUAUUGCGGGACCUUCACUGCAGACUUGACGAAGCUU 
 
C4 GGGAAUGGAUCCACAUCUACGNAUUCG ACUUCCCC G C CCCGUCCUUCACUACAGACUUGACGAAGCUU 
B4 GGGAAUGGAUCCACAUCUACGAAUUC U C C CCCUUCACUGCAGACUUGACGAAGCUU 
 
AAGGCAC motif 







F4 GGGAAUGGAUCCACAUCUACGAAUUCACAAGCGGACGGCAUGCAGCACGUGGGGCUUCACUGCAGACUUGACGAAGCUU  
Figure 6-12.  Sequences of U1A mutant N15F selection.  The static priming region is in grey text; the random region of the 
aptamer is in black text.  Heptamer motifs containing a direct match to the wildtype heptamer are in red text; differences from 
the wildtype are shown in blue.  Two clones, C4 and B4, contain both a wildtype motif and a swap motif. 
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8 of 22 members).  Three other that clones contain the A11C change showed other 
changes at U7 (clones A3, C4, and B4) indicating a lower effect of specificity 
determination at U7 for this mutation. 
Glu19 (to Gln) 
This residue, not well conserved throughout RNP-domain proteins[70, 233], was 
also predicted by DEZYMER to bring about a specificity change of G9C.  Eighteen 
rounds of stringent in vitro selection did not generate a dominate clone or family (Figure 
6-13).  The wildtype heptamer was observed in two clones of 26 (8%).  Nine of the 
clones (35%) were seen to have a variety of substitutions within the first three bases of 
the heptamer, most often to guanosine or cytidine. The change predicted by DEZYMER 
was not observed in this selection. 
Interestingly, three of the clones (12%) had an additional cytidine inserted into the 
heptamer sequence after A6.  While binding assays of these clones have yet to be 
performed, they are predicted to fold into the canonical U1 snRNA hairpin II structure.  
This is remarkable, given the fact that there exists no data supporting wildtype U1A 
recognizing more than seven bases in a loop. 
Leu44 (to Gly) 
Leucine at this position is another residue unique to U1A[70, 233] and makes 
contact with the critical guanosine[70].  Replacement of this residue with glycine has 
evolved a pool where the wildtype motif is present but not the majority of the pool (7 or 
18 members, 39%).  Many substitutions are observed within the first three bases of the 
heptamer (39%).  There are two clones (11%) that demonstrate a specificity swap at the 
critical guanosine (E10 and E11).  Guanosine here is replaced by uridine which is 
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ACUUGCAC motif [octamer] 
G7 GGGAAUGGAUCCACAUCUACGAAUUCACCAUGGCCUCA UUGCACC AUCGAGGUGGCUUCACUGCAGACUUGACGAA
F5 GGGAAUGGAUCCACAUCUACGAAUUCAACGGUCAGACCAC C UCUCGUGGUUCACUGCAGACUUGACGAA UUGCAC A
G6 GGGAAUGGAUCCACAUCUACGAAUUCAAUGUCCGCGGCCU C AUGGCCCUUCACUGCAGACUUGACGACA UUGCAC A
 
AUUGCAC motif (wildtype) 
D5 GGGAAUGGAUCCACAUCUACGAAUUCUCAG CACCCGCUGGGGAAGUCGUUCACUGCAGACUUGACGACAUUGCAC A
C5 GGGAAUGGAUCCACAUCUACGAAUUCAACA UCCGCUGCUGGUUUCACUGCAGACUUGACGACGGCAGCAUUGCAC A
 
Other motifs 
A6 GGGAAUGGAUCCACAUCUACGAAUUCACAGUCAACACGUCUCUGCC ACAGCCUUCACUGCAGACUUGACGAGCAC A
G8 GGGAAUGGAUCCACAUCUACGAAUUCACAGUCAACACGUCUCUGCC ACAGCCUUCACUGCAGACUUGACGAGCAC A
 
G5 GGGAAUGGAUCCACAUCUACGAAUUCAAGUCACCUGCGCUCACGGAUGCCGC UUCACUGCAGACUUGACGAGCAC A
H5 GGGAAUGGAUCCACAUCUACGAAUUCAAGUCACCUGCGCUCACGGAUGCCGC UUCACUGCAGACUUGACGAGCAC A
 
B8 GGGAAUGGAUCCACAUCUACGAAUUCACCUCAUCUGCGCCC C UCCGGGCCUUCACUGCAGACUUGACGAA UGCAC A
 
F8 GGGAAUGGAUCCACAUCUACGAAUUCGACCAAGCUGCGCCCAUCAC AGGGCCUUCACUGCAGACUUGACGAGCAC A
 
F7 GGGAAUGGAUCCACAUCUACGAAUUCGGGA ACCAUGUACUGCUCCGGGGCCUUCACUGCAGACUUGACGAUGCAC A
 
E8 GGGAAUGGAUCCACAUCUACGAAUUCAAGCACACUGCCAAGGGAUC G GCCCUUCACUGCAGACUUGACGAUUGC C A
 















Figure 6-13.  Sequences of U1A mutant E19N selection.  The static priming region is in grey text; the random region of the 
aptamer is in black text.  Heptamer motifs containing a direct match to the wildtype heptamer are in red text; differences from 
the wildtype are shown in blue.  Bases inserted within the wildtype heptamer are green.
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Figure 6-14.  Sequences of U1A mutant L44G selection.  The static priming region is in grey text; the random region of the 
aptamer is in black text.  Heptamer motifs containing a direct match to the wildtype heptamer are in red text; differences from 
the wildtype are shown in blue.  Bases inserted within the wildtype heptamer are green. 






























AUUCUCAC motif [octamer] 
E10 GGGAAUGGAUCCACAUCUACGACUUCACGCGC CU UUGGCGCACAACACCGUUCACUGCAGACUUGACGAAGCUU




G10 GGGAAUGGAUCCACAUCUACGAAUUCAGA ACAACA UUACUCCCCCGUUUCACUGCAGACUUGACGAAGCUU
 
ACUGCAC motif 
G11 GGGAAUGGAUCCACAUCUACGAAUUCACAUCACGAAGGC C UACGCCUGGCUUCACUGCAGACUUGACGAAGCUU







preceded by a cytidine insertion.  Currently, it is unclear whether the cytidine insertion 
functions in concert with the uridine in replacing the original guanosine.  Future binding 
assays will help to ascertain this. 
Leu49 (to Met) 
This amino acid contacts both the critical guanosine[70] and C:G base pair 
closing the hairpin[234] and has been shown to be important in phage display 
experiments.  It was demonstrated that the only other viable substitution was a change to 
methionine, which worsened the Kd by 5-fold[241].  This conservative mutation resulted 
in a selection where the final pool population was fairly winnowed, with 73% (19 of 26 
members) of the pool containing the wildtype heptamer sequence (Figure 6-15).  The 
remaining mutations include two clones (8%) that are predicted to fold into the canonical 
U1 snRNA hairpin II structure with an insertion in the heptamer sequences (clones F6 
and G6).  The remaining population shows swaps within the first three bases of the 
heptamer sequence.  In two cases (A8 and B7, 8%), folding predictions suggest that a 
hairpin II structure is being formed to create an imperfect heptamer sequence 
(ACUGCAG, changes from wildtype underlined) from a static region of the selection 
pool.  Given the sequence diversity of this selection, leucine at this position may serve for 
fine recognition of the 5’ portion of the heptamer. 
Met51 (to Ser) 
This residue has been implicated as a specificity determinant for its interaction 
with the critical guanosine base[70] as well as contacting the C:G base pair that closes the 
loop in hairpin II[234].  Our implementation of DEZYMER had predicted that a mutation 
at this position to serine would elicit an A11C swap in specificity.  80% (16 of 18 clones) 
formed canonical wildtype hairpins (Figure 6-16), while the predicted A11C change was  
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ACCCGCUGUUCGCCCGCUUCACUGCAGACUUGACGAAGCUU 
D6 GGGAAUGGAUCCACAUCUACGAAUUCAGUACC CCCGGUACAAAACCGUCUUCACUGCAGACUUGACGAAGCUU 
G7 GGGAAUGGAUCCACAUCUACGAAUUCAGGGAC UACGUCUCAUCGUCACGUUCACUGCAGACUUGACGAAGCUU 
E5 GGGAAUGGAUCCACAUCUACGAAUUCACACAUCG ACCGCGAUGGCCGCUUCACUGCAGACUUGACGAAGCUU 
H5 GGGAAUGGAUCCACAUCUACGAAUUCACACAUCG ACCGCGAUGGCCGCUUCACUGCAGACUUGACGAAGCUU 
A6 GGGAAUGGAUCCACAUCUACGAAUUCACACAUCG ACCGCGAUGGCCGCUUCACUGCAGACUUGACGAAGCUU 
E7 GGGAAUGGAUCCACAUCUACGAAUUCAAGGCCACC CAGGGUGGGACCGCUUCACUGCAGACUUGACGAAGCUU 
G8 GGGAAUGGAUCCACAUCUACGAAUUCAGAUCGAU UACGGUCGGUACGCUUCACUGCAGACUUGACGAAGCUU 
H7 GGGAAUGGAUCCACAUCUACGAAUUCCCAAGACAC CUCGUGUCGGCCCGUUCACUGCAGACUUGACGAAGCUU 
B6 GGGAAUGGAUCCACAUCUACGAAUUCACCACUUU CACCGCCAAGGCUUCACUGCAGACUUGACGAAGCUU 
E8 GGGAAUGGAUCCACAUCUACGAAUUCCAAUACCCGCC CUUGGCGGCUCGUUCACUGCAGACUUGACGAAGCUU 
F7 GGGAAUGGAUCCACAUCUACGAAUUCACCACUCUUGGC CACCGCCAAGGCUUCACUGCAGACUUGACGAAGCUU
H8 GGGAAUGGAUCCACAUCUACGAAUUCACGCCAAGA UCCCGGGGUUCACUGCAGACUUGACGAAGCUU 
E6 GGGAAUGGAUCCACAUCUACGAAUUCACGGUACCCGGACGUC CUGGACGUUCACUGCAGACUUGACGAAGCUU 
B5 GGGAAUGGAUCCACAUCUACGAAUUCCCCAAGUCUUUUAACCC CUCGGGUUCACUGCAGACUUGACGAAGCUU 
D5 GGGAAUGGAUCCACAUCUACGAAUUCCCCAAGUCUUUUAACCC CUCGGGUUCACUGCAGACUUGACGAAGCUU 
C6 GGGAAUGGAUCCACAUCUACGAAUUCCCCAAGUCUUUUAACCC CUCGGGUUCACUGCAGACUUGACGAAGCUU 
B8 GGGAAUGGAUCCACAUCUACGAAUUCCCCAAGUCUUUUAACCC CUCGGGUUCACUGCAGACUUGACGAAGCUU 
D8 GGGAAUGGAUCCACAUCUACGAAUUCCCCAAGUCUUUUAACCC CUCGGGUUCACUGCAGACUUGACGAAGCUU 
 
AUUAGCAC motif [octamer] 
F6 GGGAAUGGAUCCACAUCUACGAAUUCAAGCGCAAACCCC A UCCGGGGACUUCACUGCAGACUUGACGAAGCUU 
 
ACUUGCAC motif [octamer] 
G6 GGGAAUGGAUCCACAUCUACGAAUUCCAACGGC C UUUCGCCGCGCCCCGUUCACUGCAGACUUGACGAAGCUU 
 
CUUGCAC motif  
C7 GGGAAUGGAUCCACAUCUACGAAUUCGCAAUCCCCACCAGUCC GCCGCCGUUCACUGCAGACUUGACGAAGCUU 
 
UUUGCAC motif  
D7 GGGAAUGGAUCCACAUCUACGAAUUCACCAUCGCCACAU UCCGUGGGCCGCUUCACUGCAGACUUGACGAAGCUU
 
ACUGCAG motif  
A8 GGGAAUGGAUCCACAUCUACGAAUUCACACGCCCUCCUGCACUCCCUCCUGGGCGCUUC C GACUUGACGAAGCUU 
B7 GGGAAUGGAUCCACAUCUACGAAUUCACUCACGCCCACUGCAGCUACCACCGGCCGCUUC C GACUUGACGAAGCUU
 
AAAGCAG motif  


























A GCAC  
Figure 6-15.  Sequences of U1A mutant L49M selection.  The static priming region is in grey text; the random region of the 
aptamer is in black text.  Heptamer motifs containing a direct match to the wildtype heptamer are in red text; differences from 
the wildtype are shown in blue.  Bases inserted within the wildtype heptamer are green.
AUUGCAC motif (wildtype) 
F8 GGGAAUGGAUCCACAUCUACGAAUUCAACAGC






































F12 GGGAAUGGAUCCACAUCUACGAAUUCAAAAGGGCACACCACAAAGAAGGGGCGGGCUUCACUGCAGACUUGACGAAGCUU  
Figure 6-16.  Sequences of U1A mutant M51S selection.  The static priming region is in grey text; the random region of the 
aptamer is in black text.  Heptamer motifs containing a direct match to the wildtype heptamer are in red text. 
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not observed.  The observation that only wildtype heptamer is found in the 
population suggests that this specific residue may play a much larger role in function for 
affinity rather than specificity.   
Arg52 (to Lys, Gln) 
This residue, which contacts the C:G base pair at the loop stem[234], has 
demonstrated its significance in binding wildtype cognate RNA.  A conservative 
mutation to lysine modestly reduces affinity by 3-fold[70], while mutation to glutamine 
eliminates binding to wildtype RNA[29, 64].  In vitro selection against the R52K mutant 
illustrated that this conservative change matters little for wildtype recognition (Figure 6-
17).  89% of the clones (17 of 19) contained the canonical heptamer presented in the 
usual hairpin structure. The remaining two sequences (11%) had a specificity change of 
AUCGCAC (changes from wildtype underlined), with one of the two clones (F3) 
predicted to fold into a hairpin structure. 
The selection against R52Q had a slightly more diverse evolved pool with 56% (9 
of 16 members) possessing the wildtype heptamer.  One clone in this pool (6%) was 
observed to have the AUCGCAC sequence as above.  Additionally, two other clones 
exhibited lack of conservation of the first three bases of the heptamer (E10 and F11).  
Four clones (25%) were clonal but did not contain an obvious recognition sequence or 
were predicted to fold into U1A snRNA-like structures.  Given that the selection against 
the R52Q mutant still yielded a majority of clones containing the wildtype sequence 
indicates that this residue functions primarily in RNA affinity, rather than in specificity. 
This is not surprising given its high level of conservation within the RNP1 element that 





D1 GGGAAUGGAUCCACAUCUACGAAUUCGUGU ACCAGGACACCCUACGCUUCACUGCAGACUUGACGAAGCUU 
C3 GGGAAUGGAUCCACAUCUACGAAUUCUACGCAG UACGCUGUGUCACGCUUCACUGCAGACUUGACGAAGCUU 
B1 GGGAAUGGAUCCACAUCA-CGAAUUCAACUCACC UCAGGUGACGUGCGCUUCACUACAGACUUGACGAAGCUU 
D4 GGGAAUGGAUCCACAUCUACGAAUUCCCAUAGGC ACCGUGUCACCCGUUCACUGCAGACUUGACGAAGCUU 
B2 GGGAAUGGAUCCACAUCUACGAAUUCACGACGCCUC UUGGAGGCCGCUCUUCACUGCAGACUUGACGAAGCUU 
E1 GGGAAUGGAUCCACAUCUACGAAUUCACCACUCGCGC ACCCAGCGCACCUUCACUGCAGACUUGACGAAGCUU 
B4 GGGAAUGGAUCCACAUCUACGAAUUCACACUGCCAGC UACCGCUGGGGCUUCACUGCAGACUUGACGAAGCUU 
F2 GGGAAUGGAUCCACAUCUACGAAUUCCAACUAGCCUU UACCAAGGCGGCUUCACUGCAGACUUGACGAAGCUU 
B3 GGGAAUGGAUCCACAUCUACGAAUUCAACAUUCACGG AGUCGCCGGGCUUCACUGCAGACUUGACGAAGCUU 
E3 GGGAAUGGAUCCACAUCUACGAAUCCACUCACGACACC UCUGGGCGGGCUUCACUGCAGACUUGACGAAGCUU 
D2 GGGAAUGGAUCCACAUCUACGAAUUCCCUGUAACGGUC UUCCGACCGCCUUCACUGCAGACUUGACGAAGCUU 
E2 GGGAAUGGAUCCACAUCUACGAAUUCAUCACACGCUCC ACCGGGGCCGCUUCACUGCAGACUUGACGAAGCUU 
G2 GGGAAUGGAUCCACAUCUACGAAUUCCCAACGCACGC CAACCGCGCGUUCACUGCAGACUUGACGAAGCUU 
D3 GGGAAUGGAUCCACAUCUACGAAUUCGCUUCUGUAAAGGG ACCCGCCCUUCACUGCAGACUUGACGAAGCUU 
G3 GGGAAUGGAUCCACAUCUACGAAUUCCUCGUCCUUAGAAC ACCCGGGUUCACUGCAGACUUGACGAAGCUU
F1 GGGAAUGGAUCCACAUCUACGAAUUCAAGUCGACCUAAUGGC UCCGCCGUUCACUGCAGACUUGACGAAGCUU 
 
AUCGCAC motif 
F3 GGGAAUGGAUCCACAUCUACGAAUUCACGAAGACC C CUACCCGGUCCUCUUUCACUGCAGACUUGACGAAGCUU 
H2 GGGAAUGGAUCCACAUCUACGAAUUC C UCCGGCCCGGUCGUUCACUGCAGACUUGACGAAGCUU 



















AU GCACACCCAGGAAU  
Figure 6-17.  Sequences of U1A mutant R52K selection.  The static priming region is in grey text; the random region of the 
aptamer is in black text.  Heptamer motifs containing a direct match to the wildtype heptamer are in red text; differences from 
the wildtype are shown in blue.
























D9 GGGAAUGGAUCCACAUCUACGAAUUCACAGCACCUACG C CUGCCCCGGCCUUCACUGCAGACUUGACGAAGCUU
 
ACGGCAC motif 










Figure 6-18.  Sequences of U1A mutant R52Q selection.  The static priming region is in grey text; the random region of the 
aptamer is in black text.  Heptamer motifs containing a direct match to the wildtype heptamer are in red text; differences from 
the wildtype are shown in blue.
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Gly53 (to Ala, Val) 
This residue was selected since even conservative mutations cause large increases 
in the dissociation constant for wildtype binding[240].  Presumably, this is due to glycine 
acting as a hinge point between the β2 and β3 strands that permits a necessary 
conformational change between the unbound and bound forms of U1A[240].  Indeed, in 
vitro selection of Gly53 mutants support this theory.  G53A, which is known to bind 
wildtype RNA with 200-fold less affinity[240], only yielded only 6% (1 clone of 16) 
wildtype heptamer aptamers.  One clone (E2) contained an octamer version of the 
canonical heptamer, with a cytidine insertion after A6.  Three other clones (19%) 
contained other heptamer sequences (clones B3, E4 and F3).  The majority of the 
selection pool (69%, 11 of 16 members) did not contain evident heptamer sequences. 
The case is more pronounced in the selection against the G53V mutant, in which 
all but one clone (95%, 20 of 21 clones) did not possess an observable recognition 
sequence or any sort of familial motif.  Only one sequence (B1, 5%) was seen to contain 
a heptamer-like structure.  The inability of these selections to generate a family or 
consensus motif after 18 rounds of selections suggests that this residue is intensely 
critical for binding specificity by way of modulation of the bound and unbound forms of 
U1A.  Future binding studies of these clones will help determine if these mutations cause 
U1A to become a complete binding ‘generalist’, losing all specificity of recognition that 
is imparted when U1A conformationally changes upon ligand binding.   
Gln54 (to Phe) 
This position interacts with the critical guanosine[70] and experimental data 
illustrates that a Q54F mutation decreases affinity for wildtype RNA binding by 10 – 
100-fold[64].  Sequence analysis of the final round of selection against the N54F mutant








ACUUGCAC motif [octamer] 
E2 GGGAAUGGAUCCACAUCUACGAAUUCACCACACACGC C UCACGCGUGGCUUCACUGCAGACUUGACGAAGCUU
 
AUUUCAC motif 
B3 GGGAAUGGAUCCACAUCUACGAAUUCACAACACG U AUAACACGCCGGCCGCUUCACUGCAGACUUGACGAAGCUU
 
ACCGCAC motif 
















F4 GGGAAUGGAUCCACAUCUACGAAUUCACAUCACACACCAUACGACACCGGUCCCGCUUCACUGCAGACUUGACGAAGCUU  
Figure 6-19.  Sequences of U1A mutant G53A selection.  The static priming region is in grey text; the random region of the 
aptamer is in black text.  Heptamer motifs containing a direct match to the wildtype heptamer are in red text; differences from 



























Figure 6-20.  Sequences of U1A mutant G53V selection.  The static priming region is in grey text; the random region of the 
aptamer is in black text.  Heptamer motifs containing a direct match to the wildtype heptamer are in red text; differences from 
the wildtype are shown in blue. 
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shows the dominant clones of the selection (57%, 8 of 14 members) possess the heptamer 
sequence with a cytidine insertion after A6 (Figure 6-21).  Remarkably, wildtype 
heptamer without the insertion is not observed in this evolved pool.  One clone (7%) 
exhibits a double swap (AAUGCAC).  Five other aptamers (38%) do not have obvious 
recognition motifs or consensus sequences.  This residue may impart specificity in the 
second and third base positions of the heptamer sequence since the Q54F mutation 
facilitated the cytidine insertion clone to dominate the selection.   
Phe56 (to Ala, Leu, Trp, Tyr, His) 
Mutation of this conserved aromatic residue of the RNP1 element greatly 
decreases binding affinity for U1A by 1,000-fold (F56A)[43] or 6,600-fold (F56L)[74].  
A selection against the F56A mutant resulted in an almost completely winnowed 
selection pool (Figure 6-22), in which all but one sequence (95%, 19 of 20 members) 
were identical.  This dominate clone does not contain a recognizable sequence similar to 
the canonical heptamer, and is predicted to fold into a stable stem unlike that recognized 
by wildtype U1A.  Conversely, the selection against the F54L mutant yielded a 
winnowed selection pool where all the members (20 of 20) contained the canonical 
heptamer sequence (Figure 6-23).  It is unclear why a mutant with less affinity for the 
wildtype heptamer would yield a selection containing wildtype sequence when the milder 
F56A mutant did not. 
In order to better investigate the role of this residue for specificity rather than 
affinity, selections were performed with other aromatic amino acid substitutions.  In 
general, it appears that sequence specificity is not well-imparted by this residue, and 
likely serves to function more for affinity binding of RNA due to its conservation in RNP 
domains in the RNP1 element. 
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C AAAACCCACAAACCCGCCGCCAUUCACUGCAGACUUGACGAAGCUU 
D6 GGGAAUGGAUCCACAUCUACGAAUUC C ACUCCCCUGUCCCACCACGGCCUUCACUGCAGACUUGACGAAGCUU 
B6 GGGAAUGGAUCCACAUCUACGAAUUCCU C UCACGCCGCCAGCCUUCACUGCAGACUUGACGAAGCUU 
F8 GGGAAUGGAUCCACAUCUACGAAUUCACUUACGGCC C UUCACGGCCCGCUUCACUGCAGACUUGACGAAGCUU 
G6 GGGAAUGGAUCCACAUCUACGAAUUCACUUACGGCC C UUCACGGCCCGCUUCACUGCAGACUUGACGAAGCUU 
E5 GGGAAUGGAUCCACAUCUACGAAUUCACUUACGGCC C UUCACGGCCCGCUUCACUGCAGACUUGACGAAGCUU 
H7 GGGAAUGGAUCCACAUCUACGAAUUCACUUACGGCC C UUCACGGCCCGCUUCACUGCAGACUUGACGAAGCUU 
A5 GGGAAUGGAUCCACAUCUACGAAUUCAGGAAAAAAAC C ACACGGGGUUCACUGCAGACUUGACGAAGCUU
 
AAUUCAC motif 







E8 GGGAAUGGAUCCACAUCUACGAAUUCACACACCUCACUAAUGGCCGGCGCUCGUGCUUCACUGCAGACUUGACGAAGCUU  
Figure 6-21.  Sequences of U1A mutant N54F selection.  The static priming region is in grey text; the random region of the 
aptamer is in black text.  Heptamer motifs containing a direct match to the wildtype heptamer are in red text; differences from 


































D12 GGGAAUGGAUCCACAUCUACGAAUUCAGACAACGCAACCACUGGCCCGGCUUCCCCUUCACUGCAGACUUGACGAAGCUU  
Figure 6-22.  Sequences of U1A mutant F56A selection.  The static priming region is in grey text; the random region of the 
aptamer is in black text.
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C2 GGGAAUGGAUCCACAUCUACGAAUUCGCCCUCACAAGAACCC AUCCGGGUUCACUGCAGACUUGACGAAGCUU  
Figure 6-23.  Sequences of U1A mutant F56L selection.  The static priming region is in grey text; the random region of the 




The selection against F56W illustrated little discernable change in sequence specificity.  
All but one observed clone (92%) was seen to have the wildtype heptamer sequence 
(Figure 6-24).  The remaining clone (E4, 8%) contained a cytidine insertion after U7 with 
a specificity swap of U8A.  Likewise, the selection against the F56Y mutant also yield 
primarily clones containing the wildtype heptamer sequence (Figure 6-25).  Most of the 
clones resembled wildtype (19 of 21 members, 90%) with two clones containing different 
specificity substitutions (F7 and F8).   
The selection against F56H exhibited a greater diversity and less conservation of 
the wildtype heptamer sequence (Figure 6-26).  While the canonical heptamer is seen in 
the population (34%, 10 of 29 clones), another cytidine insertion creating an octamer 
motif is observed (1 of 29 members, 3%), as well as an A6C swap (3 of 29 clones, 10%) 
and several clones demonstrating other swaps, all occurring within the first three 
nucleotides of the heptamer (“Other motifs”).  One of those clones (A9) makes use of the 
static priming region to create an imperfect heptamer sequence (ACUGCAG, changes 
from wildtype underlined), as seen in two clones of the L49M selection.  Finally, 34% of 
the selected pool (10 of 29 individuals) are not seen to resemble the heptamer sequence 
nor form their own consensus.   
These results suggest the possibility that the exact identity of the amino acid at 
this position does not matter as much as its ability to hydrophobically stack and overlap 
electron orbitals.  The mutation of phenylalanine to histidine may result in the evolution 
of less wildtype heptamer in the selection pool due to its smaller aromatic ring, or may 
















AUCAGCAC motif [octamer] 













AU GCAC  
Figure 6-24.  Sequences of U1A mutant F56W selection.  The static priming region is in grey text; the random region of the 
aptamer is in black text.  Heptamer motifs containing a direct match to the wildtype heptamer are in red text; differences from 
the wildtype are shown in blue.  Bases inserted within the wildtype heptamer are green.























AAAGCAC motif  
F7 GGGAAUGGAUCCACAUCUACGAAUUCGAAC AA AUAUCACCUAGCCCCCGCGUUCACUGCAGACUUGACGAAGCUU
 
AUUGCCC motif  
F8 GGGAAUGGAUCCACAUCUACGAAUUCGGCAC C UCCGUGCCAACCCCGCGCUUCACUGCAGACUUGACGAAGCUU





















AUUGC C  
Figure 6-25.  Sequences of U1A mutant F56Y selection.  The static priming region is in grey text; the random region of the 
aptamer is in black text.  Heptamer motifs containing a direct match to the wildtype heptamer are in red text; differences from 
the wildtype are shown in blue.






















F12 GGGAAUGGAUCCACAUCUACGAAUUCCGGAACUC ACACGAGUUGGGC--UUCACUGCAGACUUGACGAAGCUU 
F1 GGGAAUGGAUCCACAUCUACGAAUUCAAAAGACGU ACACGUACGGACUUCACUGCAGACUUGACGAAGCUU 
C10 GGGAAUGGAUCCACAUCUACGAAUUCAAGUCCAAG ACUCGCGUCCUUCACUGCAGACUUGACGAAGCUU 
E1 GGGAAUGGAUCCACAUCUACGAAUUCAAGUCCAAGACGC ACUCGCGUCCUUCACUGCAGACUUGACGAAGCUU 
G1 GGGAAUGGAUCCACAUCUACGAAUUCAGGUCACACCGUC CCCGACGGCCUUCACUGCAGACUUGACGAAGCUU 
G2 GGGAAUGGAUCCACAUCUACGAAUUCAAGUCCAAGACGC ACUCGCGUCCUUCACUGCAGACUUGACGAAGCUU 
B3 GGGAAUGGAUCCACAUCUACGAAUUCAAGUCCAAGACGC ACUCGCGUCCUUCACUGCAGACUUGACGAAGCUU 
H1 GGGAAUGGAUCCACAUCUACGAAUUCACCCAUAGUCUGCU CCGCACCCGUUCACUGCAGACUUGACGAAGCUU 
G9 GGGAAUGGAUCCACAUCUACGAAUUCGCGAGGAUCGCAGG CUUACGCCUGUUCACUGCAGACUUGACGAAGCUU
 
ACUUGCAC motif [octamer] 
D11 GGGAAUGGAUCCACAUCUACGAAUUCCAAGUCGCACACGCC C UCCGGCCUUCACUGCAGACUUGACGAAGCUU 
 
CUUGCAC motif 
C3 GGGAAUGGAUCCACAUCUACGAAUUCACGGGGCC ACUUGCCCUUAGCCAUUUCACUGCAGACUUGACGAAGCUU 
A1 GGGAAUGGAUCCACAUCUACGAAUUCCACUCGGCC UCUCCGGCCACACGCUUCACUGCAGACUUGACGAAGCUU 
E3 GGGAAUGGAUCCACAUCUACGAAUUCACGCGCCUU C ACAAGCGCCCCCUUCACUGCAGACUUGACGAAGCUU 
 
Other motifs 
E10 GGGAAUGGAUCCACAUCUACGAAUUCAC C UUACAAAAUUAUACGGCCCGUUUCACUGCAGACUUGACGAAGCUU 
G11 GGGAAUGGAUCCACAUCUACGAAUUCGC C GCACAACAACACGCGGGGUGCUUCACUGCAGACUUGACGAAGCUU 
F11 GGGAAUGGAUCCACAUCUACGAAUUC AA AUAUCACCUAGCCCCCGCGUUCACUGCAGACUUGACGAAGCUU 
A3 GGGAAUGGAUCCACAUCUACGAAUUCACACACUA CAAUAUGGCAGGCCGGGUUCACUGCAGACUUGACGAAGCUU 
D3 GGGAAUGGAUCCACAUCUACGAAUUCACGCGCACA A ACUUGGCGCACUCUUCACUGCAGACUUGACGAAGCUU 











H3 GGGAAUGGAUCCACAUCUACGAAUUCCCUGUCACACCGUCAUCAUCACCCUGCCCCUUCACUGCAGACUUGACGAAGCUU  
Figure 6-26.  Sequences of U1A mutant F56H selection.  The static priming region is in grey text; the random region of the 
aptamer is in black text.  Heptamer motifs containing a direct match to the wildtype heptamer are in red text; differences from 
the wildtype are shown in blue.  Bases inserted within the wildtype heptamer are green.
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Thr89 (to Lys) 
Threonine has the potential of being a determinate of specificity due to its 
interaction with the critical guanosine[70] and its interactions with the CAC of the 
heptamer in the loop[35, 222].  Additionally, this residue was predicted by DEZYMER to 
cause a specificity swap of A11C if mutated to lysine.  In vitro selection of a T89K 
mutant resulted in an evolved random pool with 40% of the members (6 of 15) having the 
wildtype heptamer in the traditional structure of U1 snRNA hairpin II (Figure 6-27).  A 
uridine insertion was seen in one clone after U6 (or U7) that is predicted to fold into a U1 
snRNA hairpin II structure.  33% of the pool (5 of 15 sequences) contained non-wildtype 
heptamer motifs, including two that introduced uridine replacements at cytidine positions 
in the 3’ portion of the heptamer (clones D8 and A6).  Few of the other selections 
demonstrated a specificity change in the 3’ portion of the heptamer.  Given that this 
residue is known to make contacts with the cytosines in the heptamer sequence, it is 
likely that replacement with lysine stabilizes uridine to some extent.  Lysine, because of 
its positive charge, may allow any pyrimidine rather than maintaining specificity for 
cytidine.  This will be explored with future binding assays. 
Asp90 (to Asn) 
Aspartate at this location also makes extensive interactions with the CAC of the 
heptamer in the loop[35, 222].  We mutated this residue to asparagine in order to attempt 
a specificity change of C12U by changing the ‘directionality’ of hydrogen bonding.  The 
vast majority of the evolved pool against this mutant (D90N) yielded mostly clones 
containing the wildtype heptamer sequence (90%, 19 of 21 individuals, shown in Figure 
6-28).  Two clones (10%, 2 of 21 sequences) contained an octamer recognition sequence 









AUUUGCAC motif [octamer] 












D6 GGGAAUGGAUCCACAUCUACGAAUGCACACGGAGC C UUGGCUCCUUUUGCUUCACUGCAGACUUGACGAAGCUU
 
AUAGCAC motif 





B8 GGGAAUGGAUCCACAUCUACGAAUUCACGCUCGGCAUUUUUACGCACACGCCGACAUUCACUGCAGACUUGACGAAGCUU  
Figure 6-27.  Sequences of U1A mutant T89K selection.  The static priming region is in grey text; the random region of the 
aptamer is in black text.  Heptamer motifs containing a direct match to the wildtype heptamer are in red text; differences from 
the wildtype are shown in blue.  Bases inserted within the wildtype heptamer are green.




































H7 GGGAAUGGAUCCACAUCUACGAAUUCGCUC CACGAGCGCGAGCUGCCCGUUCACUGCAGACUUGACGAAGCUU 
F7 GGGAAUGGAUCCACAUCUACGGAUUCCGGA UUCGUCCGAUCACUGGGCUUCACUGCAGACUUGACGAAGCUU 
E7 GGGAAUGGAUCCACAUCUACGAAUUCAGAA UUACGCGCAGGC--UUCACUGCAGACUUGACGAAGCUU 
A5 GGGAAUGGAUCCACAUCUACGAAUUCACCACCACC UCCGGUGGUCGCGCUUCACUGCAGACUUGACGAAGCUU 
B6 GGGAAUGGAUCCACAUCUACGAAUUCCUCCGUUAC AACGUAUCGCGGGCUUCACUGCAGACUUGACGAAGCUU 
C6 GGGAAUGGAUCCACAUCUACGAAUUCACCACCACC UCCGGUGGUCGCGCUUCACUNGCAGACUUGAACGAAUU 
D8 GGGAAUGGAUCCACAUCUACGAAUUCACGCGGCUC UUCAGAGCCUCCGCUUCACUGCAGACUUGACGAAGCUU 
D5 GGGAAUGGAUCCACAUCUACGAAUUCUACUAACCG UUACGCGGUCGGCUUCACUGCAGACUUGACGAAGCUU 
C7 GGGAAUGGAUCCACAUCUACGAAUUCAGCUGUCAUC CACGAUGGCGGGCUUCACUGCAGACUUGACGAAGCUU 
E6 GGGAAUGGAUCCACAUCUACGAAUUCUCUACUCGCC ACACCGGCGGGCCUUCACUGCAGACUUGACGAAGCUU 
F8 GGGAAUGGAUCCACAUCUACGAAUUCGCCACUAGC CACUCGCGCCCCUUCACUGCAGACUUGACGAAGCUU 
G6 GGGAAUGGAUCCACAUCUACGAAUUCAGACAGCGCCUC ACCGGGGCGGCUUCACUGCAGACUUGACGAAGCUU 
A6 GGGAAUGGAUCCACAUCUACGAAUUCGGACGUCGCCAC CUCACGUGGCCUUCACUGCAGACUUGACGAAGCUU 
F5 GGGAAUGGAUCCACAUCUACGAAUUCAAGUACGCGGCC AUCCGGUCGCCUUCACUGCAGACUUGACGAAGCUU 
G5 GGGAAUGGAUCCACAUCUACGAAUUCAACUUUUUUGCC CUUCAGGCACGCUUCACUGCAGACUUGACGAAGCUU
E5 GGGAAUGGAUCCACAUCUACGAAUUCGAGUCAACAGUCA UCCCGGGUUCACUGCAGACUUGACGAAGCUU 
F6 GGGAAUGGAUCCACAUCUACGAAUUCACGUCAACCCAUGAA CGCCGCUUCACUGCAGACUUGACGAAGCUU 
B8 GGGAAUGGAUCCACAUCUACGAAUUCACGGAGCUCGUCCGAACC GUCGGUUCACUGCAGACUUGACGAAGCUU 
 
ACUUGCAC motif [octamer] 
A7 GGGAAUGGAUCCACAUCUACGAAUUCACCCGCCUC C ACCCCGAGGCCGCUUCACUGCAGACUUGACGAAGCUU 
E8 GGGAAUGGAUCCACAUCUACGAAUUCAACCUUACCGC C UCCGCGGCCGCUUCACUGCAGACUUGACGAAGCUU  
Figure 6-28.  Sequences of U1A mutant D90N selection.  The static priming region is in grey text; the random region of the 
aptamer is in black text.  Heptamer motifs containing a direct match to the wildtype heptamer are in red text.  Bases inserted 
within the wildtype heptamer are green.
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Asp92 (to Asn) 
This residue follows as Asp90 above, and forms hydrogen bonds with C12.  
Eighteen rounds of selection against this mutant (D92N) evolved wildtype heptamer 
sequence in roughly half the population pool (53%, 9 of 17 clones).  In this selection, 
however, it seems like this residue may impart a higher level of specificity than the 
Asp90 residue.  The remaining clones (47%, 8 of 17 clones) illustrated some variability 
from the wildtype heptamer sequence.  Two aptamers (G10 and B11) showed a 
recognition sequence with a A6C swap along with an inserted cytidine after that swap 
before U7.  One of those clones (F10) makes use of the static priming region to create an 
imperfect heptamer sequence (ACUGCAG, changes from wildtype underlined), as seen 
in two clones of the L49M selection and one clone of the F56H selection.  The remaining 
clones exhibit specificity changes within the first three residues of the heptamer 
sequence.   
Asp90 (to Asn), Asp92 (to Asn) 
We created this double mutant where we replaced the hydrogen-bond acceptor in 
the protein to a hydrogen-bond donor in order to select for uridine (H-bond accepting) 
over cytidine (H-bond donating).  Like the individual aspartate mutations above, the 
majority of the evolved pool population (72%, 13 of 18 members) contained the heptamer 
after selection (Figure 6-30).  However, a C12U specificity swap was observed here in 
11% of the pool members (2 of 18).  In one case, the swap was only at C12 (clone F4), in 
another, a second swap of U8C occurred yielding AUCGCAU.  With the exception of the 
Thr11Val U1A mutant selection, this is the only time that specificity is seen to change at 
C12.  This is likely to be a linked phenomenon, since one function of Thr11 is to 
hydrogen bound to Ser91, the residue sandwiched between these two mutations.  Without
 210
Figure 6-29.  Sequences of U1A mutant D92N selection.  The static priming region is in grey text; the random region of the 
aptamer is in black text.  Heptamer motifs containing a direct match to the wildtype heptamer are in red text; differences from 
the wildtype are shown in blue.  Bases inserted within the wildtype heptamer are green.




































B10 GGGAAUGGAUCCACAUCUACGAAUUCACACACGAGC C CUCUCGCUCGCGCUUCACUGCAGACUUGACGAAGCUU
 
AUCGCAC motif  
E12 GGGAAUGGAUCCACAUCUACGAAUUCACAAUAAGGCGC C AUCGCGCUAGCUUCACUGCAGACUUGACGAAGCUU
 
ACAGCAC motif  
G11 GGGAAUGGAUCCACAUCUACGAAUUCAAUCG CA ACCCGCGAUUCACUCGCUUCACUGCAGACUUGACGAAGCUU
 
UUGGCAC motif 
E10 GGGAAUGGAUCCACAUCUACGAAUUCGGGGACGCUCACUU G UAGCACGACCUUCACUGCAGACUUGACGAAGCUU
 
AUCGCAG motif 
F10 GGGAAUGGAUCCACAUCUACGAAUUCGGCCCGAAUACUGCACUAUCACACGGGCGCUUC C GACUUGACGAAGCUU 
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Figure 6-30.  Sequences of U1A double mutant D90N, D92N selection.  The static priming region is in grey text; the random 
region of the aptamer is in black text.  Heptamer motifs containing a direct match to the wildtype heptamer are in red text; 
differences from the wildtype are shown in blue.  Bases inserted within the wildtype heptamer are green.







































E1 GGGAAUGGAUCCACAUCUACGAAUUCACGGACCCAGC C UCACGCUGGCGGCUUCACUGCAGACUUGACGAAGCUU
 
ACUUGCAC motif [octamer] 





AUAGCAC motif  
C2 GGGAAUGGAUCCACAUCUACGAAUUCACGUCAACUAUACCC A GCACCGGGUUCACUGCAGACUUGACGAAGCUU
this hydrogen bond to stabilize the interaction of these residues with RNA[69], we 
observed uridine replacement in the last two positions in the T11V selection (Figure 6-
10).  It is likely that these C-terminal residues impart a fair amount of sequence 
determination over the last three bases of the heptamer.  
CONCLUSIONS 
The majority of changes from the wildtype heptamer sequence were observed 
mostly in the first three residues, as indicated in Tables 6-2 for a single change, Table 6-3 
for two changes, and Table 6-4 for three changes.  This is not surprising given that the 
two critical bases for wildtype recognition are located away from the beginning of the 
heptamer (G9 and A11).  
Single Swap Mutation 
CUUGCAC F56H (10%), D92N (6%), L49M (4%), D90N&D92N (6%) 
UUUGCAC L49M (4%) 
ACUGCAC L44G (11%), D92N (6%), E19N (4%), F56H (3%) 
AUAGCAC T89K (7%), D90N&D92N (6%), F56H (3%) 
AUCGCAC R52K (11%), T89K (7%), R52Q (6%), D92N (6%), F56H (3%)
AUGGCAC T11V (5%) 
AUUUCAC G53A (6%) 
AUUGUAC T89K (7%) 
AUUGCCC G53V (7%) 
AUUGCAU T11V (11%), T89K (7%), D90N&D92N (6%) 
Table 6-2.  List of heptamer sequences observed to deviate from the wildtype sequence in 
one position.  This table lists a new recognition sequence matched with the U1A mutant 
that they arose from.  Changes from the wildtype sequence are highlighted in bold, blue 
text.  Percentages reflect the relative population of that heptamer in the final selection 
pool. 
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Double Swap Mutation 
UAUGCAC F56H (3%) 
CCUGCAC T89K (7%) 
GAUGCAC E19N (4%) 
CAUGCAC L44G (11%), D92N (6%) 
UUGGCAC D92N (6%) 
CUUACAC N15V (71%) 
CUUGCGC E19N (4%) 
CUUGCCC G53V (5%) 
UUUGCGC E19N (4%) 
AAAGCAC F56Y (5%), L49M (4%), F56H (3%) 
ACGGCAC R52Q (6%) 
ACCGCAC G53A (6%) 
AAUACAC G53V (7%), N15V (6%) 
AAUGCCC N15F (36%) 
AGUGCCC N15F (5%) 
ACUGCCC N15F (5%) 
AUCGCAU D90N&D92N (6%) 
AUUGCGG G53A (6%) 
AUUGCUU T11V (11%) 
Table 6-3.  List of heptamer sequences observed to deviate from the wildtype sequence in 
two positions.  This table lists a new recognition sequence matched with the U1A mutant 
that they arose from.  Changes from the wildtype sequence are highlighted in bold, blue 




Triple Swap Mutation 
GCCGCAC E19N (8%) 
CGCGCAC E19N (8%) 
CACGCAC L44G (17%), E19N (4%)
UACGCAC R52Q (6%) 
ACAGCCC N15F (5%) 
Table 6-4.  List of heptamer sequences observed to deviate from the wildtype sequence in 
three positions.  This table lists a new recognition sequence matched with the U1A 
mutant that they arose from.  Changes from the wildtype sequence are highlighted in 
bold, blue text.  Percentages reflect the relative population of that heptamer in the final 
selection pool. 
The fact that U1A may have recognition for an octamer sequence is unanticipated 
given the protein’s high selectivity for its recognition sequence.  Regardless, octamer 
sequences that are predicted to fold into U1 snRNA hairpin II were observed in several 
selections (Table 6-5).  
Octamer Mutation 
ACUUGCAC N54F (57%), E19N (12%), D90N (11%), G53A (6%),  
D90N&D92N (6%), L49M (4%), F56H (3%) 
AUUCUCAC L44G (11%) 
AUUAGCAC L49M (4%) 
AUCAGCAC F56W (8%) 
AUUUGCAC T89K (7%) 
CCUUGCAC D92N (12%) 
Table 6-5.  List of sequences observed to possess an insertion within the heptamer.  This 
table lists an octamer sequence matched with the U1A mutant that they arose from.  
Changes from the wildtype sequence are highlighted in bold, blue text.  Bases assumed to 
be insertions are colored green.  Percentages reflect the relative population of that 
octamer in the final selection pool. 
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In all cases, insertions were seen to be pyrimidines and found within the first three 
bases of the heptamer.  It may be that these mutations spatially permit a pyrimidine in 
this region while still maintaining specificity.  Future binding studies that employ these 
octamer-containing aptamers with wildtype U1A should help determine if the wildtype 
protein is capable of specific binding to an octameric sequence, or if this phenomenon is 
limited to the destabilized mutant U1As.     
Implications for rational design 
It should be noted that this work could not have been completed within my 
graduate career without the automation of the in vitro selection process.  Remarkably, the 
twenty-one selections presented in this Chapter were executed in the span of 200 
concurrent hours.  In this fashion, we can currently execute selections one-to-two 
magnitudes faster than is performed at the bench (see Chapter 2 for more details). 
The results from these 21 selections against mutant U1A selections are highly 
suggestive that in vitro selection can be used as a tool for the extraction of binding rules 
pertaining to RNA binding domains.  While the wildtype heptamer was evolved in most 
of the selection pools, this is not surprising due to the exquisite amount of evolutionary 
conservation constrained upon U1A and its homologues; U1A is not a ‘generalist’ of 
RNA binding. 
This can be seen by observation of the pool diversity of the selected pools (Figure 
6-31).  In general, mutants would evolve aptamers containing the wildtype motif (shaded 
blue) or generate aptamers that completely lacked a wildtype-like U1A recognition motif 
(shaded purple).  Overall, there were fewer cases where the mutant protein would elicit a 
specificity change (shaded yellow), or even in some cases an octamer motif (shaded 






























































































































Figure 6-31.  Population diversity of the 21 mutant U1A selection pools.  Shown here are pie charts of the relative diversity of 
the final selection pool (Round 18) from the twenty-one mutant U1A selections.  Observed heptamer motifs are shown in black 
text; bases different from the wildtype are indicated by blue text and inserted bases forming an octamer motif are colored 
green.  The wildtype heptamer sequence (AUUGCAC) is shaded light blue and pool members with bases different from the 
wildtype are shaded yellow.  Pie slices representing octamer motifs are colored light orange, and aptamers that fail to 
demonstrate a heptamer-like sequence or structure are indicated by purple shading.
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The work presented in this Chapter is not complete due to submission dates of 
dissertations of the Graduate School.  Regardless, the continuation of this work will 
proceed in a publication-oriented manner.  Binding assays will be executed in order to 
validate or disprove the conclusions made from sequence analysis of the selected pools.  
Additionally, mutants will be tested with minimized constructs when necessary in order 
to show specificity of the hairpin structure rather than affinity from another section of the 
aptamer.   
These selections do support the theory that specificity is imparted from elements 
outside the conserved RNP1 domain, but not the RNP2 domain.  Mutations to the most 
conserved RNP element, RNP1, generally yielded either wildtype heptamer sequence or 
sequences that do not seem to contain a consensus.  Despite the high level of evolutionary 
conservation seen in both elements, mutations made in the RNP2 domain often affected a 
selective change in specificity (e.g., N15, E19).  Because mutation of these residues 
increase the Kd of U1A for wildtype RNA by a factor of 103-105, researchers generally 
assumed that this indicated that these residues functioned in only RNA affinity.  In fact, 
the N15V mutant, known to abolish binding of wildtype RNA[75], yielded a double-
substituted heptamer sequence that outcompeted wildtype RNA despite increasing 
stringent salt washing during the last six rounds of in vitro selection.  Clearly this residue 
is a partial determinant of specificity as well as a conserved residue for affinity binding. 
More interesting will be the creation of combinatorial mutants based upon the 
sequence analysis.  For instance, there were three selections in which a single swap from 
AUUGCAC to AUUGCAU was observed (T11V, T89K, and D90N&D92N).  Given the 
relative low percentage of total pool population (6-11%), it is expected that this new 
heptamer sequence would still bind less well than wildtype.  Pooling these individual 
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mutations may (or may not) yield a new mutant U1A that possesses high affinity and 
specificity for AUUGCAU. 
The ultimate goal will be to truly apply these findings to rational design.  For 
instance, if the triple mutation in the preceding paragraph really does bring about a 
specificity change for a base, then hopefully the same residue substitutions can be 
employed in RNP-domain homologues.  This would facilitate rapid design of RNA 
binding proteins that are highly specific for a certain sequence and structure.  For 
instance, mirroring these mutations in U2B” might yield a mutant that binds a novel 
nucleotide sequence that mimics its original recognized structure, U2 snRNA hairpin IV.   
EXPERIMENTAL METHODS 
The automated in vitro selection of mutant U1A protein followed in the exact 
manner as described in the “Experimental Methods” section of Chapter 5 and Table 5-2.  
The only exception is during the incubation step where random pool is incubated with 
mutant U1A immobilized to streptavidin-coated beads.  In these selections, the bead / 
RNA mixture was agitated on an orbital microplate shaker in order to ‘loosen’ the 
paramagnetic beads from the bottom of the microwells.  Otherwise, pains were taken to 
ensure the mutant selections were performed identically to that of the wildtype U1A 
selection. 
Site-directed mutagenesis 
U1A point mutants were constructed through site-directed mutagenesis based on 
selection against methylated plasmids[242] with a QuickChange Multi Site-Directed 
Mutagenesis Kit (Stratagene, La Jolla, CA).   PCR reactions were assembled according to 
the manufacturer’s instructions with 50 ng of plasmid containing the U1A gene and 100 
ng of 5’-phophorylated mutational primer (Integrated DNA Technologies, Coralville, IA) 
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per reaction (Table 6-2).  After cycling, DpnI was added to the reactions for 1 hr at 37ºC 
to digest the template plasmid.  Mutant plasmids were then transformed into XL10-Gold 
competent cells (Stratagene).  Colonies were bi-directionally sequence verified in order to 
ensure no other mutations existed in the mutated plasmid other than the desired one, 
using the methods listed under “Sequence analysis” in Chapter 5. 
Primer name Sequence (5’→3’) 
U1A.Mut01 (T11V) GACCCGCCCTAACCACGTTATTTATATCAACAACC 
U1A.Mut02 (N15V) ACCACACTATTTATATCGTGAACCTCAATGAGAAG 
U1A.Mut03 (R52Q) GGAGCCTGAAGATGCAGGGCCAGGCCTTTGTCATC 
U1A.Mut04 (G53A) GCCTGAAGATGAGGGCCCAGGCCTTTGTCATCTTC 
U1A.Mut05 (G53V) GCCTGAAGATGAGGGTCCAGGCCTTTGTCATCTTC 
U1A.Mut06 (Q54F) GAAGATGAGGGGCTTCGCCTTTGTCATCTTCAAGG 
U1A.Mut07 (F56A) GATGAGGGGCCAGGCCGCTGTCATCTTCAAGGAGG 
U1A.Mut08 (F56L) GATGAGGGGCCAGGCCTTGGTCATCTTCAAGGAGG 
U1A.Mut09 (D90N) TCCAGTATGCCAAGACCAACTCAGATATCATTGCC 
U1A.Mut10 (D92N) ATGCCAAGACCGACTCAAATATCATTGCCAAGATG 
U1A.Mut11 (D90N,D92) CCAGTATGCCAAGACCAACTCAAATATCATTGCCAAGATG 
U1A.Mut12 (E19N) TATCAACAACCTCAATCAGAAGATCAAGAAGGATG 
U1A.Mut13 (L44G) GCCAGATCCTGGATATCGGTGTATCACGGAGCCTG 
U1A.Mut14 (Q85E) ACAAACCTATGCGTATCGAGTATGCCAAGACCGAC 
U1A.Mut15 (F56W) GATGAGGGGCCAGGCCTGGGTCATCTTCAAGGAGG
U1A.Mut16 (F56Y) GATGAGGGGCCAGGCCTATGTCATCTTCAAGGAGG 
U1A.Mut17 (F56H) GATGAGGGGCCAGGCCCATGTCATCTTCAAGGAGG 
U1A.Mut18 (R52K) GGAGCCTGAAGATGAAGGGCCAGGCCTTTGTCATC 
U1A.Mut19 (L49M) CCTGGTATCACGGAGCATGAAGATGAGGGGCCAGG
U1A.Mut20 (M51A) ATCACGGAGCCTGAAGGCGAGGGGCCAGGCCTTTG
U1A.Mut21 (M51S) ATCACGGAGCCTGAAGAGCAGGGGCCAGGCCTTTG 
U1A.Mut22 (N15F) ACCACACTATTTATATCTTCAACCTCAATGAGAAG 
U1A.Mut23 (T89K) ATCCAGTATGCCAAGAAAGACTCAGATATCATTGC 
Table 6-6.  List of primers used to create U1A point mutations.  This table lists the 23 
primers designed to create point mutants of the U1A protein.  The codon being altered is 
in bold text while changed bases are highlighted with blue text.  The primers are 5’-
phosphorylated in order to be compatible with the QuickChange Multi Site-Directed 
Mutagenesis Kit (Stratagene). 
Template Construction 
After mutants were verified, they were linearly assembled with 5’ and 3’ 
transcription and translation fragments, much like described in Chapter 5.  However, 
rather than using our previous system as described in Chapter 5, we have since begun 
using a commercially available assembly kit (RTS AviTag E. coli Biotinylation Linear 
Template Kit, Roche Diagnostics, Basel, Switzerland).  In short, we subcloned the mutant 
U1A genes from the plasmids using Expand High Fidelity Plus polymerase.  This was 
done with primers designed to partially hybridize to the ends of the U1A gene and 
partially hybridize to the Roche linear template constructs.  Here, we used primers 
Avitag.U1A.5 (CGC TTA ATT AAA CAT ATG ACC ATG GCA GTT CCC GAG 
ACC) and Avitag.U1A.3 (TTA GTT AGT TAC CGG ATC CCT TAT TTC ATC TTG 
GCA ATG ATA TC).   
Next, splice-overlap extension with the same polymerase was used to generate the 
full length expression construct according to manufacturer’s instructions.  The N-terminal 
AviTag fragment (Vial #4) was used in order to label the N-terminus of U1A with biotin, 
as was done in Chapter 5.  After gel verification of the assembly reaction, larger scale 
PCR reactions (800 µl) were performed in order to generate enough linear template for 
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coupled in vitro transcription and translation.  Each 800 µl reaction was initiated with 2 
µl of the previous assembly reaction as template, and primed with Avitag.T7pro.5 (CGG 
TCA CGC TTG GGA CTG CCA TAG GCT GG) and Avitag.T7term.3 (CGA GCT TGC 
CAA CGT GCC GTG GGA GTC GCT CC).  After cycling, the reactions were gel 
verified and purified via ethanol precipitation. 
In vitro transcription and translation 
In order to express the 21 mutants that were selected against, a large coupled 
transcription and translation (TnT) master mix was constructed using reagents from the 
RTS 100 E. coli HY kit (Roche).  The reaction for each mutant was individually scaled 
up by a factor of 16-fold from the manufacturer’s instructions to ensure enough protein 
would be available for selection and post-selection affinity assays.  
The master mix was constructed with 4,032 µl of E. coli lysate, 3,360 µl of 
reaction buffer, 4,032 µl of amino acid mix, and 336 µl of methionine.  Next, 1,680 µl of 
biotin label mix was added, which was comprised of 840 µl of BirA enzyme and 840 µl 
of Energy Mix from the RTS AviTag Biotinylation Kit (Roche).  Each individual 800 µl 
TnT reaction had 2.4 mg of purified linear PCR product as template, and was added to 
water to reach a final volume of 160 µl.  Finally, 640 µl of the master mix was added to 
the water-diluted linear template, and incubated at 30ºC for six hours. 
Unincorporated biotin was removed through the use of desalting columns (Econo-
Pac 10 DG Disposable Chromatography Columns, Hercules, CA).  Columns were first 
equilibrated with 30 ml of 1x Selection Binding Buffer (1x SBB; 20 mM Tris, pH 7.5; 
100 mM KOAc, and 5 mM MgCl2).  The 800 µl TnT reactions were added to 2.2 ml of 
SBB in order to bring the volume up to 3 ml prior to loading.  After loading, biotinylated 
protein was eluted from the column with 4 ml of SSB.  Aliquots were taken before and 
after purification for analysis, and verified using Western techniques with streptavidin-
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conjugated horseradish peroxidase described under “In vitro transcription and 
translation” in Chapter 5. 
Sequence analysis 
Evolved random pools were sequenced using the methods described under 
“Sequence Analysis” in Chapter 5. 
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Appendix A:  Technical obstacles of robotic selections 
A large number of technical obstacles were surmounted in order to develop the 
automated in vitro selection system.  This Appendix is intended to provide an overview 
of the types of problems that have been encountered during this body of work and is by 
no means to be considered inclusive whatsoever.  In addition to routine molecular 
biology issues (pertaining to reagents, laboratory equipment, etc.), we have also had to 
resolve problems relating to the software of the robotic system, the hardware that 
comprises it, and other matters that fall outside the scope of software/hardware (e.g., 
consumables such as labeling tape, disposable tips, etc.).  A few selected examples of 
these types of obstacles are provided below.  
Software-based limitations 
The principle software that controls the robot is a Visual-Basic front-end (circa 
1995) that generates script commands that are fed into an on-board TCL (tool command 
language) interpreter on the robot’s mainboard.  We are currently limited to operations 
that can be conducted through the front-end interface as the manufacturer has lost the 
look-up table of available TCL scripting commands.  This has lead us to create 
complicated, repetitive in vitro selection procedures since we are unable to use advanced 
looping techniques with incremental variable addition without the look-up table. 
Other software issues have dealt with new releases of the robotic controller 
software.  For instance, the Bioworks 3.0 release, intended to bring the robotic system 
into “Year 2000 compliance”, introduced a bug into the communications system that 
would randomly cause the robot to disconnect communication with the computer 
controller between twelve to twenty-four hours of use.  Needless to say, our laboratory 
was one of the first to discover this bug.  While simply stated here, this type of obstacle is 
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indicative of most software problems that cost us effort (in running tests and controls) 
and time (testing controls and the downtime while the manufacturer develops a solution). 
Another predicament that took a significant amount of time to conclude was the 
discovery that the thermalcycler driver cannot be run on modern computers (e.g., 
Pentium 4 systems) and must instead be executed only on antiquated systems (e.g., a 
Pentium or Pentium II computer).  Running the driver on faster computers causes the 
driver to slip out of sync with the thermalcycler during an experiment, stalling the entire 
robotic system, irrespective of COM port settings.  Unfortunately, this driver stop being 
produced several years ago, and the only solution from the manufacturer at this time is 
the purchase of institutional-scale software that costs approximately $25,000. 
Disposable tip usage 
The robotic operating system is incredibly unrefined.  An issue that epitomizes 
typical software troubles is the function of discarding pipette tips.  While it may seem 
that being able to instruct the robot to eject a used tip and to get a clean tip would be 
simple, it certainly is not.  Due to uncorrected errors in the robot’s operating system, the 
software uses different ‘rules’ for how it processes a “get-new-tip” command based upon 
idiosyncratic circumstances.   
The software will or will not discard a tip in the radioactive collection bag, and 
will or will not pick up a tip immediately after that discard step depending on 1) whether 
a pipetting tool change is the immediate next step, 2) whether the tool change is between 
the same type (e.g., single-channel P-20 to single-channel P-200) or different type (e.g., 
8-well pipettor to single-channel pipettor) and 3) whether the tip was used once or 
multiple times on the previous pipette command.  This results in a confusing matrix in 
which ‘normal’ programming causes the robot to not discard tips when it should, and to 
get fresh tips and waste them when it should not.   
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This is especially troublesome given the fact that the current software is incapable 
of obtaining new tip boxes when it empties one; this step must be specifically 
programmed ahead of time.  Therefore, we must be able to plot each tip disposal 
accurately in order to ensure the platform does not stall in the middle of a run waiting for 
tips.  In order to facilitate this, we have abandoned the semi-automated tip disposal 
counting system, and instead manually program every single tip disposal movement in a 
given in vitro selection protocol. 
Mechanical & physical complications 
A majority of technical obstacles relate to mechanical failures and other 
‘physical’ issues.  Such examples include the difficulty of pipetting enzymes by a robot 
(50% glycerol at -20ºC), microplates that become warped due to sealing films that ‘pull 
up’ the edges of a plate after having a certain number of microwells punctured (resulting 
in pipetting volume errors), low viscosity liquids that drip out of pipette tips, etc.   
Enzyme cooler condensation and electrical shorts 
The enzyme coolers that our laboratory has constructed are constrained to fit 
within the small spaces of the robotic worksurface.  Because of this, the coolers do not 
have the optimum amount of insulation surrounding them and so the outer surface 
becomes cold enough to condense atmospheric water.  During times of high humidity, an 
enzyme cooler during an overnight experiment can condense enough water to spread 
across the worksurface to other peripherals.   
In the past, this has caused water to come in contact with the automated tip-latch 
mechanisms.  This subsystem locks tip boxes in place for accurate disposable tip retrieval 
and unlocks them when the box is emptied so that it can be replaced with a fresh box.  
When water comes into contact with these, a short-out occurs when the polarity on the 
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electromagnetic lock is reversed, often resulting in a large spark across the surface and 
always causing the robotic system to immediately fail.  After this occurrence, the auto-
latch subsystem may or may not need complete replacement.  We combat this by 
attempting to keep the humidity between 30-40% (Appendix E).  We are currently 
researching new insulation materials. 
PCR plate vacuum lock 
A particularly troublesome problem has been the phenomenon of vacuum lock 
that is created between a PCR microplate and the heated lid of a thermalcycler.  When a 
microwell has liquid in it (e.g., PCR reaction) a small vacuum is created due to the 
temperature difference between the liquid and that of the heated lid.  Because less air is 
present in a filled well than an empty well, the vacuum ‘force’ is stronger for a given 
filled well.   If a plate contains enough wells filled with liquid (this turns out to be three 
or more selections run in parallel), then the force is great enough for the plate to stick to 
the lid (Figure A-1). 
Determining the true source of this issue, the vacuum lock, required a significant 
amount of time due to the fact that we initially ran ‘quick’ controls rather than overnight 
runs.  The quick controls never filled enough PCR wells for the vacuum lock to overcome 
the force of the lid’s opening spring mechanism.  After determining the source of the 
problem, we tried to simply tape the PCR plate to the interior of the thermalcycler.  
Taping the PCR plate down did not resolve the issue as the vacuum created is actually 
stronger than the spring in the PCR lid mechanism and prevents the lid from opening 
more than an inch or so (Figure A-1, left side).   
Previously, we adjusted the height of the heated lid such that direct contact was 
not made with the plate in order to prevent the vacuum lock.  However, this seemed to 
greatly increase contamination seen between adjacent wells (data not shown).  
Regardless, we made height-specific adjustments of the heated lid for the number of 
targets run.  Currently, we are using a new model of thermalcycler released this year that 
obviates this issue and allows eight targets to be amplified in parallel without vacuum 
lock occurring.   
 
Figure A-1.  Photograph of automated thermalcycler lid failure due to vacuum lock.  
These two pictures illustrate the failure of a mechanical lid device due to ‘vacuum lock’ 
between the 96 wells of the PCR plate and the top of the heated lid.  Shown on the left is 
a photograph of a thermalcycler with an automated lid attempting to open.  The PCR 
plate (yellow) is stuck to the top of the lid preventing it from fully opening due to a 
collision between the plate and the lid’s hinge point.  On the right, the thermalcycler lid 
has been manually forced open and the yellow PCR plate remains locked to the heated 
lid.  Water containing blue dye is used to mimic PCR reactions. 
Non hardware/software issues 
Contamination issues are mentioned in Chapter 2, and the evolution of matrix-
binding parasitic aptamers is discussed in Appendix B.  Other general obstacles have had 
to do with consumables specific for the robotic platform.  For instance, a large lot of 
aerosol-barrier disposable tips purchased from a thrifty vendor contained ~0.2% flawed 
tips.  That is, at low frequency the robot would pick up a tip whose aerosol barrier 
actually blocked all air flow preventing aspiration of liquid into that tip.  We initially 
were baffled by what first appeared to be a chaotic problem since pipetting errors would 
 232
always occur at completely different positions and were absolutely unrepeatable.  
Currently, we only use disposable tips manufactured by Beckman Coulter or MβP. 
Labeling tape 
Another impediment was simple laboratory labeling tape (often simply called 
“colored tape” or “lab tape”).  Much to our chagrin, we discovered that different colors of 
tape actually have different physical properties.  We were previously required to use 
labeling tape to secure the PCR plate into the thermalcycler when running one-to-two 
selections in parallel to prevent the PCR plate from sticking to the top of the heated lid 
(discussed above).  We found that 
‘normal’ solid colors function well for this 
purpose.  These tapes are generally a solid 
paper strip dyed in a specific color and 
coated with glue.  However, we found that 
some of the less-frequently ordered colors, 
especially pastels like pink, aquarmarine, 
chartreuse, etc., are manufactured 
differently.  These tapes are colored paper 
that are adhered onto a separate white strip 
of paper containing the actual adhesive.  
We found that these tapes lose their 
adhesive properties when they are warmed 
near the lid of the thermalcycler.  Use of 
this tapes resulted in vacuum-lock of the 
PCR plate to the heated lid with only one 
or two targets being selected.  Again, this 
 
Figure A-2.  Example of ‘good’ and ‘bad’ 
labeling tape.  This photograph illustrates 
the difference between labeling tapes.  
Functional labeling tape capable of retaining 
its adhesive properties when exposed to heat 
are of a single-ribbon construction, such as 
the “light blue” colored tape in the back of 
this picture (indicated with yellow-outlined 
text).  Poorly functioning labeling tape that 
loses its adhesive properties when warmed 
are of a dual-ribbon construction, such as the 
“aquamarine” tape in the foreground.  The 
top ribbon contains the dye and is adhered to 
a second, white ribbon containing the 
adhesive (indicated with red-outlined text). 
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issue was initially difficult to resolve due to the fact that we did not initially perceive 
labeling tape as an actual ‘reagent’ that could be bad or have gone bad, especially since 
the adhesive properties of this tape returned when cooled back to room temperature.  
Microplate sealing film 
All of the microplates on the robotic worksurface are sealed with a film in order 
to prevent contamination as well as to prevent evaporation during their overnight 
incubation in a lower humidity environment.  We began using traditional adhesive-
backed aluminum foil film as it is readily punctured by plastic pipette tips.  After moving 
into a higher mode of throughput, we began to discover that certain microwells covered 
with this film would not have liquid aspirated out of them, and that this occurred in a 
chaotic, nonreproducible fashion.   
A large and involved series of pipetting controls led us to realize that the very low 
frequency of pipetting faults were being caused by the sealing film.  The pipette tip, when 
pushing through the aluminum foil, would infrequently ‘cookie-cut’ the foil rather than 
rip it.  This very small circle of ‘cut’ aluminum foil, exactly the diameter of the end of the 
disposable tip, would remain stuck to the end of that tip and prevent liquid from entering 
it.  We have evaluated nearly a dozen pipette tip-pierceable sealing films now, and had 
issues with all of them that include reproduction of this same problem, or other issues 
such as film thickness, pressuring-locking a tip during an aspiration step, etc.  We are 
currently using a pressure-sensitive adhesive plastic film available at local retailers (Press 
‘n’ Seal Wrap, Glad, Oakland, CA) that works quite well with our robotic platform. 
 
Appendix B:  Evolution of matrix binding nucleic acids 
During the experimentation presented in this dissertation, we evolved two matrix 
binding classes of parasitic aptamers.  After their evolution, these aptamers would ‘take 
over’ other selections performed on the automated workstation until we implement anti-
contamination procedures (Chapter 2).  Specifically, we evolved an aptamer that 
possesses high affinity for the streptavidin-coated magnetic beads that we immobilize 
targets onto.  Additionally, we generated an aptamer with specific binding properties for 
that of the PVDF filter membrane that we partition binding species from non-binding 
species associated with the bead-target complex. 
Magnetic bead binding aptamers 
Two bead binding clones (Class B & C) were isolated during the attempt to 
generate aptamers specific to serotonin (Appendix C), and two other clones (Class A & 
D) were isolated from selections following the initial serotonin experiment (Figure B-1).  
While the beads we use are conjugated with streptavidin for biotin capture, none of the 
aptamers had affinity for streptavidin in solution.  
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Class B: AACCGCGGTTCTTTG--- CG-
Class C: GTTGAATCCCCGACTATG CG-
Class D: GCGCGACCGTACTGA--- CG-




Figure B-1.  Paramagnetic bead aptamers.  Illustrated here is the random region of the 
parasitic aptamer sequences evolved to possess high specificity for streptavidin-coated 
magnetic beads.  The 5’ portion is unconserved while the 3’ portion of the random region 
contains a well-conserved 6-mer/4-mer motif highlighted in bold red text.  Three of four 
of the aptamers bridge the 6-mer and the 4-mer sequence with a CG pair; one of the four 
bridges them with TGC.   Classes B & C arose first in the serotonin selection; Classes A 
& D evolved in later selections. 
Curiously, we found that the aptamers would only bind the streptavidin-coated 
beads when the RNA was generated by the robot itself.  That is, RNA translated at the 
bench and then acrylamide gel purified, eluted, ethanol precipitated, and thermally 
denatured had no binding affinity for the beads.  Only when the robot produced RNA and 
loaded the entire mixture, undenatured, onto the beads did they bind specifically. 
In order to study this, we performed single rounds of mock selections, using either 
native random pool (Round 0) or one of the parasitic aptamers as template for the 
amplification reactions.  After the robotic platform generated the RNA for the ‘next’ 
round of selection, we allowed it to incubate that RNA (really, transcription reaction) 
with naked beads, and then manually eluted the RNA from the beads to compare relative 

















Binding signal relative to Round 0 signal
 
Figure B-2.  Bead-binding affinity of parasitic aptamers.  This graph illustrates the 
amount of RNA isolated from magnetic beads after one round of robotic selection.  The 
amount of signal is given in terms of the amount of parasitic aptamer versus Round 0 
pool eluted. 
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The mock selection demonstrated that the Class A aptamer had approximately six 
times the amount of RNA bound to the beads after one round of mock selection, as 
compared to native pool.  The Class B aptamer demonstrated high affinity for magnetic 
beads with greater than 35 times more nucleic acid bound to the beads than that of 
unselected pool.  It remains unclear why the Class C and Class D aptamer possess less 
affinity than that of unselected pool for the bead matrix.  It may be that these bind beads 
only in specific salt buffers, as a range of salt concentrations was employed in the 
selections where they evolved.   
It is also uncertain why purified RNA at the bench will not bind beads.  We 
hypothesized that these aptamers were adopting a certain shape that was disturbed by the 
traditional denaturing of nucleic acid that follows ethanol precipitation or freezing.  
Therefore, in addition to the anti-contamination protocols outlined in SELECTION 
version 6.x series, we also added nucleic acid denaturation steps directly after the 
transcription reaction prior to loading the pool onto the target.  Additionally, bead 
binding could depend on some component in the transcription reaction, such as the T7 
RNA polymerase or dithiothretiol, etc.  Regardless, these parasitic aptamers have not be 
observed in any selections since the implementations of series 6.x protocols. 
Filter membrane binding aptamers 
A selection against Bacillus spores yielded a PDVF binding aptamer (Figure B-3).  
Often, this aptamer would ‘take over’ the population of selections run on the robotic 
platform after this initially evolved.  For instance, this binding species became the 
dominant clone (>70%) of the final, eighteenth round of selection against Bacillus 
anthracis exosporium. Much like the bead binding aptamers above, this clone had to be 
amplified by the robotic platform in order to retain its matrix binding ability; manually 
translated RNA of this clone does not bind PVDF (Figure B-4). 
Again, as with the bead binding aptamers, adaptation of better nucleic acid 
handling protocols and denaturation techniques seem to have abolished this clone from 
‘taking over’ selections.  In fact, this clone has not been detected by sequence analysis 
since that time. 
GAACAGAACACACACATCAAACGAGCGCGC
 
Figure B-3.  PVDF membrane aptamers.  Shown is the random region of the parasitic 
aptamer clone evolved to possess high specificity for polyvinyldiflouride membranes. 
 
Figure B-4.  Illustration of robotic amplification reliance on the PVDF aptamer for 
binding.  This radiograph demonstrates the dependence of the PDVF aptamer to be 
amplified with robotic selection techniques.  The radiograph is of a magnified portion of 
a 96-well 0.2 µm PDVF filterplate (Corning, Actin, MA).  The arrows each point to one 
of the 96 well positions.  The blue arrow indicates a microwell that had 2 µg of manually-
amplified aptamer clone flowed through it and washed with 0.5 ml of selection buffer.  
The red arrow shows the same amount of RNA generated by the robotic platform flowed 





Appendix C:  Unsuccessful selections 
We have attempted selection of many different targets, successful and 
unsuccessful (Appendix D), often repeating ‘failed’ selections to exclude random 
mechanical issues (e.g., in the past, a few selections have failed due to a single bad 
pipette tip in a lot of a thousand).  We believe that many of the failed selections we tried 
after initially creating the robotic platform would now work with our current level of 
expertise.  Additionally, we have invested significant amounts of time on targets 
considered ‘difficult’ for nucleic acid binders (e.g., Bacillus spores) and also of small 
molecules that typically yield aptamers that bind much more weakly to their targets than 
do protein aptamers.  However, with adjustments, we have since been able to generate 
small molecule aptamers[128].  A discussion of these situations follows below. 
Initial selections with earlier SELECTION revisions 
Preliminary anti-protein selections performed on the aptamer selection system 
tended to fail to yield aptamers, while more recent anti-protein selections tend to generate 
specific aptamers.  We believe that this tend is largely due to our accumulation of 
expertise both in the fields of in vitro selection and of laboratory robots throughout the 
course of this work.  Our success ratio from ‘bad’ to ‘good’ pivoted during the 
implementation of SELECTION version 4.x series, in which we instituted higher 
stringency washing procedures specific to anti-protein selections.  For instance, initially, 
we attempted selection against yeast transcription factors in conjunction with Karen 
Browning’s laboratory, but failed to yield aptamers or amplify bound species.  Since the 
implementation of version 4.x and later, we have never failed to produce specific 
aptamers to nucleic acid binding proteins, or even basic (positively charged) proteins.   
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Bacillus spores and anthracis spore coat 
The ability to detect Bacillus anthracis or differentiate anthracis from other 
common Bacillus species such as B. subtilis has obvious and immediate applications.  
Our laboratory attempted to generate aptamers specific to B. subtilis, B. cereus, and the 
exosporium of B. anthracis.  I performed eight individual selection experiments against 
spores and exosporium comprising 108 total rounds of selection without yielding specific 
aptamers.  Additional DNA selections performed both at the bench (student Seth 
Cockrum) and in an automated fashion (student Letha Sooter) also failed to generate 
specific aptamers.   
Ultimately, a precise reason as to the inability to generate specific aptamers to 
these targets cannot be given.  Generalized excuses include the possibility of using the 
wrong buffer, wrong pool, wrong binding conditions, etc.  Additionally, Bacillus spores 
seem to make poor targets for nucleic acid aptamers.  The spore coats are hydrophobic, 
which encourage nonspecific binding of nucleic acid (especially DNA), and are also 
coated with polyglutamate which creates a charge-repulsion with nucleic acid[243, 244].   
The first selection subjected B. subtilis spores to six rounds of automated in vitro 
selection, treating the spores as magnetic beads since they are of comparable size.  The 
second selection was a repeat of the first.  The third selection was targeted against spores 
biotinylated with typical NHS esters (Chapter 2) to target any surface proteins.  We 
hypothesized that perhaps we had attenuated robotic selection to the point of requiring 
beads, so we conjugated the spores to beads.  Eighteen rounds of selection were 
executing on bead-bound B. subtilis spores, with increasingly stringent salt washing 
performed in Round 7-18. 
The fourth selection was targeted against the exosporium of B. anthracis.  The 
exosporium of anthracis was used rather than the entire spore as we were discouraged 
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from taking machinery into the BSL3 laboratory that requires frequent maintenance.  
Eighteen rounds of selection were performed with increasing levels of salt in the wash 
buffers during Rounds 7-18. 
The fifth through eighth selections were directed towards B. cereus spores.  This 
species was selected since it is genetically indistinguishable from B. anthracis with the 
exception of pXO1 and pXO2 virulence plasmids that encode the anthracis protective 
antigen, edema factor, lethal factor, and protective coat[245].  In the fifth selection, 
twelve rounds of selections were done against plain B. cereus spores, with increasing salt 
concentrations in the wash buffer in Rounds 7-12.  The sixth selection modified the fifth 
by NHS-ester biotinylation of the spores for immobilization onto beads, with constant 
washing buffers.   
At that time, we began to suspect that biotinylation of the spores may not have 
been happening due to the behavior of the beads when we manually prepared them at the 
bench.  As a result, I began to perform biotinylation controls with the spores and found 
that the NHS ester molecule was not biotinylating the spores (Figure C-1, top portion).  
Therefore, I began attempting to biotinylate B. cereus with an assortment of 
commercially available biotinylation reagents under a variety of conditions.   A 
pentafluorophenyl ester (EZ-Link PFP Biotin, Pierce, Rockford, IL) had the best 
reactivity with the spores (Figure C-1, bottom portion).   
Nonetheless, the seventh and eighth selections with properly biotinylated spores 
still failed to elicit specific aptamers.  For the seventh selection, eighteen rounds of 
selection were performed on the biotinylated, bead-bound spores.  The eighth and last 
selection was performed in an acidic selection buffer for twelve rounds.  Because the 
spore coat is highly negatively charged, we attempted to mitigate charge-charge repulsion 
of the shell and RNA by approaching the pI of the spore coat.  Regardless, aptamers were 
not evolved with this method either. 
Figure C-1.  Biotinylation of Bacillus cereus spores.  Shown here are spores until normal 
microscopy (left panels) and fluorescent microscopy (right panels).  Spores in visual-
spectrum light (left panel) show as dots when in the focal plane, and light grey ‘smudges’ 
out of the focal plane.  Biotinylation of spores was attempted with either an NHS-ester 
(top panel set) or pentafluorophenyl ester (bottom panel set).  After chemical 
biotinylation, the spores were washed several times to remove incorporated biotinylation 
reagent, and then labeled with streptavidin-conjugated fluorescein (Pierce) for visual 
detection with fluorescent microscopy (right panels).  Photographs are taken at a 
magnification of 40X. 
 242
One of three outcomes was seen in all eight selections described above.  Initial 
automated in vitro selection attempts with plain spores typically failed to detectably 
amplify the random pool past Round 1 (which led us to begin biotinylation trials).  Other 
times amplification occurred correctly, but at the end of selection no signal specific to the 
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presence of the spores was observed.  Additionally, sequence analysis demonstrated no 
noticeable winnowing of the pool or consensus sequence.   
Finally, some of the selections, notably the B. anthracis spore coat selection and 
the later B. cereus selections, evolved a parasitic aptamer.  This aptamer would ‘take 
over’ selections run after it on the robotic platform (e.g., some of the arginine-rich motif 
peptide selections performed by Travis Bayer).  It was not until we initiated the anti-
contamination procedures in SELECTION version 6.x series (Chapter 2) that we were 
able to reduce the presence of this amplicon to below levels of amplifiable detectability.  
Later analysis proved this clone to be a specific binder to the PVDF membranes we use 
on the automated selection system (Appendix B).   
Small molecules 
I had attempted to generate aptamers to small molecules before I revised the 
robotic software to SELECTION series 7.x series (Chapter 2).  In brief, this revision 
allowed less stringent wash accommodations for targets that may elicit weaker binding 
aptamers such as small molecules (typical Kds often range from the nano- to high 
micromolar).  I executed a pair of selections each against the neurotransmitters serotonin 
and amphetamine.  Each compound possesses one primary amine and was used as the 
point of biotinylation with an NHS ester (Sulfo-NHS-LC-Biotin, Pierce) used in limiting 
amounts.  The biotinylation was verified by reverse-phase HPLC. 
Biotinylated neurotransmitters were captured onto streptavidin beads and 
thoroughly washed several times to remove free neurotransmitters.  Each target 
underwent twelve rounds of selection in parallel with each other.  The washing buffer 
was constant for the first six rounds (50 mM Tris, pH 7.0; 100 mM NaCl; 5 mM MgCl2).  
The monovalent salt content was increased in Round 7-12 in steps of 35 mM, from 135 
mM to 310 mM NaCl. 
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The outcome of these two selections were selected pools that had no detectable 
specificity for either of their target molecules.  Sequence analysis of Round 12 of the 
amphetamine selection demonstrated little winnowing and no consensus sequence or 
family resolution (Figure C-2).  The Round 12 pool of the serotonin selection yielded a 
highly winnowed pool with families containing a common motif (Figure C-3).  The 
overall consensus sequence of the serotonin selection was TGCCTCTCGATCA, which 
was seen minimized in other clones (e.g., Family 3) to GCCTCTCG.   
Further analysis proved that aptamers containing the above consensus sequence 
were in fact specific bead-binding aptamers (Appendix B).  Aptamers containing this 
motif was seen to evolve in selections executed immediately after this one, including a 
modified peptide selection and some of the Bacillus selections.  As above for the filter 
membrane-binding aptamers, it was not until we initiated the anti-contamination 
procedures in SELECTION version 6.x series (Chapter 2) that we were able to reduce the 
presence of this parasitic aptamer to prevent its manifestation in other selections.  
Undergraduate Patrick Goertz is currently reselecting these target molecules using the 
newer small molecule selection procedures that generated aminoglycoside aptamers. 
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AmphR12C18 GGGAATGGATCCACATCTACGAATTCACAATGATGCCGCCGTCGGCCCCGTTTGTC-TTCACTGCAGACTTGACGAAGCTT  
Figure C-2.  Sequences of amphetamine selection.  Aptamers from the amphetamine pool after twelve rounds of robotic 
selection are shown.  The static priming region is in grey text; the random region of the aptamer is in black text.  No consensus 




















SeroR12C07 GGGAATGGATCCACATCTACGAATTCAACCGCGGTTCTT TGTTCACTGCAGACTTGACGAAGCTT 
SeroR12C12 GGGAATGGATCCACATCTACGAATTCAACCGCGGTTCTT TGTTCACTGCAGACTTGACGAAGCTT 
SeroR12C15 GGGAATGGATCCACATCTACGAATTCAACCGCGGTTCTT TGTTCACTGCAGACTTGACGAAGCTT 
SeroR12C16 GGGAATGGATCCACATCTACGAATTCAACCGCGGTTCTT TGTTCACTGCAGACTTGACGAAGCTT 
 
Family 2 
SeroR12C09 TGGAATGGATCCACATCTACGAATTCGTTGAATCCCCGACTA TTCACTGCAGACTTGACGAAGCTT 
SeroR12C14 GGGAATGGATCCACATCTACGAATTCGTTGAATCCCCGACTA TTCACTGCAGACTTGACGAAGCTT 
SeroR12C17 GGGAATGGATCCACATCTACGAATTCGTTGAATCCCCGACTA TTCACTGCAGACTTGACGAAGCTT 
SeroR12C20 GGGAATGGATCCACATCTACGAATTCGTTGAATCCCCGACTA TTCACTGCAGACTTGACGAAGCTT 
 
Family 3 
SeroR12C01 GGGAATGGATCCACATCTACGAATTCGCGATACGAATCGCAACCCTA-A TTCACTGCAGACTTGACGAAGCTT 












Figure C-3.  Sequences of serotonin selection.  Aptamers from the serotonin pool after twelve rounds of robotic selection are 
shown.  A consensus sequence (TGGCCTCTCGATCA) is highlighted in bold red text.  A possible intrafamilial similarity is 
highlighted in blue text.   
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Appendix D:  Robotic selection technology in Ellington lab 
The development of a robotic in vitro selection platform has been described 
(Chapter 2), as well as initial modifications made for proofing selections (Chapter 3) and 
further enhancements necessary for accomplishing anti-protein selections (Chapter 4).  
However, the creation of the robotic aptamer selection system has been a greatly 
collaborative effort within the Ellington laboratory and has served more than my own 
research interests.  Currently, the system has been used to yield RNA aptamers specific to 
small molecules, peptides, and proteins.  Additionally, extensive work has been placed 
into the development of an automated DNA aptamer selection system (refer to the 
dissertation of Letha Sooter, also undergoing defense).   
We have attempted to generate specific RNA aptamers on the robotic platform 
against all the targets listed below in Table B-1.  Some of these selections performed by 
other laboratory members are briefly described below.  Additionally, some advances by 
other students involving upstream and downstream components of in vitro selections are 
mentioned. 
 
Target Modification Collaboration Researcher 
Oligo (dT)25   J. Colin Cox 
Oligo 15mer sequence   J. Colin Cox 
PNA 15mer sequence   J. Colin Cox 
Lysozyme (hen egg)   J. Colin Cox 
CYT-18 (N. crassa)  Lambowitz @ UT J. Colin Cox 
MEK1 (human)   J. Colin Cox 
Rho (Thermatoga)  Friedman @ Purdue J. Colin Cox 
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US11 (HSV-1)  Coen @ Harvard J. Colin Cox 
Trinitrotoluene (TNB)  Jhaveri @ NRL J. Colin Cox 
Serotonin  Mihic @ Waggoner J. Colin Cox 
Amphetamine  Mihic @ Waggoner J. Colin Cox 
hnRNP R RNP domain 1   J. Colin Cox 
hnRNP R RNP domain 2   J. Colin Cox 
hnRNP R RNP domain 3   J. Colin Cox 
hnRNP R RNP domain 4   J. Colin Cox 
PTB-1 RNP domain 1   J. Colin Cox 
PTB-1 RNP domain 2   J. Colin Cox 
PTB-1 RNP domain 3   J. Colin Cox 
PTB-1 RNP domain 4   J. Colin Cox 
Bacillus subtilis spores  Jackman @ Hopkins J. Colin Cox 
Bacillus cereus spores  Jackman @ Hopkins J. Colin Cox 
B. anthracis exosporium  Jackman @ Hopkins J. Colin Cox 
IMP dehydrogenase  Stanton @ Brandeis J. Colin Cox 
U1A (human)   J. Colin Cox 
P24 TXN factor  Browning @ UT J. Colin Cox 
P28 TXN factor  Browning @ UT J. Colin Cox 
β-Galactosidase   J. Colin Cox 
Horse radish peroxidase   J. Colin Cox 
Lysozyme K30 pool  J. Colin Cox 
Ricin A-chain  Robertus @ UT J. Colin Cox 
BamHI enzyme   J. Colin Cox 
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EcoRI enzyme   J. Colin Cox 
EcoRV enzyme   J. Colin Cox 
HinDIII enzyme   J. Colin Cox 
NdeI enzyme   J. Colin Cox 
PstI enzyme   J. Colin Cox 
PvuI enzyme   J. Colin Cox 
XhoI enzyme   J. Colin Cox 
Lysozyme (hen egg) Buffer A  J. Colin Cox 
Lysozyme (hen egg) Buffer B  J. Colin Cox 
Lysozyme (hen egg) Buffer C  J. Colin Cox 
Lysozyme (hen egg) Buffer D  J. Colin Cox 
Lysozyme (hen egg) Buffer E  J. Colin Cox 
Lysozyme (hen egg) Buffer F  J. Colin Cox 
Lysozyme (hen egg) Buffer G  J. Colin Cox 
Lysozyme (hen egg) Buffer H  J. Colin Cox 
U1A mutant #1 (T11V)   J. Colin Cox 
U1A mutant #2 (N15V)   J. Colin Cox 
U1A mutant #3 (R52Q)   J. Colin Cox 
U1A mutant #4 (G53A)   J. Colin Cox 
U1A mutant #5 (G53V)   J. Colin Cox 
U1A mutant #6 (Q54F)   J. Colin Cox 
U1A mutant #7 (F56A)   J. Colin Cox 
U1A mutant #8 (F56L)   J. Colin Cox 
U1A mutant #9 (D90N)   J. Colin Cox 
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U1A mutant #10 (D92N)   J. Colin Cox 
U1A mutant #11 (9&10)   J. Colin Cox 
U1A mutant #12 (E19Q)   J. Colin Cox 
U1A mutant #13 (L44G)   J. Colin Cox 
U1A mutant #15 (F56W)   J. Colin Cox 
U1A mutant #16 (F56W)   J. Colin Cox 
U1A mutant #17 (F56H)   J. Colin Cox 
U1A mutant #18 (R52K)   J. Colin Cox 
U1A mutant #19 (L29M)   J. Colin Cox 
U1A mutant #21 (M51S)   J. Colin Cox 
U1A mutant #22 (N15F)   J. Colin Cox 
U1A mutant #23 (T89K)   J. Colin Cox 
λ phage N protein peptide   Travis S. Bayer
P22 phage N protein pep.   Travis S. Bayer
φ21 N protein peptide   Travis S. Bayer
HIV Rev peptide   Travis S. Bayer
HIV Rev N7D peptide   Travis S. Bayer
HIV Rev R11Q peptide   Travis S. Bayer
HIV Rev R10Y peptide   Travis S. Bayer
HTLV Rex peptide   Travis S. Bayer
HIV Tat peptide   Travis S. Bayer
BIV Tat peptide   Travis S. Bayer
BMV Gag peptide   Travis S. Bayer
CCMV Gag peptide   Travis S. Bayer
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PRP6 ARM peptide   Travis S. Bayer
U2AF peptide   Travis S. Bayer
RNAP σ factor peptide   Travis S. Bayer
Testis/Brain RNA BP  Robertus @ UT Travis S. Bayer
Unnatural amino acids  Aslyn @ UT Gwen Stovall 
O:157 LPS (E. coli)  Clickenbeard @ OSU Gwen Stovall 
Lysozyme Bob White Quail Willson @ U. Houston Gwen Stovall 
Lysozyme Japanese Quail Willson @ U. Houston Gwen Stovall 
Lysozyme California Quail Willson @ U. Houston Gwen Stovall 
Anthracis protective anti.  Dickens @ Battelle Gwen Stovall 
TGF-β receptor  Sousa @ UTHS Gwen Stovall 
Lysozyme Acidic buffer  Gwen Stovall 
Lysozyme Buffer 1  Gwen Stovall 
Lysozyme Buffer 2  Gwen Stovall 
Lysozyme Buffer 3  Gwen Stovall 
Csk kinase   Carlos Garcia 
Src kinase   Carlos Garcia 
Lysozyme (hen egg) PBS buffer  Carlos Garcia 
hnRNP A1 derv. UP1   Carlos Garcia 
hnRNP A1 derv. UP1 R50 pool  Carlos Garcia 
HRP 38 (Drosophila)  Rio @ UC Berkeley Carlos Garcia 
HRP 40 (Drosophila)  Rio @ UC Berkeley Carlos Garcia 
Murine PD-1  Almo @ Einstein U. Carlos Garcia 
CTLA-4  Almo @ Einstein U. Carlos Garcia 
Lysozyme (hen egg) Pool aliquot 1  Fang En Lee 
Lysozyme (hen egg) Pool aliquot 2  Fang En Lee 
Lysozyme (hen egg) Pool aliquot 3  Fang En Lee 
Lysozyme (hen egg) Pool aliquot 4  Fang En Lee 
Lysozyme (hen egg) Pool aliquot 5  Fang En Lee 
Lysozyme (hen egg) Pool aliquot 6  Fang En Lee 
Lysozyme (hen egg) Pool aliquot 7  Fang En Lee 
Lysozyme (hen egg) Pool aliquot 8  Fang En Lee 
β-Galactosidase R50 pool  Fang En Lee 
Serotonin   Patrick Goertz 
Dopamine   Patrick Goertz 
Tobramycin   Patrick Goertz 
Kanamycin A   Patrick Goertz 
Neomycin B   Patrick Goertz 
Creatine Kinase   A. Szafranska 
Lysozyme R50 pool  Brian Gehrke 
Arginine   Brian Gehrke 
Table B-1.  List of automated RNA selections attempted in the Ellington laboratory.  
Presented in this table is a complete list of all the selection targets attempted on the RNA 
aptamer selection system.  Targets are listed by name, a ‘modifier’ if applicable, a 
collaborator if applicable, and the main collaborator of the selection.  A modifier may 
indicate the difference between selections against the same target, as when different 
buffer conditions are investigated.  Collaborations are listed by the last name of the 
principle investigator’s laboratory followed by abbreviation of their affiliation. 
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Selected automated in vitro RNA selections 
Testis/Brain RNA binding protein 
Former student Travis Bayer performed a selection in collaboration with the 
Robertus laboratory against an RNA binding protein expressed only in the brain and the 
testis, Testis/Brain RNA Binding Protein (TB-RBP).    This nucleic acid binding protein 
is involved in the regulation and transport of messenger RNA in brain and male germ 
tissue[246, 247].  This RBP contains a GTP binding site that seems to modulate the 
specificity of nucleic acid binding[248].  In order to further investigate this, Travis Bayer 
performed in vitro selection against this protein both in the absence and in the presence of 
free GTP.  The Robertus laboratory is currently working on minimizing the evolved 
aptamers for crystallization purposes. 
Arginine-rich motif peptides 
Travis Bayer also performed selections against fifteen peptides containing 
arginine-rich motifs (ARMs) from various viruses, bacteria, and eukaryotes.  Nine of 
these selections were considered successful, having generated specific aptamers to their 
respective ARM peptide; the other selections were unsuccessful due to contamination of 
a matrix binding species (Appendix B).   Since ARMs only have a preponderance of 
arginine residues in common with each other, it is unclear how specificity for a nucleic is 
encoded within an ARM.  To examine this, he then performed a cross-reactivity matrix of 
aptamer pools with the various peptides in order to examine the specificity of ARMs (an 
example of this data is shown in Figure D-1).  Undergraduate student Lauren Booth is 
currently finishing the analysis of these interactions since Travis Bayer’s graduation from 
this school prior to submission of the manuscript. 
Rev N7D R11Q R10Y P22 N BMV Gag CCMV gag BIV Tat Rex
anti-Rev 18.5 192 220 no 310 no no no no 420
anti-N7D A05 250 118 no no no no no no no
anti-R11Q 3 no no 96 no no no no no no
anti-P22 N 3 no no no no 300 no no no no
anti-BMV Gag 2 no no no no no 16 260 no no
anti-CCMV Gag 2 no no no no no 480 280 no no
anti-BIV Tat 5 no no no no no no no 280 no
anti-Rex 1 382 418 450 no no no no no 260
Single amino acid variants of Rev
Figure D-1.  Example of cross-reactivity of ARM-peptide aptamers.  Shown is a cross-
reactivity binding matrix between the predominant clone of an aptamer pool (listed in the 
left column) with several ARM-peptides (listed left-to-right along the top).  N7D, R11Q, 
and R10Y are single amino acid variants of the wildtype Rev peptide.  Numbers indicate 
the Kd of the cross-reactive complex in nanomolar.  “no” indicates that cross reactivity is 
not seen at equimolar concentrations of aptamer and peptide at concentrations of 512 nM 
and lower.  This figure is provided by the courtesy of Travis Bayer. 
Aminoglycosides 
Aminoglycosides were the first successful small molecule selections performed 
on the automated selection system.  This is largely due to the advancements made in the 
SELECTION version 7.x series in order to yield aptamers to targets that may bind 
nucleic acid much more weakly than proteins can, such as small molecules.  We chose 
aminoglycosides as they have been successful selection targets for manual selections[46, 
249] and their positive charge would likely increase the probability of nucleic acid 
association.  Undergraduate Patrick Goertz executed selections against tobramycin, 
neomycin B, and kanamycin A[128].  In some cases, his robotically evolved aptamers 
bound tighter to the aminoglycosides than aptamers reported from the manual 
aminoglycoside selections in the literature (e.g., kanomycin aptamer KanR12CA 
dissociation constant is between 10 – 30 nM).  Having accomplished this, he is now 
performing selections against more interesting small molecules, such as the 
neurotransmitters serotonin and dopamine. 
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hnRNP A1 derivative UP1 
Former student and now current technician Carlos Garcia is investigating the 
heterogeneous nuclear RNP A1, which is proteolytically cleaved into UP1.  UP1 lacks 
the glycine-rich C-terminal region of A1[250].  Both proteins have been found to 
promote telomere elongation by actively recruiting telomerase in mammalian cells[251, 
252].  Because telomerase activity has been detected in the vast majority of human 
tumors, it is an attractive target for potential anticancer therapy[253].  Besides potential 
therapeutic uses, A1 and UP1 can be used to address new questions regarding specificity. 
Both hnRNP A1 and its derivative UP1 have been found to bind to vertebrate 
single-stranded telomeric repeats in vitro; however, the proteolytic derivative UP1 has 
been found to bind human telomere RNA much more efficiently[254].  Therefore, any 
difference in in vitro selected sequences can be used to determine how the glycine-rich 
region of hnRNP A1 absent in UP1 modifies its binding characteristics and activities.  At 
this time, Carlos Garcia has assembled the UP1 template, transcribed and translated it, 
and performed 18 rounds of selections against it.  This has resulted in a winnowed and 
specific pool containing a 6-mer consensus sequence.  He is currently in the process of 
assembling the full length A1 gene. 
Pool population investigations 
Because the theoretical diversity of the pool (440 = 1024) is much, much greater 
than the actual diversity of the synthesized pool (~1015), it is assumed that each 
amplifiable sequence is a unique sequence.  Typically, we attempt selections while 
maximizing the diversity of the pool in order to yield the ‘best’ aptamer that exists in the 
pool for that target. 
Student Fang En Lee is performing several selections against the same target 
using different sub-aliquots of the same pool synthesis.  By ‘assaying’ binding species 
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with different populations of the same synthesis, she will be able to survey much more of 
the sequence landscape given what arise each time she performs the selection.  For 
example, an individual that is the ‘best’ binder of an entire synthesis might outcompete 
other ‘very good’ binding species for the same target.  By performing selections using 
sub-aliquots, other aptamers that might otherwise be overshadowed by a predominant 
clone will be observed.   
Analysis of the different ‘best binders’ of each sub-aliquot provides the ability for 
several interesting explorations about functionality in regards to sequence space.  For 
instance, in each case, the aptamers can be inspected for total fitness.  The dissociation 
constant of a binding specie for its ligand is not the only evolutionary force applied to it, 
and can be affected by the thermostability of its secondary structure, ability to replicate 
its sequence at a speed relative to the overall population, etc.  These explorations may in 
fact allow us to isolate ‘better’ aptamers, in the case that most ‘winners’ are in fact just 
relatively good binders that happen to out amplify the better binding species.  That is, this 
study answers the question regarding whether selections yield the global optimum 
aptamer of the population, or a local optimum species capable of outcompeting the global 
optimum aptamer outside the basis of nucleic acid : ligand affinity alone. 
Buffer-specific effects on selections 
Former technician and current student Gwen Stovall is currently exploring the 
effects of different kinds and amounts of salts in a selection buffer on the outcome of the 
selection.   As described elsewhere (Chapter 4), in vitro selection is a tedious art in need 
of empirical investigation of its experimental variables.  One variable where there is no 
literature available is the selection buffer.  A handful of experiments have evaluated the 
effect of pH value[209, 213], monovalent salt concentration[210, 212], and divalent salt 
concentration[211, 214] on the binding abilities of selected aptamers, but to date, no one 
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has published data concerning the consequence of buffer choice on species evolution.    
This is likely due to the difficulty involved in preciously repeating in vitro selection 
experiments, along with the large effort involved in screening many buffer variables.   
Gwen Stovall is now tackling this problem, using the repeatability and 
reproducibility available from the robotic aptamer selection system.  She has developed a 
‘Round 0’ buffer assaying system on our robotic platforms[127]. This assay system 
determines the relative amount of binding with the initial random nucleic acid pool to a 
given protein target in 96 different buffer conditions.  We have theorized that perhaps 
selections may evolve ‘better’ binding species, or require less rounds of selections, if 
evolved in a buffer which the initial pool demonstrates a modest amount of affinity for 
the target (0 – 5% at a given concentration).   Currently, the system probes binding of 
‘Round 0’ affinity to a target using a sparse matrix approach[255, 256]. 
In its current configuration, the system assays initial binding of pool to target in a 
matrix of four different monovalent salts (at three different concentrations each) and two 
different divalent salts (at three concentrations each, plus one set with both together, and 
one set with neither) at a given pH value (Figure D-2).  Such a matrix can test 96 
individual buffer conditions per execution; the value of 96 is chosen due to the size of the 
dot-blot manifold we have integrated on the worksurface.  While specific salts and 
concentrations are shown in Figure D-2, these are easily changed to different salts and 
values, as is the pH composition. 
Lysozyme again is being used as the target choice, for reasons listed in Chapter 4.  
Gwen Stovall has performed this assay on lysozyme in repetition, and is currently 
carrying out selections against lysozyme in three different buffers.  My ‘original’ 
selection buffer (Chapter 4) is chosen as a reference, and it happened to score in the 
middle of the buffers.  The specific buffer formulation that provided the highest Round 0 
binding signal is the second buffer, with the buffer demonstrating the worst Round 0 
binding signal as the third buffer for reference.  We hope that the outcome of these and 
future ‘buffer’ selections will enable us to execute a higher number of successful 




SALT] 100 mM 160 mM 220 mM 100 mM 160 mM 220 mM 100 mM 160 mM 220 mM 100 mM 160 mM 220 mM
DIVALENT
SALT 1 2 3 4 5 6 7 8 9 10 11 12
0 A
1 mM MgCl2 B
1 mM CaCl2 C
5 mM MgCl2 D
5 mM CaCl2 E
2.5 mM MgCl2 &
2.5 mM CaCl2 F
10 mM MgCl2 G
10 mM CaCl2 H
NaCl LiCl KCl KOAc
20 mM Tris, pH 7.5
Figure D-2.  Example of layout for testing 96 selection binding buffers.  The columns (1-
12) are divided into four monovalent salts at three preselected concentrations.  The rows 
(A-H) are divided into seven different divalent salts, with one row containing no divalent 
salt whatsoever (row A).  One single pH buffer is employed per plate per test.  For 
example, well G6 would test initial random pool binding to target in the presence of 20 
mM Tris (pH 7.5), 220 mM LiCl, and 10 mM MgCl2.  This figure is provided by the 
courtesy of Gwen Stovall[127]. 
Assay and preparation throughput 
In addition to facilitating selections, we have employed the robotic workstations 
for other uses as well.  Some uses (e.g., performing ‘Round 0’ binding assays, 
determining aptamer affinity, and pre-selection preparation) are discussed below. 
Automated dissociation constant assay 
Previous undergraduate Travis Bayer has physically integrated a 96-well dot-blot 
filtration manifold in order to perform automated binding assays to determine the 
dissociation constants of aptamers.  This fully automated assay takes a protein and 
aptamer stock, and performs serial dilutions and constructs binding reactions at 
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predetermined concentrations.  Typically, these binding reactions are repeated anywhere 
from three to eight times in order to account for discrepancy between different sheets of 
nitrocellulose (which we have observed in the past).  The reproducibility inherent in a 
robotic system generally generates binding curves with one-quarter the deviation between 
































































Figure D-3.  Eight-replicate automated dissociation assay.  A limiting amount of 
lysozyme aptamer (~10 pmol) is used to access fraction of lysozyme bound at different 
concentrations in order to determine the Kd.  This assay was performed with eight 
replicates, each identified on the binding curve by a different color.  In several instances, 




The automated dissociation constant assay has been used to determine Kds of 
aptamers for several published selections[71, 146].  When performing binding reactions 
in triplicate, the standard deviations yielded are generally +/- 1 – 10% of the averaged 
data point values[71].  
Automated ‘Round 0’ buffer assay 
The ‘Round 0’ buffer assay is described above under “Buffer specific effects on 
selections”. 
Robotic in vitro selection preparation 
Technician Carlos Garcia and undergraduate Ankit Barasia have developed 
protocols on the automated workstation to facilitate the preparation of distributing 
various reagents to microplates prior to the start of an automated in vitro selection 
experiment.  This includes distributing reaction buffers containing radionucleotides, 
generating a washing buffer plate in which each one of eight targets may have its own 
particular buffer, and the conjugation of biotinylated target onto streptavidin-coated 
paramagnetic beads.  Excess protein is removed from the beads by repeated washing of 
the conjugated beads via magnetic manipulation in a magnetic particle separator.   
This automated procedure is coded for one-to-eight selection targets, and requires 
less than an hour to prepare all the reagent plates required for a full eight-target selection.  
Not only do these procedures replace the roughly two-to-three hours required to perform 
these movements manually, but greatly increases the reproducibility of all scientists 
running in vitro selection experiments on the automated aptamer selections systems. 
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Appendix E:  Aptamer selection facility 
An Aptamer Selection Facility (ASF) has been built on the 4th floor of the Moffett 
Molecular Biology Building (MBB 4.402) in conjugation with the Institute for Cellular 
and Molecular Biology, as well as the College of Natural Sciences.  The ASF is an 
approximately 1,100 square foot space (Figure E-1) rated for Bio-Safety Levels (BSL) 1 
& 2, and licensed to possess 10 mCi of β-emitting radiation. 
 
Figure E-1.  Schematic of the Aptamer Selection Facility.  This floor plan illustrates the 
position of equipment within the ASF.  General areas are shaded blue; robotic 
workstations are shaded pink; a ‘clean bench’ area for preparing robotic in vitro selection 
experiments is shaded yellow; and a ‘dirty bench’ area for archiving and handling post-
selection products is shaded orange.  Controlling computer are indicated by a computer 




Currently, this research space houses four robotic workstations, but can be 
reconfigured to house five total.  The workstations are integrated onto optical-grade 
worktables to prevent calibration errors that occur from vibrations caused by rapid 
acceleration / deceleration events.  Each robot has its own dedicated computer controller 
and peripheral set. 
The first and second workstations are Beckman Coulter Biomek 2000 laboratory 
automated workstations that we have custom outfitted to perform automated in vitro 
selection experiments.  This includes a computer-controlled thermalcycler with a remote 
connection dock for a smaller footprint, an orbital microplate shaker, a microplate 
vacuum filtration system, and an in-house constructed enzyme cooler.   Additionally, 
these robots are equipped with a gripping tool that interfaces with an adjacent stacking 
carousel in order to provide new disposable tips and fresh reagents in real time.  These 
robots are each capable of performing six rounds of selection per day against one-to-eight 
selection targets in a completely automated and unattended fashion. 
The third robotic workstation is also a Biomek 2000 robot, and has had a dot-blot 
manifold custom integrated onto the worksurface.  The manifold device facilitates rapid 
execution of dissociation constant determination experiments or ‘Round 0’ buffer assays 
(Appendix D).  Additionally, this platform is also used to prepare reagent plates for in 
vitro selection experiments performed on the other two Biomek 2000s. 
Our fourth robotic workstation is a Biomek FX, a larger-scale platform capable of 
96-well pipetting.  This robot has an integrated gripping tool within the pipetting head, a 
vacuum filtration apparatus, microplate shaker, microplate incubator, and stacking 
carousel for disposable pipette tips.  This robot is most often employed for ‘brute-force’ 
pipetting procedures, such as multiple plate replication.  Technician Carlos Garcia is 
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currently planning to perform partially automated and then fully automated in vitro 
selection experiments on this robot in the future, providing a selection throughput of 
either 96 or 384 targets in parallel.   
GENERAL EQUIPMENT 
The ASF is furnished with basic molecular biology equipment to facilitate typical 
pre- and post-selection procedures (e.g., thermalcyclers, gel rigs, heating blocks, etc.).  In 
addition, a -80ºC freezer stores competent cells and archived cultures.  A Class II Type 
B1 continuous exhaust biological hood has been installed and is reserved for future tissue 
culture work.  Also, a CEQ 2000 XL capillary DNA sequencer (Beckman Coulter, 
Fullterton, CA) is installed and can be used with modified sequencing protocols in order 
to generate 192 aptamers sequences per day.   
The room contains one refrigerator, one freezer, and one ‘door-sliding’ 
refrigerator used for protein chromatography separations.  There are personal bench areas 
that serve as primary research areas for students that use the selection robots most often.  
Equipment benches provide dedicated areas for gel running and processing, manual 
vacuum filtration, etc.   
A ‘Round 0’ PCR flowhood is housed within a small room of this facility 
(Chapter 2).  This flowhood, which constantly expels air out of it, rather than into it, 
serves as our ‘cleanest’ environment where there exists the most minimal chance of 
amplicon contamination of the pre-selection reagents due to procedural controls, in 
comparison with any other area of our laboratory.  Buffer master mixtures and all native 
random pool handling is performed within the confines of this flowhood to ensure 
prevention of amplicon ‘infection’ of the native pool stocks or reagents prior to the start 
of an in vitro selection experiment.  In this fashion, we are more assured that any 
contamination is taking place at the bench or the robotic worksurface, rather than the 
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possibility of the entire selection pool being contaminated. Needless to say, it is easier to 
decontaminate a surface than to resynthesize an entire random pool. 
Environment and safety 
The ASF contains cleanroom-like environmental controls for temperature, 
humidity, and air cleanliness.  Humidity is kept constant between 30% – 40% by a series 
of four small industrial-scale dehumidifiers that drain into the sink.  Humidity is 
controlled in order to minimize the amount of condensation formed on the enzyme 
coolers.  In the past, excessive condensation has caused short-outs to occur on the 
peripherals located on the robotic worksurface (e.g. the automated tip-latch controller). 
Metal parts rubbing and interacting together in a dry environment tend to build up 
static electric charges quite rapidly, and accrue dust (and possible airborne contaminating 
amplicons) at a surprising rate.  Airborne particulate is removed by one large HEPA-rated 
air filter and two large particle ionizers that function in a constant duty cycle. 
The ASF meets all minimal safety requirements and also additional ones imposed 
by our own laboratory.  Two exits provide escape in the case of a fire, which would be 
combated manually with fire extinguishers or automatically by the sprinkler system.  An 
overhead shower and eye-wash station are installed for chemical emergencies, and a 
spill-kit is present inside the facility.  Additionally, lab coats, goggles, latex gloves, and 
nitrile gloves are provided as personal protection equipment. 
Radiation badges are provided to monitor and ensure minimal exposure to the 
beta radiation we use (32P) to monitor the RT-PCR and translation reactions on the 
aptamer selection system.  An automated selection will have 70 – 500 µCi of activity on 
the worksurface depending on the number of selection targets.  Because the robotic 
worksurface is an ‘open’ environment that is difficult to completely shield, we take great 
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pains to notify personal when large runs occur to the point of partitioning a portion of the 
room while the selection system is running.   
Additionally, we work very closely with the Radiation Safety Deputy in order to 
ensure that we are consistently functioning at safety levels much higher than the 
minimum legal requirement.  As an example, the Ellington laboratory is the second-
highest user of radiation on this campus.  As such, one might expect our work areas to 
have a greater amount of radiation contamination due to the large volume of radiation 
handled by so many students.  However, our extra safety procedures are so effective in 
preventing radioisotope contamination that the Office of Environmental Health and 
Safety often uses our laboratory space as a ‘showcase’ area when demonstrating safety 
procedures to external agencies (e.g., the Texas Department of Health and Safety). 
Electrical and communication connections 
The ASF has been constructed with five independent 25A 120V power lines 
suspended from the ceiling for each possible robotic platform.  The placement of an 
electrical conduit from the ceiling allows us to place the robots in the middle of the room, 
rather than directly adjacent along a wall like most laboratory equipment.  Such a 
configuration permits convenient access to the front, sides, and back of the workstations.   
In addition, circuit plugs line all the walls of the room, providing an isolated 20A 
120V circuit for each of the four walls.  This wiring was installed with the heavier 
electrical use of robotic equipment in mind, and the implementation of isolated circuits 
ensures that an electrical surge or blow-out from one robot will not affect any of the other 
robots or equipment currently in use in the facility.  For example, the dehumidifiers, rated 
at 18A, will sporadically pull more than 20A and blow their circuit.  However, because of 
the enforced electrical isolation, this has never directly affected an in vitro selection 
experiment. 
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Appendix F:  Prospects for biological computation 
When I joined the Ellington laboratory, one of the current research projects at the 
time was the investigation of the use of nucleic acids for purposes of mathematical 
computation.  Initially, I was attracted to the possibility of “DNA computation” or 
“biological computation” by the same characteristics that attracted mathematicians.  
DNA is easily manipulated in a molecular biology laboratory, it is a data storage 
molecule with a higher storage capacity (4-bit) than silicon memory (2-bit), and DNA 
already performs parallel processing.  That is, the function of hybridization is a 
technically energetic ‘parallel process’ whereby a mixed population of single-stranded 
DNA does not need to evaluate every single of piece of DNA in a tube in order to 
hybridize to its reverse complement.  Conversely, a computer given the same ‘problem’ 
needs to empirically match a test strand to the entire list of different strands in order to 
‘hybridize’ to the best matching ‘reverse complement’.   
However, it rapidly became apparent that DNA is a poor choice with which to 
attempt to perform computation.  For instance, previous students from the Ellington Lab 
have determined that the error rate for hybridization using short oligomers typical of 
biological computation is roughly 1 in 3,000 nucleotides[257].  This, of course, is many 
many many magnitudes higher than computational mistakes made by a current central 
processing unit (CPU) or a floating-point processing unit (FPU).  This, in part, suggests 
why organisms speed a significant amount of resources on genome repair.   
Provided below are two publications.  The first is a “Quick Guide” written by my 
advisor and myself to broadly introduce researchers to the subject of biological 
computation[258].  The second publication, a review written by myself, my advisor and a 
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former post-doctoral fellow details many of the tribulations inherent in using DNA as a 
mathematics-performing molecule[259]. 
“DNA computation function” 
“What is it?”  DNA computation is the generic term for computers made with 
DNA, not unlike the computers that are supposed to be on board the Star Trek ship 
Voyager. Current applications and film representations are equally fictitious. 
“What is it based on?”  It has been observed that 22 is four, and that four is the 
number of types of bases in a DNA molecule. Therefore, it seemed essential that DNA be 
tied in some way to computing, just as the fact that there are 64 codons in the genetic 
code has previously been tied to the I Ching. In fact, the idea that embedding either 
variables or instructions in DNA sequence, and then allowing those variables or 
instructions to act upon themselves to perform complex calculations, is a brilliant insight. 
The putative benefit of DNA computation is that many different operations can be carried 
out in parallel, rather than serially. 
“Does it work?”  The brilliant insight and initial implementation of DNA 
computation was by Len Adleman and co-workers at USC. In this implementation – a 
version of the ‘traveling salesman’ problem (a Hamiltonian Path problem) – the 
sequences of individual DNA strands represents cities and paths between cities. When 
strands hybridize, it represents the joining of two cities by a path. When an ‘answer’ of 
the correct length assembles, it represents the solution to the problem of how to pass 
through each city exactly once. 
“Then why aren't there DNA computers?”  While this was truly a brilliant insight 
and a very nice proof-of-principle, not all possible paths between cities were represented 
– a computer could have solved the equivalent problem in just under a nanosecond. There 
have been no further attempts to expand upon the number of cities and possible paths that 
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could be assembled. This may be because DNA is a terrible medium for computation: the 
error rates of assembly for any real set of oligonucleotides would be far in excess of the 
equivalent error rates in silicon. 
“But what about all that cool parallelism?”  Again, all that cool parallelism only 
works if you can make enough different oligonucleotides to solve an important problem, 
and you can be competitive with a real computer. For example, Richard Lipton at 
Princeton University hypothesized that the data encryption standard, DES, could be 
broken using a DNA computer… as long as you could make 7×1016 different 
oligonucleotides. Other researchers have suggested that the necessary number of 
oligonucleotides for useful computations – 1070 – would be just slightly less than the 
number of particles in the Universe – 1080. Even Craig Venter would have problems with 
those projects. In fact, shortly after Lipton hypothesized that a superhuman effort to 
synthesize bathtubs full of DNA could break DES, it was in fact broken… using 
conventional computers in a highly parallel fashion. 
“Maybe DNA computers are good for other things?”  That's probably true, as long 
as those things aren't computation. While there have been a number of other extremely 
clever implementations of DNA computation, for the most part these have been based on 
the same ‘hybridization logic’ that Adleman originally conjured, and are ultimately 
limited for the same reasons. However, methods that attempt to use DNA computers to 
interface with biology may have some interesting applications. For example, a simple 
DNA ‘AND’ gate that could release or regulate the synthesis of insulin based on a 
combination of physiological signals – high blood sugar, low glucagon levels –  might be 
a useful device for diabetics. Such DNA computation, though, is already carried out on a 
daily basis by the pancreas of non-diabetic individuals. 
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“So we need to focus on cellular computers?”  Some folks certainly think so. But 
at some level a cellular computer is really no different than metabolism and gene 
regulation. 
“The Complexities of DNA Computation” 
Abstract 
Over the past few years, a handful of insightful researchers have bridged the gap 
between biological computing theory and actual DNA-based computation. By using 
ingenious encoding techniques and clever molecular-biological manipulations, simple 
versions of computationally complex problems have been experimentally approached or 
resolved. However, the technical problems revealed during the execution of these 
scientific set pieces make it unlikely that DNA will ever rival silicon for the solution of 
any real-world problem.  
Introduction 
Following the demonstration by L. Adleman[260] that a directed Hamiltonian-
path problem (HPP) could be encoded in DNA and evaluated, the use of nucleic acids for 
computational purposes has been the focus of extensive speculation. Proponents 
hypothesize that, as nucleic acid hybridization is akin to massively parallel computation, 
DNA computers may have an inherent, although currently unrealized, superiority over 
silicon-based computers. Thus, computationally hard problems [like the nondeterministic 
polynomial-time complete (NP complete) set of problems] may be soluble with a linear 
increase in time for additional variables in an equation or nodes in graph, rather than the 
polynomial or exponential increase in time that constrains silicon-based computers[261]. 
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The lure of bypassing mathematical constraints has led to DNA being touted as an 
appropriate computational medium for problems ranging from the simplistic addition of 
two binary integers[262] to the development of a working Turing machine[263-266], a 
hypothetical mathematical device created by Alan Turing in 1936 in order to model 
computation and perhaps the most powerful digital model of computation[267]. 
The reality is that, to date, no large, computationally complex problem has yet 
been encoded in DNA and solved by molecular-biology methods[268]. The failure of 
DNA to rival silicon may, in part, be the result of the nascent and evolving nature of the 
interactions between the molecular-biology and computer-science communities[269], but 
is more likely to reflect the inherent intractability of DNA as a computational medium. 
DNA computers 
All DNA computations so far attempted rely on what might be called 
‘hybridization logic’: the ability to encode and solve computational problems by forming 
correct base pairings and avoiding incorrect base pairings. Hybridization logic is not the 
only possibility for DNA computation – for example, an alternative approach that we will 
examine below is the use of nucleic-acid enzymes as parts of nucleic-acid logic circuits; 
in this case, it would be catalytic transformation, rather than hybridization, that would 
drive computations. 
Furthermore, DNA computations can be loosely classified as ‘generative’ or 
‘subtractive’: generative DNA computations build correct sequence solutions from 
component oligonucleotides, usually via the molecular-biology operations of 
hybridization, ligation and amplification; subtractive DNA computations remove 
incorrect sequence solutions from large solution sets, usually via the molecular-biology 
operations of hybridization, cleavage with endonucleases or RNase H, and amplification. 
So far, most computational-biology experiments have focused on attempting to solve 
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classic, computationally complex problems, such as the HPP, the satisfiability problem 
and the maximal clique problem. 
The Hamiltonian path problem 
NP-complete problems are a subset of NP problems in which all possible paths 
(variables, nodes etc.) must be separately evaluated. As the complexity of NP-complete 
problems increases linearly, the time required to solve them increases exponentially. 
Thus, NP-complete problems can generally only be solved by a ‘brute-force’ approach. 
In order to determine whether massively parallel DNA computations might prove 
useful for the solution of NP-complete problems, Adleman[260] encoded and evaluated a 
particular type of computationally complex, NP-complete problem, the HPP, using a 
generative algorithm. Abstractly, the HPP explores a given graph, attempting to 
determine if a path exists in which all of the nodes are visited or traversed once (Figure 
F-1). Using silicon-based computers, the amount of time required to solve this problem 
becomes huge with the number of nodes still in the double digits, owing to the 
exponential increase in hierarchical possibilities with the addition of each node. Adleman 
encoded a graph that contained seven nodes connected by six edges, using one set of 
oligonucleotides that represented the nodes and a partially overlapping, complementary 
set of oligonucleotides that represented the edges connecting these nodes. The 
oligonucleotides were allowed to hybridize in solution and ligated together into paths. 
The paths were amplified and then successively sieved, again by hybridization, to 
determine whether paths that contained all nodes at least once were present. The presence 
of an oligonucleotide that met these demands correctly revealed that a Hamiltonian path 
through the graph did exist.  
C A T TG A T C A G C G …… A C T A T TA C G T A T
N6
G T AA G C C T A G C T A G CA T T A G
N5
A T AA T G C A T A C A T T CG G A T C G A T C G T AA T C G T A A C T A G TC
P4 5 P5 6
N4  
Figure F-1.  Hamiltonian Path Problem.  The graph to be encoded is shown on top.  The 
Hamiltonian path is represented as red lines and paths off the Hamiltonian as green lines.  
A representation of the nucleic acid encoding process is illustrated on the bottom.  A 
unique 20-mer sequence represents a node, and paths between nodes are encoded so that 
the last (3’-most) ten bases of the path leading to a node are complementary to the first 
(5’-most) tend bases of the next node, while the path leading away from a node is 
complementary to the last ten bases of the node.  In the example shown, the path P4→5 
hybridizes to the last half of node N4 and the first half of node N5. 
The maximal clique problem 
Ouyang et al.[270] encoded and evaluated another type of NP-complete problem, 
the maximal clique problem, using a subtractive algorithm. A clique is defined as the 
group of nodes in which all the nodes are joined to all other nodes by some edge, 
according to a given graph (Figure F-2). The maximal clique is the clique with the largest 
number of nodes.  
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As in Adleman's experiments, a graph was encoded using oligonucleotides but, in 
this case, each node had a binary possibility: present (an oligonucleotide) or absent (no 
oligonucleotide). Thus, when the nodes were linked by hybridization and ligation, the 
resultant oligonucleotides were not paths between nodes but sets of extant, connected 
nodes. Illegal connections (as determined by the initial graph) and short cliques were 
removed from the population using restriction enzymes specific for the encoded edges. 
The remaining nodes were amplified and the shortest amplified product was the maximal 
clique. The size of the PCR product indicated how many nodes were present in the 
maximal clique and sequencing the product showed which particular nodes were part of 
that clique. 
P6 V5 P5 V4 P4 V3 P3 V2 P2 P1 P0  
Figure F-2.  Maximal clique problem.  The graph to be encoded is shown on the top.  The 
nodes in Figure F-1 were meant to be visited in sequence but the nodes in this graph are 
to be grouped into sets.  A clique is a set of nodes in which all the members are 
interconnected; the maximal clique in this graph are highlighted with green lines; all 
other edges are shown as black lines.  A representation of the nucleic acid encoding 
process is shown on the bottom.  Oligonucleotide spacers of length 20 (defined as Pn) 
were synthesized to mark the positions of data bits.  The actual value of the data bits 
(defined as Vn) was (arbitrarily) set to ten nucleotides long for a value of one and zero 
nucleotides long for a value of zero.  The maximal clique for the encoded graph is the 
binary value 111100 and would be represented as a 180-mer oligonucleotide that contains 




However, Ouyang et al.[270] did not truly solve a computational problem in the 
same way that Adleman did: smaller cliques already known not to be maximal were 
removed from the set of sequence solutions prior to amplification. In other words 
information outside the bounds of the DNA computation itself was used to solve the 
problem. 
The ‘knight problem’ 
Richard Lipton has proposed that DNA computation could be applied to solve 
another type of NP-complete problem, the satisfiability problem (SAT)[271]. In this class 
of problem, logical expressions of any length or complexity are evaluated to determine 
whether there exists a set of values that can satisfy (make true) the expression. The 
solution of SAT problems increases exponentially in time with the linear addition of 
variables. Lipton suggested a method for both encoding SAT problems in DNA and 
evaluating these problems using standard nucleic acid manipulations, such as 
hybridization, ligation and restriction digestion[271]. 
Using Lipton's schemes as a starting point, Cukras et al.[272] have encoded a 
subset of an NP-complete SAT problem, the ‘knight problem’, in another informational 
biopolymer, RNA. This problem queries a chessboard of size n × n squares about how 
many possible ways a knight can be placed on it so that no other knight on the chessboard 
may attack it (Figure F-3). Even though Cukras et al. have not yet set up the experiment 
in an NP-complete format, it is a significant advance in the field of biological computing 
for three reasons.  
First, the researchers have demonstrated that RNA can be used as readily as DNA 
for molecular computation. Second, it is an excellent example of a subtractive algorithm, 
in which correct answers are isolated from a pool of all possible answers. The same pool 
can potentially be reused for other problems or the same problem set up in a different 
configuration. Third, the pool is a mixture of complex RNA words that are linked 
together in binary strings by a synthetic strategy akin to the ‘pool and split’ strategies 
used for the construction of peptide libraries. This strategy or others, such as the synthesis 
of DNA-word libraries on chips[273], may in the future allow the ready construction of 
the large, encoded oligonucleotide sets that will be required for the evaluation of truly 
computationally complex problems.  
PR E FI X SUFF I XBIT 10SPAC E R 9SP A CE R 2BI T 2SPAC E R 1BIT 1
Figure F-3.  The ‘knight problem’.  An example of a ‘correct’ chessboard is given on the 
left, in which no knight is in a position to attack any other knight; an incorrect chessboard 
is shown on the right.  The format by which both of these representations are encoded is 
shown on the bottom.  Ten sequence elements representing bit values are separated from 
one another by nine spacers, similar to the set-up of the maximal clique problem 
described in Figure F-2.  The ten-bit binary string is flanked by prefix and suffix elements 
to facilitate amplification.  Incorrect answers (those in which the knights can attack one 
another) are removed by RNase H digestion.  
Integer addition 
Any computer, whether based on carbon or silicon, would presumably have to be 
capable of performing routine mathematical calculations, such as addition. To this end, 
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Guarnieri et al.[262] have developed a generative algorithm that is able to add two non-
negative rational binary numbers. Their algorithm is clever in the fact that the encoded 
DNA strand acts as both the operator of the reaction and a register of the 
reaction/addition history. It even allows for ‘carrying the one’ and adding a new place 
digit. However, it does not allow addition to occur in a parallel fashion, the main reason 
one might choose a biologically-based computing system over a silicon-based one. 
Problems with DNA computations 
Although the methods described above are novel and clever, their scope and 
power is extremely limited. Any problem that would give pause to a supercomputer can 
only be resolved as a DNA computation using a large number of specifically-encoded 
oligonucleotides. The HPP was encoded with 20 oligonucleotide strings, a maximal 
clique problem was encoded in 28 strings[270], a binary addition was carried out with 
seven strings[262] and a method for encoding DNA words was tested with 108 
strings[273]. 
Physical limitations 
Following the publication of Adleman's paper, a rash of critical letters to the 
editors were published some months later. One group of researchers stated that a HPP 
with 23 nodes would start to require kilogram quantities of DNA[274]. Going further, 
another group estimated that if the number of nodes was increased from 7 to 70, then the 
amount of DNA required to solve such a problem would require 1025 kg of nucleic 
acids[275]. It was also argued that, even though Adleman was able to solve a small, 
seven-node HPP, this does not imply that a DNA computer could be used to solve ‘real-
world problems’ because the practical difficulties of encoding and manipulating large 
ensembles of oligonucleotides are not taken into account[276]. One critic goes on to 
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estimate that an extensive combinatorial database would require nearly 1070 
nucleotides[276]; by comparison, the universe is estimated to contain roughly 1080 
subatomic particles. 
Decryption 
An example of a proposed real-world application for DNA computation that now 
seems inaccessible is the attempt to break the data encryption standard (DES). DES is the 
cryptographic algorithm developed by IBM and the US National Bureau of Standards in 
the early 1970s to provide multiplatform computer data security. The current DES system 
entails a password that the user chooses, which is used to create a 56-bit encryption key 
that ‘scrambles’, or encrypts, a 64-bit message that can only be ‘descrambled’ 
(decrypted) with the intended recipient's 56-bit key password[277, 278]. 
Boneh et al.[279] suggest a DNA computation that might be capable of breaking 
this system without knowing the password. However, their approach is intractable for two 
reasons. First, the number of DNA strands necessary to decrypt any piece of information 
that was encrypted using a 56-bit key would be roughly 7×1016, and these would not be 
random strands but strands encoded with specific information. It is currently unclear how 
any encoded ensemble of this size could be realistically synthesized. That 
notwithstanding, the DES has become outdated and is far surpassed by commercial 
encryption software such as Pretty Good Privacy (PGP). The latest version of this 
software package (6.0) defaults to generating password keys of 2048 bits, with the ability 
to generate keys up to 4096 bits long. According to Boneh et al.'s decryption algorithms, 
breaking PGP's 4096-bit key would require 24096 (101233) strands of DNA, which would 
require a volume of roughly 101216 liters (at ~0.17 µM). 
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Accuracy 
To determine whether large, computationally complex problems might eventually 
be attempted using DNA as a medium, we devised a search algorithm in which over 16 
million possible sequence solutions were simultaneously appraised in order to find a 
single correct sequence solution. Irrespective of whether the search algorithm was 
evaluated using chemical ligation[280] or enzymatic ligation, a variety of incorrect 
answers were returned with the correct answer. 
The average error rate during the evaluation of the algorithm was on the order of 
three mistakes per dodecamer sequence solution. As there are 5940 three-mutant variants 
(from the formula {[12!/(9!3!)] × 33}) of the correct sequence solution, the error rate for 
the search algorithm carried out with a dodecamer pool could be calculated – 5940 three-
mutant variants and 16,777,216 oligonucleotides to be considered, implying 
approximately one wrong oligonucleotide per 2824 oligonucleotides considered[281]. 
This number approaches some estimates of the frequency of mistakes generated by Intel's 
formerly flawed Pentium chip (up to 1 mistake in 105 divisions), although it is still far 
from Intel's own estimates of the frequency of mistakes (1 mistake in 9x109 
divisions)[282]. 
Alternatively, the number of mistakes yielded by this DNA computation can be 
estimated as the number of wrong answers produced per correct answer, rather than per 
operation performed. In this case, the error rate for DNA computation with a dodecamer 
pool would be 5940 wrong oligonucleotides ligated in place for every correct sequence 
solution. Although the large number of errors that accumulated during the evaluation of 
our search algorithm does not bode well for the evaluation of large, computationally 
complex problems using DNA, it should be pointed out that lower error rates may be 
possible, for example by the introduction of error-correction procedures[269, 283] and 
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that, under some conditions, our search algorithm behaved flawlessly. However, the 
optimization of the algorithm to reach such conditions was both idiosyncratic and 
lengthy, both anathema to the concept of a general computational device. 
Prospects for DNA computation 
Although DNA may not be a useful medium for computational problems, this 
does not mean that computations or logical evaluations should not be carried out with 
DNA. Instead, the problems that are approached using DNA should be redefined to be 
relevant to DNA itself. Such approaches frequently move away from the ‘hybridization 
logic’ inherent in DNA encoding schemes. For example, Conrad and Zauner[284] 
describe a method whereby binary integers might be encoded as B- and Z-DNA 
fragments, and the ‘value’ of an encoded oligonucleotide might be read by circular 
dichroism, and Kulic[285] has suggested encoding values via the linking number of 
supercoiled DNA. 
Along the same lines, by coupling analyte-binding aptamers to the hammerhead 
ribozyme, Breaker has developed ‘aptazymes’ that can return a catalytic signal (RNA 
cleavage) dependent on whether analytes are present[286]. Similarly, a ‘molecular 
transistor’ has been developed that can read one sequence signal and catalytically return 
another sequence[287]. This ‘transistor’ consists of an RNA ligase that is allosterically 
activated by an oligonucleotide effector. In the presence of the ‘read’ effector, the ligase 
‘writes’ a ligation product. Moreover, the ‘transistor’ has recently been augmented with 
the aptazyme chemistry pioneered by Breaker to make a molecular ‘And’ gate that can 
simultaneously read oligonucleotide and small-molecule effectors and ‘write’ a ligated 
product[287]. Such molecular devices may be the basis for new types of computation in 
which operations as well as information are encoded in discrete molecules. 
 282
Nucleic acid-based computation is obviously still not as practical as its silicon 
counterpart. Nonetheless, great strides have been made, in that a method that was mere 
speculation a few years ago has now spawned numerous proofs-of-principle. As the 
interactions between computer scientists and molecular biologists flourish, faster and 
more accurate biological-computing algorithms will continue to evolve. However, the 
problems inherent in nucleic-acid-based computation make it unlikely that time-
consuming or complex algorithms will ever be conveniently addressed. Instead, nucleic 
acid computation may find extremely important reflexive applications, in which they will 
serve as ‘integrated circuits’ that measure biological signals (e.g. insulin levels), decide 
between a limited set of desired outcomes (e.g. too little or too much insulin) and 
transduce biological function (e.g. release or retain insulin).  
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